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ABSTRACT
Soy protein isolate was hydrolysed with gastrointestinal enzymes, pepsin and 
pancreatin. The hydrolysate (SPH) was sequentially fractionated using ultrafiltration 
(UF), gel filtration (GF) and high performance liquid chromatography (HPLC) and 
tested at each stage to select the bioactive fractions. All fractions were tested for 
antioxidant activity by the peroxide value and TEARS methods in a linoleic acid 
containing system. Compared to the untreated control the GF fraction (GFF36) 
significantly decreased (p < 0.05) TEARS production to 0.02 pg/ml like synthetic 
EHT. Further purification with HPLC did not improve the antioxidant activity 
(TEARS 0.13 pg/ml).
Investigation of the mechanism of antioxidant activity showed that SPH and the 2 kD 
fraction scavenged superoxide, hydroxyl radical and DPPH free radicals and chelated 
iron. SPH showed hydrogen peroxide scavenging activity. The 2, 5 and 10 kD 
fractions demonstrated copper chelating activity in a copper-pyridine pyrocatechol 
system. The 2 kD fraction also formed complexes with copper and catalysed ascorbic 
acid oxidation. Affinity chromatography purified fraction (P4 fraction) from SPH 
chelated copper. Additionally, 300 pg/ml P4 prevented copper dependent LDL 
oxidation (antioxidant activity 54.57%); however, this was less effective than the 
GFF 36 fraction which had 56.84 % antioxidant activity at only 10 pg/ml.
All soya fractions exhibited ACE inhibitory activity, especially the UF and GF 
fractions containing smaller peptides. However, further purification by HPLC to 
three fractions (HPF15, 16 and 17) showed less activity than the parent GFF 57 
fraction. The ACE inhibitory activity values for the SPH, 10 kD, 5 kD, 2 kD, GFF 57 
and HPFs 15, 16 and 17 fractions were 17.70, 29.50, 43.66, 58.87, 84.68, 32.18, 
44.07 and 20.86 % respectively.
The 2 kD fraction had anti-proliferative properties in caco-2 cancer cell line but not 
in normal HCEC line. The 2 kD fraction was toxic and increased ROS production in 
caco-2 cells at high concentrations and blocked the cell cycle at GO/Gl phase at the 
tested concentrations. In contrast, the 2 kD fractions showed antioxidant activity in
normal HCEC cells at 10, Sand 5 pg/ml, and protected them against peroxide tBHP 
and oxidized methyl linoleate toxicity.
In the endothelial cancer EA.hy 926 cell line, the 2 kD fraction was toxic at all tested 
concentrations except 0.0001 mg/ml as determined by the MTT assay. The 2 kD 
fraction did not protect EA.hy 926 cells against cytotoxic effects of tBHP. Flow 
cytometry showed ROS production did not change in cells treated with tBHP and 2 
kD fraction compared to those treated with 2 kD alone indicating the possible 
protective effect of 2 kD; i.e 2 kD fraction overcome the toxicity of tBHP with 
regards to ROS production. Further, morphological changes were observed in EA.hy 
926 cells treated with 2 kD fraction, 2 kD +tBHP and tBHP compared to the 
untreated cells, confirming their toxicity. Nitric oxide production (marker for 
hypertension) was decreased in EA.hy 926 cell line treated with 2 kD fraction.
Fractions from soy protein isolate comprising potent peptides and possibly 
polyphenols demonstrated antioxidant, antihypertensive and anticancer properties in 
vitro', these fractions could be developed further as neutraceuticals.
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1.0 GENERAL INTRODUCTION
1.1. Protein structure
Proteins play a significant role in biological systems and evolution. Although the 
information necessary for evolution is within the DNA, enzymes are important 
proteins that catalyse biochemical processes. Besides, proteins are structural 
components of cells (such as elastin, keratin). The structure of a protein specifies its 
function (Damodaran, 2008). In all organisms, from bacteria to human beings, 
proteins are made up of about 20 different amino acids. An amino acid comprises an 
amino group, a earboxyl group and an R group that charaeteiizes the different 
properties of the amino acid (figure 1.1). The R groups of amino acids vary in size 
and structure and can affect protein solubility. Based on the properties of the R group 
or the side chain, amino acids are categorized into five major groups:
1) Amino acids wich possess nonpolar, aliphatic R groups: glycine, leucine, 
isoleucine, valine, proline and alanine and methionine.
2) Amino acids containing aromatic side chains are phenylalanine, tryptophan 
tyrosine.
3) Polar, uncharged R groups are found in: serine, threonine, cysteine, 
asparagine and glutamine.
4) Lysine, arginine, and histidine are amino acids possessing positively charged 
R groups.
5) Negatively charged R groups are found in aspartate and glutamate (Nelson, 
2008).
H H O
I I I I
H—N—C—C—OH
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R
Figure 1.1. Structure of an amino acid
Four levels of structure exist in proteins namely, primary, secondary, tertiary and 
quaternary structure (Damodaran, 2008).
1.1.1. Primary structure
The primary structure of the protein is the order in which amino acids are bound 
together to make the polypeptide chain (Ritter, 1996) via amide or peptide bonds. 
Thus, an amino group from one amino acid forms a peptide bond with a carboxyl 
group from another amino acid by the removal of one molecule of water (figure 1.2).
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Figure 1.2. Binding of amino acids via peptide bond
The resulting peptide shows directionality since all amino groups are on the same 
side of the a-carbon and all carboxyl groups on the other side. Therefore, at one end 
of the protein there will be a free amino group, which is known as the N-terminus, 
and at the other end a free carboxyl group or the C-terminus (Lodish, 2008).
1.1.2. The secondary structure
The secondary structure is the repeating spatial arrangement of amino acids at special 
parts of the polypeptide chain. Two forms of secondary structure are seen in proteins: 
the a-helix and extended (3-sheets (Damodaran, 2008).
I.I.2.I. The a-helix
The a-helix is a spiral structure in the polypeptide chain in which each oxygen of the 
carbonyl group is bound to the amide-hydrogen of the amino acid four residues 
farther via a hydrogen bond (figure 1.3). All the amino and carboxyl groups within 
the a-helix are bonded in this way except for the amino acid residues at the very 
beginning and at the end of the chain resulting in the formation of the helix. The 
hydrogen-bonded oxygen and hydrogen atoms in the a-helix give the polypeptide 
chain a very stable and rod-like cylinder form in which the R groups or the side 
chains point outwards from the chain ( Lodish, 2008).
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Figure 1.3. The a-helix structure of the proteins
I.I.2.2. p-sheets
Another type of secondary structure is the P-sheet, which is a fully extended segment 
of the polypeptide. Unlike the a-helix, the hydrogen bonds in the P-sheet occur 
between atoms of two separate sheets not in the same strand. The P-sheets, like the a- 
helices, have directionality, which is defined by the orientation of the peptide bond 
i.e. in a sheet the beta strands can be oriented in the same direction or in the opposite 
direction (Lodish, 2008).
1.1.3. Tertiary structure
The tertiary structure is the three-dimensional arrangement of the atoms in a protein. 
Unlike the secondary structure, the tertiary structure considers sequences of amino 
acids in a longer-range aspect. In the secondary structure of proteins, amino acids 
may interact within the folded structure to give the tertiary structure. The most 
important determinant forces for tertiary structure are hydrophobic forces (Nelson, 
2008).
1.1.4. Quaternary structure
Proteins having two or more polypeptide chains, different or identical, arrange in 
three-dimensional complexes, giving the quaternary structure. Proteins with 
quaternary structures can exist as dimers, trimers and tetramers which are the 
subunits of the protein (Nelson, 2008).
1.2. The soybean
Soya beans have been a part of Asian cuisines for many years, but have had a less 
significant role in the Western diet (British Nutrition Foundation 2002). The soybean 
plant (Glycine Max), was cultivated in China for the first time. Soya beans are 
economically important since they provide good quality protein. Soya beans contain 
a mixture of storage proteins (globulins) and other active proteins such as Kunitz- 
trypsin inhibitor. Bowman -Birk trypsin and chymotrypsin inhibitor. A variety of soy 
products are available now including soy infant formula, soy milk, soy flour, isolate 
and concentrate. Moreover, a number of soy foods including tofu, miso, tempeh 
(fermented products) and soy drinks are available. Due to the beneficial effects 
reported, the consumption of soy foods is increasing (De Mejia and De lumen, 2006; 
(Friedman and Brandon, 2001).
1.2.1. Nutritional composition of soybeans
1.2.1.1. Macronutrients 
Protein
Proteins comprise almost 40% of the soybean (De Mejia and De Lumen, 2006). The 
soybean seeds provide good quality protein. In order to evaluate the quality of the 
proteins, WHO and FDA introduced protein digestibility corrected amino acid score 
(PDCAAS). To find a value for protein quality, the PDCAAS uses an amino acid 
score based on the requirement of amino acids for 2-5 year old children along with a 
correction factor for protein digestibility. Generally, beans have a reasonable 
PDCAAS, but the overall value might be reduced due to their lower digestibility. 
The PDCAAS value for soy protein isolate and soy flour is 95 and 86 (WHO 
technical reports). The highest possible PDCAAS is 1.00 (Messina, 1999). The 
methionine (an essential amino acid) content of soybean is low. Besides, the 
methionine content is further decreased during food processing and storage, reducing 
the nutritional quality of the soy products. Therefore, soybean products are fortified 
with methionine. Moreover, efforts are being made to produce soybeans which can 
over-express the L-methionine (Friedman and Brandon 2001). Metabolism of 
sulphur amino acids, such as methionine, results in the production of hydrogen ions, 
which cause demineralisation of bones and excretion of calcium in the urine. 
Therefore, methionine deficiency in soybean seeds is an advantage (Messina, 1999).
Fat
The amount of lipid in beans is low and about 5% of the energy comes from the fat 
in beans. The two exceptions are chickpea and soybeans; 15% and 47% of the energy 
is provided through the fat content. The predominant fatty acid in beans is linoleic 
acid (7-8%); however, they contain a small amount of a-linolenic acid. Since the 
overall fat content of the beans is low, their contribution to a-linolenic acid is low. 
The ratio of linoleic acid to a-linolenic acid is 7.5:1. The low content of a-linolenic 
acid of soybeans could be compensated by consumption of full fat soy products. 
Linoleic and a-linolenic acids need to be consumed through the diet (Messina, 1999).
Fibre
Fibre is a heterogeneous material that is classified as fermentable-soluble and non- 
fermentable-insoluble (Burkhalter et a l, 2001). Beans, including soybeans, are good 
source of soluble and insoluble fibre. Consumption of high-bean and high fibre diets 
in hypercholesterolemic individuals has been proved to decrease the serum 
cholesterol levels. Beans have a low glycémie index due to the fibre content 
therefore; beans are suitable for diabetic patients (Messina, 1999).
1.21.2. Micronutrients
The micronutrient and macronutrient composition of some beans, including soybean 
is given in the table 1.1. Beans are high in folate and iron. A serving of beans contains 
more than the recommended dietary allowance (RDA) for folate. Although beans are 
a good source of non-heme iron, their bioavailability of iron is low and, therefore, 
their role as a source of iron is diminished. Bioavailability of zinc from legumes and 
beans is good and is around 25%. Calcium bioavailability among legumes and beans, 
including soybeans, is generally 20% (Messina, 1999).
Bean Protein 
% of 
Energy
Fat 
% of 
Energy
Dietary
fibre
g
Riboflavin
lig
Folate
lig
Ca
lig
Zn
lig
Fe
lig
Chick pea t7 .3 ,22$ 2.2,15 2.9 50 141 40 1.26 2.37
Kidney 7.7, 27 0.5,4 3.2 50 115 25 0.95 2.60
Lentil 9.0, 31 0.4,3 4.0 75 179 19 1.25 3.30
Soy bean 14.3,38 7.7,47 0.9 25 47 138 0.99 4.42
Pinto 7.0, 24 0.5,3 3.4 80 147 41 0.93 2.24
Table 1.1. Micronutrient and macronutrient content of beans. Amounts represented 
in the table are per serving size, which is « 90 g or 1/2 cup boiled beans (fMinimum 
value, $ Maximum value) (Messina, 1999).
I.2.I.3. Non-nutritive and anti-nutritional factors of soybean
The non-nutritive compounds in soya are trypsin inhibitors including Kunitz trypsin 
inhibitor and Bowman-Birk trypsin and chymotrypsin inhibitor (a serine protease), 
lectin or hemaglutinnins and phytates. Kunitz trypsin-, Bowman-Birk trypsin and 
chymotrypsin inhibitors interfere with protein digestion through inhibiting digestive 
enzymes and result in nutritional deficiencies. The amount of these factors varies in 
different soy products. Non-nutritive factors are removed during industrial food 
processing and moist-heat treatment at home. Lectin or haemagglutinins, which are 
present in red kidney beans and other legumes including soya are able to damage red 
blood cells and intestinal cells, causing symptoms like nausea, vomiting and 
diarrhoea. Phytates present in soybean bind to minerals like, zinc, iron and 
magnesium and decrease their bioavailability (British Nutrition Foundation, 2002).
Isoflavones are flavonoids common to legumes. Two major isoflavones in soya are 
daidzein and genistein and their concentration depends on the variety of soybean, 
geographical conditions, and the extent of soybean processing. Glycosides of 
genistein and daidzein are found in the human diet. Intestinal bacteria can modify 
isoflavones which be absorbed and undergo hepatic metabolism. Isoflavones in the 
human diet mainly come from soybean, although they are present in other legumes in 
lower quantities.
I.2.I.3.I. Structure o f soy isoflavones
Genistein and daidzein and their glycosides are the isoflavones found in soybeans 
(Ho et a l, 2002). Figure 1.4 demonstrates structure of soy isoflavones. Basically, 
flavonoid structure is composed of two benzene rings (A and B) (flavone nucleus) 
which are linked together via a pyrane C-ring. The flavonoids are classified based on 
the position of their B ring. If the B ring is linked via the 3^  ^position of the C-ring, 
the flavonoid is called an isoflavone. Genistein and daidzein are the primary 
isoflavones in soybean followed by their glycosides genistin and daidzin. In case of 
glycosides, the sugar moiety is linked to the 7 position of the A-ring (Messina, 1999).
HO,
“OH
HO,
OH
Daidzein
(4',7-dihydroxyisoflavone)
Genistein
(4',6,7-trihydroxyisofiavone)
Figure 1.4. Structure of soy isoflavones.
1.2.1.3.2 Physiological effects o f isoflavones
It is reported that isoflavones have positive effects on endothelial function. Feeding 
soy protein containing isoflavones significantly improved vascular function in rhesus 
female monkeys compared to soy protein without isoflavones. Intravenous 
administration of genistein produced similar results in female monkeys (Honoré et 
a l, 1997).
In spontaneous hypertensive rats (SHR), the animal model of essential hypertension, 
soy protein was reported to attenuate blood pressure (Nevala et a l, 2000) whereas 
isolated isoflavones could not change blood pressure (King and Head, 2000). Several 
human studies investigated the effects of soy protein (with different isoflavone 
content) on blood pressure (Burke et a l, 2000; Hodgson et a l, 1999). These studies 
mostly show that soy protein is involved in reducing blood pressure and the role of 
isoflavones was uncertain.
Isoflavones have been proved to have estrogenic activity. There are two types of 
estrogen receptors: ER-a and ER-p. Isoflavones tend to bind to ER- P more than ER- 
a. The expression of these two receptors varies in different tissues, which explains 
why isoflavones have different roles. Apart from their estrogenic activity.
isoflavones have antioxidant, antiproliferative and antiangiogenic activity. The last 
two activities are related to cancer and cell differentiation and angiogenesis. The 
richest source of isoflavones among beans is soybeans (British Nutrition Foundation, 
2002).
Studies have shown that isoflavones have in vitro antioxidant activity (Lai and Yen 
2002; Kerry and Abbey, 1998). Results obtained from in vivo studies show that 
isoflavones cannot inhibit oxidation of low density lipoprotein probably due to the 
inability of isoflavones to incorporate into low density lipoprotein (Samman et a l,
1999). On the other hand, soy protein seems to increase plasma total antioxidant 
potential (Bazzoli, 2002). Isoprostanes are markers of lipid oxidation in the plasma 
and soy protein is capable of decreasing the isoprostane concentration in the plasma 
(Wiseman et a l, 2000) whereas isoflavones alone do not have this effect (Djuric et 
al, 2001). The metabolism of isoflavones influence their in vivo antioxidant 
activities. Soy protein with isoflavones can reduce oxidative stress but further 
research needs to be done to clarify role of isoflavones (Hodgson, 2003).
1.2.2. Soy protein products
Defatted soy flakes are the starting material to make soy protein products. Soybeans 
are dehulled and defatted with a solvent which is removed prior to making protein 
products. Soy protein products are not consumed directly, but they have other 
applications. For example, they are used as ingredients in bakery, meat and dairy 
products. Moreover, they are used in infant formula and milk analogs (Barac, 2004).
Soy protein products comprise soy flour, soy protein concentrate and soy protein 
isolates. Low cost, easy availability and high nutritional value are factors which 
affect the high acceptance of soy products such as soya isolates and concentrates. It 
is the composition and structure of the soya proteins, which affect the quality of the 
soya products (Barac, 2004). Soy flour contains 50% protein and is grouped as low 
fat, high fat and defatted soy flour. Soy protein concentrate is made through alcoholic 
extraction of defatted soy flour and contains 70% protein. The residue includes 
insoluble carbohydrates. Soy protein concentrate is treated with acid followed by
alkali to make soy protein isolate; this results in removing soluble and insoluble 
carbohydrates and produces a refined product with invaluable functional properties. 
The protein concentration of soy protein isolate is about 90%. Soy potein isolate is 
used to make meat analogs, infant formulas and dairy product (Liu, 2004).
1.2.3. Soya proteins
The major proteins in soya are storage proteins, which are globulins and are 
classified based on sedimentation rate; they include 2S, 7S, IIS, and 15S. The main 
storage proteins are 7S and IIS, which comprise about 87% of the soluble proteins. 
Their content varies among different varieties of soya beans (Barac, 2004). Among 
soy proteins, only the IIS and 15S are pure proteins (Wang and De Mejia, 2005). 
Table 1.2 shows the different protein fractions of soya along with the composition of 
each fraction.
Protein fractions Extractable protein (%) Protein content of the 
fractions
15S 10 polymer of glycinin
l i s 33
glycinin
78 33 bcta-conglycinin 
gamma- conglycinin 
a-amylasc 
lipoxygenase 
lectins
28 20 kunitz trypsin inhibitor 
BBI
cytochrome C 
a-conglycinin
Table 1.2. Protein fractions of soybean and their composition (Wang and De Mejia, 
2005).
Glycinin (IIS) with a molecular weight of 360 kD, is a hexagon made up of 6 
subunits. Each subunit has an acidic and basic polypeptide, which is attached via
10
disulfide bonds except for the subunit A4, p -Conglycinin is the major protein of the 
7S fraction which has 3 subunits named a-, a'-, and p interacting together to produce 
7 isomers. The molecular weight of 7S fraction is 150-180 kD and basically it is a 
glycoprotein. The carbohydrate moiety includes 38 molecules of mannose and 12 
molecules of glucoseamine, which are attached to the N-terminal of the protein 
(Barac, 2004).
Glycinin( IIS) <— The main storage soy proteins p-conglycinin (7S)
subunits A„Bn Bo-Be
i
acidic polypeptide basic polypeptide (a, a 'p2, ap2, aa 'p , tt2P, aza, as)
Ai-Ag B1-B4
Figure 1.5. Main storage protein fractions of soya and their subunits.
1.3. B ioactive peptides
Aside from providing essential amino acids and energy, proteins provide the body 
with bioactive peptides, that have additional health benefits. In the process of protein 
degradation to amino acids, entry of dietary protein into the stomach stimulates 
gastrin secretion from the gastric mucosa. Gastrin itself stimulates parietal cells to 
secrete hydrochloric acid which denatures the proteins and causes the peptide bonds 
to be accessible to enzymes. Pepsinogen converts to pepsin by autocatalytic 
cleavage. Pepsin cleaves the peptide bonds at the aromatic amino acid residues Phe, 
Trp, and Tyr and produces small peptides from polypeptides. Further hydrolysis 
continues in the small intestine (Nelson, 2008).
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Proteins exert their physiological role either directly or after enzymatic hydrolysis in 
the gut. Proteins are sources of bioactive peptides with health effects. Peptides that 
are released from the protein become active. This can be done through enzymatic 
hydrolysis in the digestive tract, through fermentation process or by using enzymes 
derived from microorganisms. Their activity depends on their size and amino acid 
composition and sequence. Many bioactive peptides are multifunctional (Pihlanto, 
2006). In structure-function relationships of the peptides, peptide size is of 
significant importance. The size of the peptides depends on the degree of hydrolysis. 
For instance, antimicrobial peptides have 20-46 amino acid residues and ACE- 
inhibitory peptides contain 2-12 amino acids but sometimes 27 residues have been 
identified (Qi et a l, 2007). To produce peptides with a very small size (<1 kD) the 
degree of hydrolysis (DH) should be 50-70% (Damodaran, 2008).
1.3.1. Physiological functions of soybean-derived bioactive peptides
It is accepted that soy is effective in preventing certain types of diseases and some of 
these effects have been ascribed to proteins and peptides. Although the European 
Food Safety Agency ( EFSA) has denied the stablished relationship between 
consumtion of soy protein isolate reduction of blood LDL-cholesterol concentrations, 
but it has been proved that soy-derived bioactive peptides have hypocholesterolemic 
and hypotiiglyceridemic effects as well as being hypotensive, anticarcinogenic, 
antioxidant and capable of regulating food intake.
1.31.1. Hypocholesterolemic and hypotriglyceridemic effects of soy peptides
Pepsin-digested soy protein has the highest bile-acid binding activity among plant 
proteins. This effect has been attributed to high molecular weight peptide fractions. 
Upon digestion and release, they bind to bile acids, inhibit their re-absorption, 
increase bile-acid faecal excretion, and reduce cholesterol levels (Sugano, 2005). A 
high molecular weight peptide purified with microbial protease from soya was able 
to decrease the serum cholesterol levels by binding to conjugated bile acids and 
increase its faecal excretion (Sugano et a l, 1990). A peptide, synthesized from 127- 
150 in 78 globulin of Croksoy R 70 (a commercial soy concentrate low in
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isoflavones) was able to enhance the LDL uptake and degradation (Lovati et ah,
2000). Besides, soy 7S fraction has been shown to increase LDL uptake in Hep-G2 
cells which was dose-dependent. The IIS  had a lesser effect, which was not dose- 
dependent. These effects were attributed to the up-regulation of LDL-receptors and 
clearance of LDL from plasma (Lovati et al., 1992).
1.3.1.2. Fat-regulatory intake and anti-obesity effects of soy peptides
The anti-obesity effect of soy peptides may involve an increase in the metabolism of 
lipids. It has been postulated that a certain type of peptide or amino acid sequence is 
responsible for the anti-obesity effects of soy protein (Sugano, 2005) by stimulating 
fat metabolism. This effect has been attributed to the 7S fraction (p- conglycinin), 
which increases p-oxidation in the liver and consequently faecal excretion of 
triglycerides. All these effects have been attributed to the specific amino acid 
composition of the 7S fraction (Sugano, 2005). Some bioactive peptides are satiety 
signals (Pupovac and Anderson, 2002). In vivo studies have shown the inhibition of 
food intake using soy protein. A high fat diet containing soy protein, given to mice 
for 13 weeks, showed that mice gained less fat compared to those on a high fat diet 
without soy protein (Jang et a l, 2008). Peptides with an arginine residue are capable 
of stimulating the release of cholecystokinin. The synthetic peptide 
VRIRLLQRFNKRS, corresponding to residue 51-63 of p-conglycinin P-subunit, 
stimulates the release of cholecystokinine (CCK), the peptide hormone, and therefore 
suppresses the food intake (Sugano, 2005).
1.3.1.3. Anticarcinogenic effects of soy peptides
The incidence of cancer in societies consuming soybean products is lower than those 
not consuming soya products. It has been suggested that soy proteins and peptides 
might be effective against carcinogenesis. Two potease inhibitors, Bowman-Birk 
trypsin and chymotrypsin inhibitor (BBI) and kunitz trypsin inhibitor (KTI) are 
capable of suppressing cancer and metastasis although other components such as 
isoflavones have been proved to have anticarcinogenic properties. Bowman-Birk
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inhibitor, a trypsin and chymotrypsin inhibitor is a protein of 8000 Da which can 
prevent the process of initiation in carcinogenesis (Kennedy, 1998; Sugano, 2005). 
Anticarcinogenicity of BBI is due to the ability to prevent release of oxygen free 
radicals. Also, the antiinflammatory ability of BBI could be responsible for its anti­
carcinogenic activity since cancer and inflammation are inter-related (Kennedy, 
1998). A new anticarcinogenic peptide isolated from soya is lunacin. It is effective 
against chemical carcinogens both in vivo and in vitro. Lunacin bioavailability does 
not change via oral administration; therefore, its oral administration is possible for 
cancer patients. Lunacin does not affect cells with normal growth and established 
cancer cell lines. It selectively kills newly formed cell lines (de Lumen, 2005).
I.3.I.4. Hypertension and antihypertensive peptides
It was stated by the U.S. Food and Drug Administration that eating 25 g of soy 
protein along with low fat, low cholesterol foods may decrease the risk of heart 
disease, a major health problem. Hypertension, (systolic blood pressure > 140 mm 
Hg, and diastolic blood pressure > 90 mm Hg) is a health problem and can lead to 
atherosclerosis, stroke, and coronary heart disease (Lo and Li-Chan, 2005). About 
one fifth of the global population suffer from hypertension. Hypertension rises with 
age and around 65% of aged people between 65-74 years in the Western countries 
are affected by high blood pressure. Diet therapy and life style modifications can 
attenuate hypertension. Moreover, consumption of fruits, vegetables and low-fat 
diets are influential in controlling hypertension (Vermeirssen et ah, 2004).
Angiotensin converting enzyme-inhibitory (ACE-I) peptides have been studied for 
their ability to decrease blood pressure. The antihypertensive peptides could be used 
as food additives in the food industry (Li et al., 2004). Several studies in humans and 
spontaneously hypertensive rats (SHR) reported the antihypertensive effect of 
bioactive peptides. Bioactive peptides could be used as nutraceuticals to prevent and 
treat hypertension. Compared to synthetic drugs, bioactive peptides have several 
advantages. They have no side effects, have low cost and can be included in the diet 
easily (Vermeirssen et al., 2004). The first ACE-inhibitory peptides were isolated 
form snake venom and had 5-13 amino acids and the C-terminal sequence in most of
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them was Ala-Pro or Pro-Pro. Peptide-based drugs are now commonly used to 
control hypertension (Li et al., 2004).
ACE is a membrane bound dipeptidyl carboxypeptidase enzyme that converts 
angiotensin I (a decapeptide) to an octapeptide angiotensin II, a potent 
vasoconstrictor, by removing the C-terminal dipeptides from Angiotensin I. It is 
found in many mammalian tissues such as vascular endothelial cells, absorptive 
epithelial cells and neuroepitheial cells and male germinal cells. It also has been 
found in the soluble form in the plasma, but it is thought to be the result of 
membrane-bound enzyme. ACE helps in releasing aldosterone, a steroid from the 
adrenal cortex, which causes sodium retention and increases the tendency for 
hypertension. Moreover, ACE is responsible for degradation of bradykinin, a 
vasodilator and blood pressure lowering agent. Therefore, ACE enzyme is a target of 
therapeutic approaches to treat hypertension (Li et a l, 2004; Rho et a l, 2009). ACE 
cleaves a dipeptide from the C-terminus of the oligopeptide substrates, which can be 
ACE inhibitors. To distinguish between real inhibitors and substrates, peptides are 
combined with ACE prior to measuring ACE-inhibitory activity. Based on this 
method, ACE -inhibitory peptides are divided generally into three groups:
1- True inhibitors: Peptides with an IC50 value (the concentration that inhibits 50% of 
the activity) that does not change after preincubation with ACE.
2- Prodrug-type inhibitors: Upon action of ACE, these peptides will convert to true 
inhibitors after digestion with gastrointestinal proteases.
3- The substrate group: Peptides with weak activity or no activity, which are cleaved 
by ACE (Li et a l, 2004).
Binding to ACE is strongly dependent on the tripeptide at the C-terminus of the 
peptide. The C-terminal tripeptide interacts with the three subsites SI, ST and S'2 at 
the active site of the enzyme. ACE prefers hydrophobic amino acid residues at the C- 
terminal positions. It has been demonstrated in many studies that potent inhibitory 
peptides possess phenylalanine, tyrosine, tryptophan or proline at their C-terminus 
and branched aliphatic amino acids at their N-terminus. An important factor in 
determining the inhibitory activity of the peptide is the hydrophobic-hydrophilic
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property of the peptide. Moreover, for a strong inhibitory activity, the amino acid 
adjacent to the proline at the C-terminus must be a hydrophobic one (Li et al., 2004).
1.3.1.4.1. Components o f the renin-angiotensin-aldosterone-system (RAAS)
The RAAS cascade starts with the production of renin in juxtaglomerular cells (JG 
cells), which are present in the afferent and sometimes efferent kidney arterioles. 
Renin produced as preprorenin, is converted to its active form by removing a 43- 
amino acid peptide fragment which is located at the N-terminus of the prorenin. 
Renin is stored in JG cells granules and is secreted via an exocytic pathway into the 
systemic circulation.
The first step of the RAAS begins with the cleavage of the large molecular weight 
globulin, angiotensinogen, from the N-terminus to produce the decapeptide 
angiotensin I. Angiotensinogen is produced primarily in the liver although its 
mRNA expression occurs in different tissues too. The liver produces angiotensinogen 
constantly so there are no acute changes in plasma concentration of this protein.
In addition to converting angiotensin I to angiotensin n, ACE is also involved in 
metabolizing some vasodilators such as bradykinin and kallidin to inactive 
metabolites. Therefore, functionally, ACE increases vasoconstriction and decreases 
vasodilation. Other products like Ang IE and Ang IV are produced from Ang II by 
removal of the peptides from its N-terminus by amino acid peptidases A and N in the 
kidney and brain. Ang III is a heptapeptide formed from Ang II by removing the first 
N-terminus amino acid for maintenance of the blood pressure in the brain. Ang IV 
cooperates with Ang II in increasing blood pressure. Four types of angiotensin 
receptors have been described. Many physiological functions of the angiotensin H, 
including its effects on the cardiovascular system are mediated by the type-1 
receptor; it helps to control Ang Il-related cell proliferation and cell growth. The 
type-II receptor is active during foetal life and its expression decreases in the adult 
but, despite the reduced expression, it might be involved in vasodilation and 
antiproliferative and apoptotic effects in vascular smooth muscles. The role of the 
type-3 receptor is not understood yet. The type 4 receptor controls the secretion of
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plasminogen activator inhibitor 1 by Ang II as well as N-terminal truncated peptides 
(Ang ni and Ang IV) (Atlas, 2007).
1.3.1.4.2. Gastrointestinal absorption o f the peptides
The ACE-inhibitory activity of the peptides does not confirm their antihypertensive 
activity. For effective antihypertensive properties in vivo, a peptide should be 
absorbed through the intestinal tract with no degradation. Many peptides having 
inhibitory effect do not exert antihypertensive activity since they are degraded by the 
digestive enzymes after oral administration or by the plasma peptidases and cannot 
reach the target organs. It has been proved that C-terminal peptides containing 
proline residues can withstand gastrointestinal enzymes and, more specifically, 
tripeptides having two proline residues are potent antihypertensive agents since they 
are resistant to proline-specific peptidases. Therefore, to be effective in controlling 
hypertension, a peptide must be absorbed in its intact form. By contrast, some 
peptides that have weak in vitro inhibitory activity become potent inhibitors after 
oral administration, probably because they are prodrug type inhibitors. These 
inhibitors become active after digestion with gastrointestinal proteases (Vermeirssen 
et al., 2004).
Pepsin (pH 2) starts protein digestion in the stomach. Then polypeptide cleavage 
continues in the small intestine by enzymes such as trypsin, a-chymotrypsin, elastase 
and carboxypeptidase A and B. It results in the production of the oligopeptides and 
free amino acids. Free amino acids are absorbed in the small intestine via transport 
systems. Oligopeptides are cleaved further by four different enzymes at the brush 
border of small intestine:
1- Aminopeptidase N and A: cleave the oligopeptides from the N-terminus of neutral 
and anionic amino acids,
2- ACE: cleaves the oligopeptides from the C-terminus with proline, phenylalanine 
or leucine at the ultimate point.
3- Dipeptidyl amino peptidase IV: cleaves the penultimate N-terminal proline or 
alanine (Vermeirssen et al., 2004).
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Therefore, many released peptides are of x-proline type. Tri- and dipeptides are 
absorbed through the brush border more favourably compared to free amino acids. 
One of the peptide transporters is PepTl, which uses an electrochemical proton 
gradient to transfer peptides with broad specificity (Vermeirssen, et a l, 2004).
In the cytoplasm of enterocytes, different peptidases, including aminopeptidase, 
which cleaves the peptides from the N-terminus and iminopeptidase or prolidase with 
specificity for the x-proline or hydroxyproline type peptides, are present. Peptides 
can enter the portal circulation via different mechanisms:
1- Large water-soluble peptides can enter paracellularly from the tight junctions 
between the cells.
2- Hydrophobic peptides can enter via passive diffusion and transcellular pathway.
3- Peptides may also find a way to the cells by endocytosis and vésiculation.
4- Some peptides may enter via carrier-mediated route through a peptide transporter 
(Vermeirssen et a l, 2004).
1.3.1.4.3. Studies on ACE-inhibitory peptides
Several investigations have focused on the isolation of ACE-inhibitory peptides 
from different food sources, using different enzymes including pepsin, pancreatin, 
chymotrypsin and microbial proteases. An ACE-inhibitory peptide was purified from 
tofuyo using Monascus purpureus acid protease, the key enzyme in the production of 
tofuyo. This is an aspartate proteinase, which is similar to pepsin (Kuba et al., 2005).
Pepsin and pancreatin have been used to purify ACE-inhibitory peptides from soya. 
To be an ACE-inhibitor, hydrophobic and aromatic amino acids must be present at 
the C-terminus of the peptide. Since pepsin cleaves the peptide at the carboxyl end of 
hydrophobic and aromatic amino acids, it produces peptides with such amino acids at 
the C-terminus (Lo and Li-Chan, 2005). Pepsin has been used to purify the ACE- 
inhibitory peptides form sunflower protein isolate. The isolated peptide belonged to 
helianthinin, the IIS  storage protein of sunflower seed (Megias et al., 2004). 
Antihypertensive peptides have been isolated from different food sources such as 
douchi, a fermentation product of soya procured in various parts of China. It is
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mentioned that tripeptides with branched chain amino acids at the N-terminus and 
amino acids proline, tryptophan, phenylalanine, and tyrosine are the most suitable 
ones for ACE inhibitory activity. The C-terminus of the tri-peptides can interact with 
the subsites SI and 82 of the ACE molecule and inhibit substrate binding (Fan et al., 
2009).
Three ACE-inhibitory and antihypertensive peptides were purified from casein. Two 
peptides had tyrosine residues at the C-terminus and one had proline at 
antepenultimate position, which had been shown to increase binding to the enzyme. 
The importance of the proline residue in the antepenultimate position had been 
demonstrated in other studies by isolating peptides such as NLHLPLPLL which was 
found in sodium caseinate hydrolysate digested with L.helveticus NCC2765 
(Contreras et al., 2009).
1.4. Oxidation and antioxidants
1.4.1. Free radicals and antioxidants
In scientific and biomedical literature, the term free radical is used for those species 
that are generated through excited states or free radical reactions. A free radical is an 
independent-existing species which has one or two unpaired electrons. These 
unpaired electrons make the free radical very unstable since they need an electron to 
become stable (Willcox et al., 2004). These are very short half-life species (ms, [is, 
ns)
1.4.2. Antioxidant defence systems
Antioxidants are substances capable of neutralizing free radicals. Antioxidants are 
substances that delay or prevent (at low concentration) oxidation significantly 
(Willcox et al., 2004). Antioxidants could be categorized as endogenous and 
exogenous antioxidants.
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I.4.2.I. Endogenous antioxidants
Endogenous antioxidants comprise various enzymes like superoxide dismutase 
(SOD), catalase, glutathione peroxidase. Some antioxidant enzymes can exist in 
membrane, cytosolic and plasma forms, the level and location of which are critical 
for cell survival (Willcox et al., 2004).
I.4.2.2. Exogenous antioxidants
Diet plays a pivotal role in providing natural antioxidants. Vegetables, herbs, spices, 
and fruits are good sources of antioxidants. Generally, dietary natural antioxidants 
can be divided into three groups:
1- Vitamins, such as E, C, and P-carotene.
2- Phenolic compounds.
3-Essential minerals like zinc, selenium, manganese and copper, which are part of 
the antioxidant enzymes. For instance, SOD contains zinc and glutathione peroxidase 
contains selenium (Kasase, 2009).
Antioxidants are provided through diet in synthetic forms. They include butylated 
hydroxytoluene (BHT), butylated hydroxyanisole (BHA), butylhydroquinone (BHQ), 
and propyl gallate (PG). Antioxidants exert their influence by forming stable 
phenolic compounds which neither catalyse the other molecules nor react with 
oxygen (Kasase, 2009). Butylated hydroxytoluene is a synthetic phenolic compound 
which is used as an antioxidant in the food industry as a food additive. It has 
preventive and enhancing effects on cancer development, since it can act either as a 
prooxidant or antioxidant (Sharma and Bhat, 2009). Phenolic antioxidants form 
stabilized phenolic radicals, which are not able to catalyse other molecules (Kasase, 
2009). BHT exerts its antioxidant activity by donating a hydrogen atom to the free 
radical and breaking the chain reactions (Fujisawa et al., 2004).
Diet affects the oxidation process by providing substrates. For example, 
polyunsaturated fatty acids (PUFA), which contain two or more double bonds, are 
prone to oxidation and free radical attack. Therefore, the presence of antioxidants 
next to the double bonds will result in oxidation of the antioxidant instead of the free
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radical. Besides, the fat in the diet determines membrane lipoprotein fatty acids. The 
beneficial effects of olives and olive oil rely on the presence of monounsaturated 
fatty acids with fewer double bonds available for oxidation (Willcox et al., 2004).
Antioxidants can be divided into primary and secondary antioxidants. Those 
classified as primary or chain-breaking antioxidants act by inhibiting or delaying the 
initiation step of oxidation chain reactions through reaction with a lipid radical or 
react with peroxyl or alkoxyl radicals and inhibit the propagation step. Secondary or 
preventive antioxidants delay oxidation reactions rates through different ways such 
as by the quenching of the singlet oxygen.
1.4.3. Different lines of defence mechanism
Prevention, interception and repair are three main defence mechanisms against 
reactive oxygen species and free radicals.
1.4.3.x. Prevention
Prevention of the formation of reactive oxygen species (ROS) occurs at all levels of 
life from the planktons in the sea to the human being. Prevention can be achieved in 
several ways. Metal sequestering proteins are classified as preventive antioxidants. 
Prevention against ultraviolet radiation may occur through specific pigments such as 
melanin. The whole turnover of the intestinal cells (intestinal mucosa), which are 
exposed to oxidative damage continuously, prevents spreading of the reactive species 
to other cells (Sies, 1993).
1.4.3.1.1. Metal sequestering proteins
Metal chelation by metal sequestering proteins such as transferrin, ceroluplasmin, 
and ferritin is an example of prevention. Metal ions have a central role in lipid 
oxidation; therefore, these proteins prevent the oxidation reactions catalysed by metal 
ions (Sies, 1993).
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1.4.3.1.2. Superoxide dismutase
Superoxide dismutases (SOD) are enzymes found in all aerobic organisms. Four 
types of SODs exist. Namely, SODs containing copper and zinc at the active site; 
iron-containing; nickel-containing and manganese- containing. Mammals contain 
three types of superoxide dismutases, CuZnSOD in the cytoplasm, MnSOD in 
mitochondria and extracellular SOD. SOD works by dismuting the two molecules of 
superoxide to yield one molecule of oxygen and one molecule of hydrogen peroxide 
(Kasase, 2009).
1.4.3.1.3. Catalase
Catalase converts the hydrogen peroxide to molecular oxygen and water. Catalase is 
a heme-containing enzyme present in all organisms in cellular organelles called 
peroxisomes (Kasase, 2009).
1.4.3.1.4. Glutathione peroxidase
Glutathione peroxidase, a selenium containing enzyme, reduces hydrogen peroxide 
and organic hydroperoxides to water, alcohol and oxidized glutathione (Kasase, 
2009).
2GSH + H2O2 ^  GSSG + 2H2O 
2GSH + ROOH ^  GSSG + H2O + ROH
GSSG is harmful to cells; therefore NADPH converts it to its reduced form.
NADPH + + GSSG 2GSH + NADP+
1.4.3.2. Interception
Interception is the process of deactivation or stopping a free radical once it is formed 
and formation of the non-radical end-products. In the case of interception, the first 
objective is to deactivate the free radicals by antioxidants. The second objective is to
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transfer the radical to less sensitive sites in cells, which are less sensitive, for 
example, from a hydrophobic site to an aqueous phase i.e. from the membrane to the 
cytosol or from lipoprotein to blood plasma. In other words, antioxidants react with 
free radicals at the proper rate and, then, regenerate by interaction with the aqueous 
phase. Vitamin E and ascorbic acid are two interceptive antioxidants (Sies, 1993).
1.4.3.2.L Ascorbic acid
Ascorbic acid is a carbohydrate-like compound, highly polar, soluble in aqueous 
solutions and insoluble in nonpolar solvents. It has two isomers known as L-ascorbic 
acid and D-ascorbic acid. These two isoforms are exclusively used as food 
ingredients due to their reducing and antioxidant activities. In addition to its function 
as an essential nutrient it has been added to foods as a reducing agent and 
antioxidant. It protects oxidizable compounds by different mechanisms including 
reducing activity and free radical scavenging. L-ascorbic acid is oxidized to 
dehydroascorbic acid (DHAA) by two-electron oxidation and hydrogen dissociation 
and its concentration is a function of ascorbic acid oxidation. Oxidation of ascorbic 
acid can take place through processes: either a two one-electron transfer process or a 
single two-electron reaction without production of the intermediate 
semidehydroascorbic acid. In one-electron donation, one electron is transferred to 
form the stable free radical semi-DHAA. In the next step, one electron is lost which 
yields DHAA. Ascorbic acid is highly susceptible to oxidation by metal ions such as 
Cu^ ,^ Fe Factors accelerating the process are light and heat (Damodaran, 2008).
Interception is a useful strategy to deactivate free radicals, which do not have a very 
short life span or in other words, it is an efficient mechanism for radicals with life­
span extends into the range of seconds. Therefore, hydroxyl radicals cannot be 
intercepted because of a short life span (ns) and deactivating them via interception 
requires very high concentrations (up to 100 mM) of intercepting agents (Sies, 1993).
1.4.3.3. Repair
Since the prevention and interception are not effective enough to prevent damage 
occuring, oxidation products are continuously formed and accumulated. Therefore,
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repair mechanisms, such as different enzymes serve the repairing function. Damage 
to the DNA, lipid and proteins, all can be repaired with enzymes (Sies, 1993).
1.4.4. Oxidative stress and reactive oxygen species
Free radical generation is under control by various antioxidant mechanisms. When 
the body is under various environmental stresses such as pollutants, cigarettes, 
radiation, UV light and toxic chemicals, the balance between production and removal 
of free radicals may be disturbed which results in ‘oxidative stress’, the cause of 
more than hundred human diseases and ageing ( Devasagayam et al. 2004).
There is always a continuous low-level oxidative damage in our body. Our defence 
system is capable of managing it through up regulating the synthesis of antioxidant 
via alterations in gene expression. If there is over-production of free radicals, the 
production and removal of the free radicals will not be balanced. As a result cell 
injury and oxidative damage to different types of biomolecules including DNA, 
proteins, lipids and carbohydrates will occur resulting in different diseases including 
cancer, diabetes, cardiovascular disease and neurodegenerative disease (Willcox et 
al., 2004; Halliwell and Cross, 1994).
I.4.4.I. Oxidative damage to biomolecules 
Oxidative damage to DNA
ROS-dependent damage to DNA is called oxidative DNA damage which causes 
multiple modifications in DNA such as DNA-protein cross links. Oxidative DNA 
damage is involved in pathogenesis of some disease including neurodegenerative 
disease, cancer and ageing. DNA repair enzymes are responsible for correcting 
oxidative DNA damage. If the oxidative damage is left unrepaired, mutations will 
take place (Bohr, 2002).
Oxidative damage to proteins
Protein oxidation products are produced by reactive oxygen and nitrogen species. 
These products can generate other radicals by interaction with transition metal ions
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(Devasagayam et al., 2004). In mammalian cells, oxidative stress may result in 
increase in the plasma level of some ions including calcium and iron by damaging 
protein structures, which are responsible on keeping these ions intact. Iron ions 
increase the generation of the hydroxyl radical and DNA fragmentation can occur 
due to increase in the level of free calcium which activates endonucleases (Halliwell 
and Cross, 1994). Lipofuscin is an aggregate of proteins and peroxidized lipids 
which accumulates in the lysosomes of the brain cells of patients suffering from 
Alzheimer’s disease (Devasagayam et ah, 2004).
Oxidative damage to lipids
Lipids can undergo lipid peroxidation by free radicals. A large number of lipid by­
products are produced in the process of lipid peroxidation, which can have 
undesirable effects even in the sites away from the site of generation. Hydroxyl 
radical is highly reactive and can interact with most molecules in organisms. It 
initiates the lipid peroxidation process by abstracting and adding hydrogen, 
transferring electron from non-radical molecules and initiation of the oxidation 
process which can be summarized as follows (Willcox et al., 2004; Devasagayam et 
al., 2004).
In the initiation step (first step), the free radical abstracts a hydrogen atom adjacent to 
the double bond in the fatty acid, leaving the molecule with one unpaired electron:
LH + *0H —> *L + H2O
The new generated radical is an alkyl radical. When this free radical is formed, it 
stabilizes itself by delocalisation over the double bonds.
The second step, which is the propagation, has two reactions; a lipid peroxyl radical 
is generated through the reaction of the alkyl radical with oxygen. Oxygen is a 
biradical since it contains two electrons with same spin directions, which cannot be 
in the same orbital. The free radicals on oxygen can react with the alkyl radical.
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•L +O2 —> LOO*
In the next step, the high energy of the peroxyl radical allows it to attack another 
fatty acid molecule and abstract a hydrogen atom. Hydrogen addition to the peroxyl 
radical results in the formation of the lipid hydroperoxide and generation of another 
alkyl radical:
LOO* + LH *L + LOOH
The final step is termination, whereby lipid peroxidation is terminated by an 
antioxidant such as a-tocopherol (a-TOH) or by combination of two alkyl or peroxyl 
radicals to form nonradical species.
LOO* + a-TOH LOOH + a-TO*
*L + *L non-radical species
LOO* + LOO* —> non-radical species
Lipid oxidation products are divided into two distinct categories, primary and 
secondary products. Primary products are compounds (fatty acid hydroperoxides) 
that are produced in the initiation and propagation step of lipid oxidation. As 
oxidation proceeds, and during the later stages, the concentration of primary lipid 
products decreases since their decomposition rate becomes faster than their rate of 
formation. They are not volatile, and do not contribute to off-flavours and off-aromas 
of foods. Secondary products are compounds arising from decomposition of fatty 
acid hydroperoxides. They give the off-aroma and off-flavour of foods. Since it is not 
possible to measure all secondary products, the present methods measure a group or 
groups of them, for example carbonyl compounds. These methods have drawbacks 
and advantages. Under certain circumstances, for example, the use of antioxidants, 
concentration of the secondary products might be low. Moreover, some functional 
groups such as sulfhydryl group of proteins can react with secondary products and 
make it difficult to measure their concentrations. These are the drawbacks of
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measuring the secondary products in foods. The advantages of these methjods are 
that theyr are inexpensive, simple and fast (Damodaran, 2008).
1.4.5. Oxidative stress and cardiovascular health
Cardiovascular disease can be classified as coronary heart disease, cerebrovascular 
disease and peripheral vascular disease. Most cardiovascular diseases are secondary 
to atherosclerosis. Formation of the atheroma (atherosclerotic plaque) is a common 
feature in all the classifications. The nutrient and oxygen supply to the tissues is 
compromised in myocardial infarction and stroke, which are the acute manifestations 
of plaque formations (Fearon and Faux, 2009).
1.4.51. Pathophysiology of atherosclerosis
Atherosclerosis is a complex process of thickening of the arterial wall and narrowing 
of the lumen of the artery by accumulation of lipids, primarily oxidized lipids and 
cholesterol in the inner layer of the artery in combination with connective tissue and 
calcification (Mahan, 2004). Atherosclerosis begins with fatty streaks that are lipid 
deposits in the innermost layer of the arterial wall (intima). Fatty streaks are common 
during childhood. T-lymphocytes and monocytes enter the area from circulation to 
ingest the lipid particles. After engulfing the lipids, they die and a fibrous cap is 
formed on the fatty core by smooth muscle cells proliferation. The fatty core and the 
fibrous cap are called atheroma or plaque. The plaque grows and protrudes into the 
lumen of the artery and narrows the lumen and obstructs the blood flow. The plaque 
will resist blood flow. There is the possibility of the rupture of the plaque and 
hemorrhage to the plaque will form thrombus which, in turn will block the blood 
flow and lead to acute myocardial infarction or death of heart muscle (Bonetti et al., 
2003; Brunner, 2004).
The primary cause for onset of atherosclerosis is endothelial dysfunction, which is the 
result of injury to the endothelium. Endothelial dysfunction is abnormalities in 
vasomotor control, fibrinolysis, thrombosis, inflammatory response and growth of 
vascular smooth muscle cells. It is the endothelial dysfunction which allows 
accumulation of lipoproteins into the intima. Many risk factors, which are related to
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cardiovascular disease and atherosclerosis, are associated with endothelial 
dysfunction. For instance, hyperlipidemia, hypertension, diabetes and cigarette 
smoking result in excess production of reactive oxygen species and eventually 
oxidative stress. Angiotensin H, a potent vasoconstrictor and an important factor in 
onset of hypertension, stimulates proliferation of smooth muscle cells in the artery 
wall, increasing the risk of atherosclerosis. Endothelial dysfunction occurs when the 
bioavailability of the vasodilators is decreased compared to vasoconstrictors. Nitric 
oxide is a vasodilator which is produced from endothelial cells. Other functions 
attributed to nitric oxide are inhibition of platelet aggregation and smooth muscle cell 
proliferation and reduction of monocyte adherence. If the concentration of nitric 
oxide decreases, the likelihood of plaque rupture increases. Some of the reactive 
species react with nitric oxide and decrease its bioavailability, thereby increasing the 
risk of endothelial dysfunction and atherosclerosis. Reduced levels of nitric oxide are 
seen in patients suffering from chronic heart disease, hypertension, diabetes and 
smokers. Therefore, restoring nitric oxide levels is of great importance (Mahan, 
2004; Bonetti et al., 2003).
1.4.5.1.1. The initial steps in atherosclerosis
LDL enters endothelial cells (EC) via transcytosis, a process by which 
macromolecules are transported from the interior of a cell via vesicles. In the next 
stage, monocytes are attached to the endothelial cells via adhesion molecules like 
selectin. Activation-differentiation of monocytes to macrophages occurs in the 
intima.
For the initiation of atherosclerosis process, two steps are essential:
- Increased endothelial transcytosis of plasma LDL and other lipoproteins and their 
accumulation in the subendothelial area that is rich in proteoglycan,
- Movement of blood monocytes to the intima, which is increased with 
hyperlipidemia. Chemoattraction of monocytes is enhanced by monocyte 
chemoatractic factor (MCP-1), a protein generated from endothelial cells and smooth 
muscle cells. Oxidized LDL (ox-LDL) is a stimulating factor and chemoattractant.
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Moreover, ox-LDL inhibits migration, thus prolonging the time macrophages remain 
in the intima (Schwartz et al., 1991).
Formation of foam cells
Foam cells are macrophages containing oxidized LDL. Elevated plasma lipoproteins 
(LDL and other liporoteins such as VLDL) enter the endothelial cells (EC) via 
transcytosis or vesicular transport, become oxidized by reactive oxygen species, 
stimulate production of MCP-1 and attract monocytes from the circulation. 
Monocytes adhere to endothelial cells and move to the subendothelial space (SES) 
via direct guidance of MCP-1. Within SES, monocytes differentiate to macrophages, 
and through the scavenger receptors take up oxidized LDL and transform to 
cholesteryl-ester-rich foam cells (Schwartz et al., 1991).
Formation of fatty streak
The foam cells make close contact with endothelial cells and make a fatty streak 
under them. As a result, the EC becomes attenuated, thin and often distorted by the 
foam cells. Smooth muscle cells then move to the SES and take up lipoproteins. 
Formation of foam cells continues with up-take of oxidized LDL with scavenger 
receptors. Monocyte recruitment and attachment to EC continues .The plasma LDL or 
other lipoprotein concentration determines the development of the fatty streak to the 
atherosclerotic lesion. If the LDL concentration increases, the amount of LDL 
available for entry to endothelial cells and getting oxidized to form fatty streaks 
increases (Schwartz etal., 1991).
Lesion progression
When the influx of LDL exceeds the capacity of scavenger receptors to remove the 
oxidized -LDL, these particles accumulate in the intima and cause injury and death 
to EC and smooth muscle cells and macrophages. Damage to macrophages results in 
the secretion of lipid content into the extracellular part of the intima, generating an 
atheros or core composed of cholesteryl esters. Smooth muscle cells (SMC) of the
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plaque migrate from the media to the intima through the effect of chemoattractants 
and the lesion grows rapidly. Growth of the SMC is controlled by certain mitogens 
such as platelet-derived growth-factor (PDGF) and similar compounds derived from 
endothelial cells, macrophages and the SMC themselves. PDGF regulates cell growth 
and division, which are key factors in angiogenesis (Schwartz et al., 1991).
Several natural antioxidants delay LDL oxidation in vitro. These include peptides 
(Davalos et a l, 2004; Lee et a l, 2005), vitamin C (Retsky et al., 1999), and 
polyphenols (Aviram and Fuhrman, 1998).
Sum m ary and aim s
Due to greater awareness of a direct connection between diet and health, there is 
substantial interest by the public to consume healthier food options which can 
decrease development of chronic diseases. To avoid the side effects of chemical 
medicines, it is attractive to use less harmful options and natural resources.
The aim of this study is to investigate ACE inhibitory and antioxidant properties of 
soya protein hydrolysates and peptides in cell-free systems and cell culture and, in 
particular to prepare soy protein hydrolysate and its fractions with lower molecular 
weight with ultrafiltration and chromatography techniques in order to study:
1. Antioxidant activity of the fractions in linoleic acid model system.
2. Mechanism of antioxidant activity.
3. Metal chelating activity of the fractions and assessing the ability of the 
fractions in preventing LDL oxidation.
4. ACE inhibitory properties.
5. Anti-cancer activity in caco-2 cells and antioxidant activity in HCEC line and 
EAhy-926 cell line.
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CHAPTER 2
2.0 ANTIOXIDANT ACTIVITY OF 7S AND IIS PROTEIN 
FRACTIONS OF SOY BEANS, SOY PROTEIN HYDROLYSATE 
AND RELATED PEPTIDE FRACTIONS
2.1. Introduction
Lipid peroxidation in foods is responsible for deteriorating food quality, rancidity, 
unpleasant taste, smell and texture. Consumption of rancid foods containing 
oxidative products may contribute to serious medical conditions such as 
cardiovascular and Alzheimer’s disease and diabetes mellitus. Free radicals arising 
from lipid oxidation are capable of attacking vital molecules such as lipids, proteins 
and DNA (Naqash and Nazeer, 2010). Several antioxidants delay or prevent the 
oxidative damage from free radicals including synthetic antioxidants such as BHT 
and BHA. Since synthetic antioxidants are not totally safe to use in biological 
systems and food, there is a trend to find safe antioxidants among natural sources 
(Liu et al., 2010). Synthetic antioxidants are regulated as they may be unsafe in high 
concentrations; therefore, research has recently focused on developing natural 
antioxidants that are effective but not toxic (Naqash and Nazeer, 2010) such as 
ascorbic acid, vitamin B, plant polyphenols and, more recently, bioactive peptides.
Bioactive peptides, proven to have antioxidant activity, can prevent oxidation 
reactions in the human body and food (Correa et al., 2011). They are usually 
composed of 2-20 amino acids their function depends on their molecular weight, 
amino acid composition and sequence (Liu et al. 2001; Klompong et al., 2007). 
Bioactivity of the peptides might be related to the presence of individual peptides or 
synergistic effects of the combination of peptides (Correa, et al., 2011). Antioxidant 
peptides have been purified and investigated from squid, fish and chicken (Kasase, 
2009; Sarbon, 2011), egg yolk, sunflower protein (Ren et al., 2010), chickpea 
protein hydrolysate (Zhang et al., 2011) milk proteins (Pihlanto, 2006), catfish
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protein isolate (Theodore et ah, 2008), com gluten meal (Li et al., 2008), whey 
protein hydrolysates (Pena-Ramos and Xiong, 2001) and gelatin hydrolysates from 
sea cucumber (Wang et al., 2010). In this study, the antioxidant activities of 
hydrolysates derived from soy protein isolate as well as cmde 7S and IIS fractions 
and their hydrolysates purified from soy beans were examined.
2.2. M aterials
Soya beans (500 g) were purchased from Tesco supermarket, Guildford. Soy protein 
isolate was obtained from Kerry ingredients, Bristol, UK. Pepsin, pancreatin, n- 
hexane, petroleum ether, Sephadex G-25 resin, trifluoroacetic acid (TFA), 
acetonitrile, ethanol, linoleic acid, ferric chloride, thiobarbituiic acid, 
tetraethoxypropane, BHA and BHT, genistein, daidzein, genistin, daidzin and 
formononetin, formic acid, zinc acetate and potassium ferrocyanide were purchased 
from Sigma-Aldiich, Dorset, UK. Viva spin ultracentrifuge cartridges were obtained 
from Sartorius Ltd. Epsom, Surrey, UK. The remaining chemicals were purchased 
from Fisher Scientific, Loughborough, UK. All the chemicals except TFA and 
acetonitrile were analytical grade.
2.3. M ethods
2.3.1. Purification of 7S and IIS  protein fractions from soya beans
Dry soya beans were blanched in boiling water for 15 min and transferred to cold- 
water to help remove the skins. The husk was removed by normal mbbing and the 
beans were oven-dried at 65 °C overnight and ground to flour which was passed 
through a fine sieve to obtain fine flour (Khetarpaul et al., 2004). The fine flour was 
defatted with «-hexane (soy flour/hexane =1:5, v/v) for 1 h. The mixture was 
centrifuged at 8000 x g, 15 min, 4° C. The process was repeated for the precipitate 
twice more. The defatted flour was used for protein extraction (Khetarpaul et al., 
2004).
The defatted soya flour was dispersed in Tris-HCl (0.065 M, pH 7.8) and stirred for 
90 min at 22 °C (the soy flour:Tris-HCl =1:20). The suspension was then centrifuged
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at 15000 % g, for 20 min at 20°C. The pellet was removed and the supernatant was 
adjusted to pH 6.6 with 2 M HCl and dialysed against 0.065 M Tris-HCl at the same 
pH for 24 hours at 4°C. The suspension was centrifuged at 15000 x g for 20 min and 
2°C and the precipitate (IIS fraction) was collected, washed and freeze-dried. The 
supernatant was diluted twice with ice-cold water and adjusted to pH 4.8 with 2 M 
HCl. Next, the solution was centrifuged at 6500 x g, for 20 min at 4°C and the pellet 
was washed twice and the pH was adjusted to 7.5 and then freeze-dried (Comfort, 
1995).
2.3.2. Enzymatic hydrolysis of soy protein isolate
Soy protein isolate was dissolved in distilled water (protein to water ratio 1:25) and 
the pH was adjusted to 2.0 by 1 M HCl. The digestion process was started by adding 
pepsin (1:25 enzyme to protein ratio) at 37° C. After 1 h, pepsin was deactivated 
using NaHCOa 0.9 N. Then, the pH was adjusted to 7.5 by 1 M NaOH and 
pancreatin was added (1:35 enzyme to protein ratio). After 2 hours, the sample was 
heated in a boiling water bath for 10 min and then centrifuged at 12000 x g for 15 
min. The supernatant was collected and freeze-dried and kept at -80° C for further 
use (Kasase, 2009).
2.3.3. Determination of protein content by the Kjeldahl method
A sample aliquot (0.6-1 g) to be analysed for protein content was weighed on a filter 
paper and placed in kjeldahl tubes. Two selenium tablets and 20 ml of 95-97% 
sulphuric acid were added two each tube. The tubes were placed in the Kjejldhal 
digestion systems (Digestion system 6, 1007 Digester) which were pre-heated to 
450° C. The samples were digested for 3 h. Distillation of the samples was done 
automatically in a Kjeldahl nitrogen distillation unit (Foss Kjeltec ™ 2200), with 
adding 70 ml of water and 20 ml NaOH (40% w/v), for 3 min. The produced 
ammonia was collected in 30 ml 4% boric acid in the receiver flask. Hydrochloric 
acid was (0.05 M) to titrate the receiver solution. The amount of nitrogen and protein 
was calculated using the following equation:
%N = [100 X (ml of titrant of sample) x 0.0014] / gram of sample 
%protein = N x 5.8 (Milton and Dintzis, 1981).
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2.3.4. Fat analysis by Soxhlet extraction
The sample to be analysed (~ 1 g) was weighed into a thimble. The thimble was 
placed in the metal collection cup to which 100 ml of petroleum ether was added. 
The thimble was inserted into the Soxhlet instrument (FOSS Soxtec ™ 2055). The 
lipids were extracted by heating and condensing of the solvent for 60 min. The 
instrument rinsed the thimbles before solvent evaporation. After evaporation, the 
thimbles were weighed and % fat in the sample was calculated using the weight of 
the sample before and after defatting.
2.3.5. Membrane ultrafiltration
A soy protein hydrolysate solution (1% in distilled water) was prepared and 
fractionated sequentially using 10, 5, and 2 kD Vivaspin ultrafiltration cartridges by 
centrifugation (3500 x g, 35 min). The fractions were collected after centrifugation 
and freeze dried (Kasase, 2009).
2.3.6. Gel filtration cbromatograpby
The 2 kD fraction was dissolved in 50 mM sodium phosphate buffer (40 mg/ml) and 
loaded on a column (2.5 x 90 cm) (GE Healthcare, Buckinghamshire, UK), which 
was previously filled with Sephadex G-25 resin. The column was equilibriated with 
50 mM sodium phosphate buffer (pH 7.0) prior to connecting to the FPLC 
instrument (Dionex Ultimate 3000 FPLC system). The fractions were collected in 5 
ml tubes at 1 mFmin within 10 h. The absorbance of each collected fraction (5 ml) 
was monitored at 215 and 250 nm on the FPLC system and at 215 nm on a 
spectrophotometer separately (Kasase, 2009).
34
2.3.7. High performance liquid chromatography
The most bioactive fraction based on antioxidant activity ( see 2.4.4) from gel 
filtration chromatography was dissolved in 0.1% TFA in distilled water (10 mg/ml) 
and loaded on a Partisil 10 ODS-1 C l8 (9.5 mm x 500 mm) preparative reversed 
phase HPLC column (RP-HPLC) (Whatman pic, UK) which was connected to the 
FPLC system. Two buffers were used to elute the fractions, 0.1%TFA in distilled 
water and 0.1% TFA in acetonitrile. The flow rate was 1 ml/min with a linear 
gradient of acetonitrile from solvent A to solvent B (table 2.1). Peptides were 
collected in 2 ml fractions, pooled and freeze dried. The FPLC system (Dionex, 
Ultimate 3000 HPLC system) comprised a UV detector which detected the fractions 
at two wave lengths (215 and 250 nm), a pump and a fraction collector. The 
following table shows the acetonitrile gradient which was used to elute the peptide 
from the column (Sarbon, 2011).
Time (min) TFA in water (0.1%) TFA in acetonitrile (0.1%)
0 100 0
50 30 70
60 30 70
65 100 0
70 100 0
Table 2.1. Gradient profile for chromatographic run.
2.3.8. Determining antioxidant activity of the soy protein isolate, soy 
protein hydrolysate, and 7S and IIS  protein fractions purified from soya 
flour using a linoleic acid model system by measuring formation of 
peroxides
Based on antioxidant activity of different concentrations of samles 60 mg of the 
sample (2.4 mg/ml) was selected as it gave the highest antioxidant activity (appendix
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6). The fraction to be tested, (60 mg), was dissolved in 10 ml 50 mM potassium 
phosphate buffer (pH 7.0) and mixed with 4.87 ml distilled water, 0.13 ml linoleic 
acid and 10 ml absolute ethanol. The tubes were sealed and kept at 40°C in the dark. 
BHT (100 ppm) was used as standard. In the negative control tube, sample was 
replaced with water.
2.3.8.1. Ferric thiocyanate method
Prevention of hydroperoxides generation can be used as a suitable means to assess 
the antioxidant activity of the potential samples (Antolovich et a l, 2002). In this 
study linoleic acid was used in linoleic acid model systems since it is a 
polyunsaturated lipid and is oxidized more rapidly than the monounsaturated fatty 
acids. Oxidation was started under mild temperature i.e. 40°C.
In the FTC method, the peroxides produced from the oxidation of linoleic acid 
oxidize ferrous iron to ferric iron that reacts with thiocyanate ions to form a red 
complex. The absorbance of the red complex, which is determined using a 
spectrophotometer at 500 nm, is the indirect indicator of the degree of linoleic acid 
oxidation (Bai et al., 2011). This is a valuable method of evaluating antioxidant 
activity in the early stages of lipid oxidation using mild conditions (Antolovich et al., 
2002). Once every 24 hours, an aliquot of the linoleic acid model systems (100 pi) 
was placed in a test tube to which 4.7 ml of 75% ethanol, 100 pi 30% anunonium 
thiocyanate (w/v) and 100 pi 20 mM ferrous chloride solution in 3.5% HCl were 
added. After 3 min of the addition of ferrous chloride, the absorbance was measured 
at 500 nm on a spectrophotometer (Uvikon 860, Kontron instruments, Zürich) 
(Rezaeizadeh et al.,2DlV).
In order to calculate the peroxide value from the absorbance of the solution a 
standard curve was prepared according to the following method. A serial dilution of 
different concentrations of ferric chloride was prepared as standard solutions. A 100 
pi aliquot of each concentration was withdrawn and placed in a tube containing 5ml 
of absolute ethanol and 200 pi of hexane. The mixture was vortexed and 100 pi of 
30% ammonium thiocyanate was added to the tubes. The mixture was vortexed again
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and the absorbance of the solution was determined on a spectrophotometer (Uvikon 
860, Kontron instruments, Zürich) at 500 nm exactly after 3 min (Pearson, 1991).
2.3.S.2. Thiobarbituric reactive species (TEARS method)
Hydroperoxides are unstable and are decomposed easily to secondary lipid oxidation 
products such as epoxides, ketones, saturated and unsaturated aldehydes and 
hydrocarbons. Therefore, in order to have a better judgment of a substance’s 
antioxidant activity, it is helpful to use other methods. Formation of lipid oxidation 
secondary products and antioxidant activity of a substance against production of lipid 
oxidation secondary products can be assessed using thiobarbituric acid reactive 
substance (TEARS) method. This is a widely used method in which reaction of 
malondialdehyde and thiobarbituric acid (TEA) forms a pink pigment which can be 
detected spectrophotometrically at 532-535 nm (Antolovich et al, 2002) . The 
drawback of the procedure is that the reaction is not specific and is subject to 
reaction conditions.
At 24 hour intervals, 50 pi aliquots of the linoleic acid model systems were placed 
in a test tube to which 0.8 ml distilled water, 0.2 ml 8.1% sodium dodecyl sulfate 
(w/v), 1.5 ml of 20% acetic acid (pH, 3.5) and 1.5 ml of 0.8% TEA solution was 
added. The mixture was heated at 100 °C for 1 h in the dark, centrifuged and the 
supernatant was measured for TEARS on a spectrophotometer (Uvikon 860, Kontron 
instruments, Zürich) at 532nm. Production of secondary products was evaluated for 7 
days (Rezaeizadeh et a l,2Q ll).
In order to determine TEARS value a serial dilution of 1,1,3,3 tetraethoxypropane 
(TEP) in distilled water at different concentrations was prepared. To 1 ml of TEP 
standard solutions, 100 pi of 0.2% BHA (w/v), 150 pi of 25% HCl, 150 pi of 1% 
TEA solution (in 50 mM NaOH) and 750 pi of distilled water were added. The 
mixture was incubated in a water bath at 80°C for 30 min. The mixture were 
centrifuged at 3000 x g for 10 min and the absorbance was measured at 532 nm on a 
spectrophotometer (Uvikon 860, Kontron instruments, Zürich) (Tug et al., 2005).
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2.3.9. Amino acid analysis of the fractions
2.3.9.1. Preparation of samples and standards for amino acid analysis
The sample to be analysed (10 mg) was weighed into a screw-cap tube and dissolved 
in 6 M HCl. The tubes were evacuated with nitrogen gas prior to putting in an oven 
at 110 ° C for 24 h. Samples were filtered using Millipore 0.22pm filters prior to 
further analysis.
2.3.9.2. Derivatization with phenylisothiciyanate (PITC)
Twinty microlitre of drying solution (200 pi methanol + 200 pi IM sodium acetate + 
100 pi triethylamine (TEA) were added to the samples and the solution was vacuum- 
dried. Next, 20 pi of derivatizing reagent (140 pi methanol + 20 pi distilled water + 
20 pi PITC) was added. The samples were kept at 22°C for 20 min after which the 
solution was dried under vacuum for 20 min and reconstituted in eluent A [0.22 M 
sodium acetate buffer containing 0.05% (v/v) TEA (pH 6.2)] (GonzalezCastro et al., 
1997).
2.3.9.3. HPLC equipment and condition
An HPLC system (Dionex ultimate 3000) comprising a pump, an auto sampler, a UV 
detector and analysing software (chromeleon) was used to perform RP-HPLC. A 
C-18 reversed-phase column (Nova-Pak, Waters separations, Elstree, UK) with 
diameters of 3.9 x 150 mm with 5 pm particle size was used to separate the peptides. 
Two solutions (A and B) were used as the mobile phase. Solution A was 0.22 M 
sodium acetate buffer containing 0.05 % triethylamine and solution B was 
acetonitrile and water (60:40, acetonitrile to water).The gradient profile is shown in 
table 2.2. The samples were detected at 254 nm.
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Time (min) Flow rate (1 ml/min) % solution A % solution B
0 1.0 100 0
10.0 1.0 54.0 46.0
10.5 1.0 0.0 100.0
11.5 1.0 0.0 100.0
12.0 1.5 0.0 100.0
12.5 1.5 100.0 0.0
20.0 1.5 100.0 0.0
20.5 1.0 100.0 0.0
Table 2.2. Gradient profile for HPLC chromatographic run,
2.3.10. Gel electrophoresis
The sample buffer stock solution was prepared by mixing 4.8 ml water, 1.2 ml 0.5 M 
Tris-HCl, 2.0 ml 10 % SDS, 1 ml glycerol and 0.5 ml 0.5 % bromophenol blue. Just 
before use, 50 pi of mercaptoethanol were added to 950 pi of stock solution. A 
10 mg/ml solution of the 7S and 11s fraction was prepared in distilled water and an 
aliquot of this solution was added to the sample buffer solution containing 
mercaptoethanol. The solution was vortexed and heated in boiling water (100° C) for 
10 min. An aliquot (2 pi) of the prepared solution was transferred on to a 12.5% 
agarose mini gel and run on a Phast system (Pharmacia).
2.3.11. Determination of isoflavone content of soy protein isolate and 
related fractions by HPLC
2.3.11.1. Sample preparation- Soxhlet extraction
Isoflavone content of soy protein isolate, soy protein hydrolysate, 10, 5, and 2 kD 
fractions were determined (Gumbs, 2005). The dry sample in duplicate (200 mg) was 
extracted by 80 % methanol using a Soxhlet machine at 128° C for 70 min. The 
extract was filtered and 150 pi of the internal standard (0.5 mM formononetin in 
80% methanol) was added to each sample. To 10 ml of the sample 0.5 ml of Carrez 
A and B reagents were added in order to remove the proteins and fats. The sample
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was vortexed for 20 min after addition of each Carrez solution. Samples were 
centrifuged and the supernatant was removed, evaporated under nitrogen to 3 ml and 
filtered using 0.22 pm Millipore filters.
2.3.11.2. Preparation of standards
The standards of isoflavones were prepared in 1% formic acid in deionized water 
(table 2.3).
Amount
on
column
(nmole)
Daidzin
(pl)
Daidzein
(pl)
Genistin
(pl)
Genistein
(pl)
Internal
standard
(pl)
Formic 
acid in 
DI
water
0.15 5 5 5 5 31.8 948.2
0.3 10 10 10 10 31.8 928.2
0.6 20 20 20 20 31.8 908.2
1.2 40 40 40 40 31.8 808.2
204 80 80 80 80 31.8 648.2
Table 2.3.Quantities of isoflavone and chemicals used to produce standards for soya 
fraction analysis.
2.3.11.3. HPLC analysis
High performance liquid chromatography (HPLC) was used to identify the presence 
of isoflavones in the soya samples. Isoflavones have characteristic UV spectra. 
Oxidation patterns of isoflavones are different based on the A and B ring of
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isoflavones, therefore, each possesses a distinct pattern of UV spectra. The condition 
of HPLC is detailed in table 2.4.
Time (min) Solvent A (0.1% formic 
acid+ water)
Solvent B ( 0.1% formic 
acid + acetonitrile)
0 90 10
5 90 10
20 78 22
35 70 30
36 54 46
56 20 80
60 15 85
65 90 10
75 90 10
Table 2.4. HPLC conditions for analysing isoflavones.
2.3.12. Determination of amino acid and isoflavone content using NMR  
spectroscopy
Samples (20 mg/ml) were dissolved in D2O and/or methanol and poured into NMR 
test tubes. Spectra were recorded on an AVANCE m  500 NMR spectrometer, 
operating at 11.7467 T and equipped with a 5 mm BBO probe. Data were collected at 
298 K, 32K complex points, using a zg 30 pulse length. 16 scans were acquired with 
a spectral width of 10330578 Hz, an acquisition time of 3.9998 s. The NMR spectra 
were processed by TopSpin software. The spectra were Fourier transformed with FT 
size of 64K and 0.3 Hz line-broadening factor, phased and baseline corrected, and 
referenced to the TMS peak (0 ppm). The presence of amino acids and isoflavones 
was determined against standard samples of amino acids and four isoflavones 
(genistein, genistin, daidzein, daidzin and formononetin).
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2.3.13. Statistical analysis
All the analysis was done by ONE-WAY ANC VA in Microsoft excel 2010.
2.4. Results
2.4.1. Determination of protein and fat content of soy protein isolate and 
soya flour
The protein- and fat-content of the soya protein isolate and soya flour was 
determined using Kjeldahl and Soxhlet methods are shown in table 2.5.
Sample % Protein 
(N x5.8)
% Fat
Soy protein isolate commercial 
(SPI)
86.65 + 0.31
Soy protein hydrolysate (SPH) 66.13 + 0.05 -
Full fat un-sieved flour from 
soybean
82.18 + 0.08 33.26
Full fat sieved flour 79.7 + 0.69 22.05+ 0.32
The remnant after sieving 81.99 + 4.86 16.85 + 0.43
Defatted sieved flour 94.78 + 0.59 -
Table 2.5. Protein and fat content of SPI, SPH and soya flour. The values are 
average of two replicates.
2.4.2. Enzymatic hydrolysis of soy protein isolate
Enzymatic hydrolysis is preferred over chemical hyrolysis (Foh et al., 2010). In this 
study, soy protein isolate was hydrolysed using two different enzymes, pepsin and 
pancreatin, to obtain bioactive peptides, since they are the enzymes secreted during 
gastrointestinal food digestion; therefore, peptides produced by the action of these
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two enzymes would resemble the peptides produced in the digestive tract (Whitaker, 
1994).
Pancreatin contains a group of enzymes including trypsin, chymotrypsin, elastase 
and carboxypeptidase altogether cleaving peptide bonds. Trypsin is a serine protease, 
which cleaves at the C-terminus of long, positively charged amino acids arginine and 
lysine. Chymotrypsin is similar to trypsin in its primary structure, but cleaves at the 
C-terminus of bulky aromatic amino acids phenylalanine, tyrosine and tryptophan 
(Olsen, 2006). Elastase recognizes and breaks the peptide bond after amino acids 
containing small side chains (Stryer, 2002).
2.4.3. Determination of antioxidant activity of soy protein isolates (SPI) 
and soy protein hydrolysate (SPH) with different molecular weight by 
measuring the peroxide and TEARS value in a linoleic acid model systems
The results obtained from the FTC method showed that all the fractions had excellent 
antioxidant activity (Fig.2.1) and they could prevent formation of lipid peroxides 
effectively compared to the control (Fig.2.2). The peroxide value was significantly 
higher in the negative control in comparison with the samples for all days of storage 
(p < 0.05). In this study there was no significant difference between the peroxide 
values of SPH, 10 kD, 5 kD and 2 kD (p > 0.05). There was no difference between 
SPH fraction and BHT in terms of inhibitory effect on the production of peroxides (p 
> 0.05). After 7 days of storage peroxide value in model systems containing SPH, 10 
kD, 5 kD, 2 kD and BHT was 0.51, 0.33, 0.44, 0.45, 0.14 respectively (figure 2.2).
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Figure 2.1. Inhibitory effects of soy protein hydrolysate (SPH) fractions 
with different molecular weights (2, 5, and 10 kD) (
2.4 mg/ml) on the production of peroxides in a linoleic acid model system during 7 
days of storage at 40° C in the dark. The values are an average of three independent 
experiments.
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Figure 2.2. Peroxide values in linoleic acid model systems containing different 
fractions of SPH with different molecular weight (2, 5 and 10 kD)(2.4 mg/ml) as 
antioxidants, after 7 days of storage at 40°C in the dark. Values are an average of 
three independent experiments. Tubes were tested in triplicate. BHT(100 ppm) was 
used as a positive control. CNT indicates a negative control.
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Results showed that when SPI was used as antioxidant, the amount of peroxide 
produced was significantly higher (p < 0.05) compared to that of BHT (figure 2.3). 
Thus, in terms of antioxidant activity BHT worked better than SPI. Figure 2.4 shows 
peroxide values after 7 days of storage. In contrast, SPI showed significantly better 
inhibitory activity and lower TBARS concentration compared to control.
'SPI •BHT •CNT
0)
30
25
20
10
5
0
5
days
Figure 2.3. Inhibitory effect of SPI (2.4 mg/ml)on the production of peroxides and 
its comparison with BHT(100 ppm) as positive control, in a linoleic acid model 
system at 40° C. The values are an average of two experiments and the tubes were 
tested in triplicate. CNT indicates a negative control with no antioxidant.
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Figure 2.4. Comparison of peroxide value in linoleic acid model systems, using SPI 
(2.4 mg/ml)and BHT(100 ppm) as antioxidants after 7 days of storage at 40 ° C in 
the dark. CNT indicates a negative control. The tubes were tested in triplicate.The 
results are an average of two independent experiments.
All the fractions had anti oxidant activity and could effectively inhibit the production 
of TBARS (figures 2.5 & 2.6) compared to the control (p < 0.05). The control 
sample showed an initial increase followed by a decrease in TBARS levels during 7 
days of storage. All the fractions and BHT showed differences in terms of TBARS 
levels from the control (p<0.05). Low TBARS values were not statistically different 
among the fractions (p > 0.05). TBARS concentrations after 7 days in linoleic acid 
model containing SPH, 10 kD, 5 kD, 2 kD, BHT and control were 0.13, 0.12, 0.12, 
0.11, 0.08 and 0.53 pg/ml respectively.
46
5 kD10  kD 2 kD -4 K -B H TSPH CNT
2.00 
1 .80  
1 .60  
^  1 .40  
1  1.20 
—  1.00 
^  0 .8 0  
H 0 .6 0
0 .4 0
0.20
0.00
Days
Figure 2.5. Inhibitory effect of SPH and fractions with different molecular weight 
(2.4 mg/ml) against production of TBARS in linoleic acid model systems that were 
incubated at 40 ° C for 7 days in the dark. The tubes were prepared in triplicate and 
the results are an average of three independent experiments.
0 .7 0  
0 .6 0  - 
0 .5 0  - 
0 .4 0  - 
0 .3 0  
0.20 
0.10 
0.00
0 .5 3
0.13 0.11
0.12 0.12 0 .0 8
I
SPH 10  kD 5 kD 2 kD BHT 
Fractions
CNT
Figure 2.6. Comparison between production of TBARS in linoleic acid model 
systems using SPH with different molecular weight (2, 5, 10 kD) (2.4 mg/ml) and 
BHT (100 ppm) (positive control) as antioxidants after 7 days of storage incubated at 
40 ° C in the dark. The tubes were prepared in triplicate and the results are an average 
of three independent experiments.
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SPH and its fractions were subjected to HPLC to determine their amino acid 
composition. The results showed that almost all amino acids are present in the 
fractions. Amino acids are able to mop up free radicals but the amino acids Trp, Phe, 
Leu, Lys, Tyr and Arg are more prone to react with free radicals (Nazeer, 2011), 
despite the presence of higher quantities of these amino acids in the 2 kD fraction, 
(table 2.6), its antioxidant activity was not significantly different from other fractions 
(p >0.05).
%  composition
Amino acid SPH 10 kD 5 k D 2 k D
Asp 7.9 ± 0.4 8.64 + 0.99 5.00+1.85 6.03 + 0.41
Glu 13.9 + 0.59 13.78 + 0.68 9.17 + 2.24 9.44 + 0.28
h.pro 0.36 ± 0.01 0.33 + 0.01 0.26 + 0.01 0.22 + 0.04
Ser 6.85 + 0.11 6.71+0.25 6.29 + 0.41 5.85 + 0.31
Gly 10.51+0.11 9.64 + 0.17 11.0 + 0.82 9.17 + 1.03
His 0.43 + 0.02 0.50 + 0.06 0.29 + 0.18 0.47 + 0.01
Arg 5.59 + 0.02 5.53 + 0.06 5.08 + 1.12 7.24 + 0.23
Thr 4.17 + 0.05 4.19 + 0.09 2.77+1.17 3.59 + 0.18
Ala 5.52 + 5.14 4.17 + 3.58 7.45 + 5.37 6.13 + 1.24
Pro 6.79 + 7.16 6.53 + 7.39 6.65+4.35 3.20+1.41
Tyr 2.79 + 0.39 3.04 + 0.19 4.03 + 0.51 5.41 + 0.90
Val 4.04 + 0.56 4.57 + 0.89 3.26 + 0.67 4.52 + 1.07
Met 0.78 + 0.22 1.36 + 0.0 1.79 + 0.84 1.66 + 0.05
Cys 0.28 + 0.15 0.44 + 0.06 0.77 + 0.38 0.57 + 0.01
lieu 3.80 + 0.41 4.00 + 0.58 2.67 + 0.76 3.61+0.62
Leu 7.37 + 0.17 7.72 + 0.06 6.86+1.78 9.86 + 0.38
Phe 3.91 ±0.30 4.02 + 0.18 4.44 + 0.25 6.14 + 0.56
Trp 6.93 + 0.17 6.88 + 0.47 14.37 + 8.05 7.53 + 1.18
Lys 8.05 + 0.15 8.64 + 0.21 7.85 + 1.07 9.36 + 0.61
Table 2.6. Amino acid composition of the soy protein hydrolysate fractions. 
The results are averages of four replicates.
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The antioxidant activity of the SPH and its fractions, as shown by the FTC method, 
was higher compared to the SPI (unhydrolysed protein isolate), probably due to the 
release of peptides and amino acids from the protein after hydrolysis. During 
hydrolysis, peptide bonds are decomposed, which leads to the exposure of free amino 
acids and carboxyl groups. Protein hydrolysates can form a membrane around the oil 
droplets in lipid emulsion systems, preventing the reactive oxygen species access to 
the oil droplets; therefore, protein hydrolysates prevent formation of lipid 
hydroperoxides. Hence, the original starting protein source might not have the same 
or similar antioxidant activity as the protein hydrolysate obtained from that protein 
(Park and Chin, 2011).
Many studies cited in the literature state that biological activities of the protein 
hydrolysates and peptides are improved following membrane ultrafiltration (Jeon et 
al., 2000; Ajibola et at., 2011; Chen et al., 2012), In contrast to what is mentioned 
above, in this study, the antioxidant activity of the SPH, determined with both FTC 
and TBARS methods, did not increase with ultrafiltration to 10, 5 and 2 kD fractions 
and there was no significant difference in the antioxidant activity of SPH and the 
fractions. The fractions might have similar antioxidant activity in a linoleic acid 
model system, but, they might behave differently when other methods are used to 
assess the antioxidant activity, or they might be different from each other when other 
biological activities are assessed (Jamdar et al., 2012),
The amino acid profile of the SPH and the fractions show that amino acids Asp, Glu, 
Arg, Gly, Ala, Tyr, Leu, Phe, Trp and Lys were present in all the fractions in high 
amounts. Some of these amino acids are more abandent in some fractions. Aspartic 
acid and alanine concentration was higher in the 10 kD fractions compared to the 
5 kD fraction, which had higher Gly and Trp concentration, or the 2 kD fraction that 
had higher amounts of Arg, Tyr, Leu, Phe and Lys. Therefore, the antioxidant 
activity of the SPH and the fractions is the sum of the interaction of the peptides 
containing these amino acids and/or amino acids alone. Amino acid analysis of SPH, 
10 kD, 5 kD and 2 kD fractions by proton NMR spectroscopy did not show all the 
amino acid peaks like HPLC, since the concentrations of the amino acids in the 
samples were not high enough to be detected with NMR (see appendices 2-4 and
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figure 2.12). The amino acids which were detected by NMR were Tyr, Phe, Lys, Gin, 
Ala and Ser. Consideration was given to the possibility that the antioxidant activity 
of the SPI, SPH and the related fractions was not only due to the presence of 
peptides. Analysis of samples for the presence of isoflavones showed that all samples 
contained isoflavones. It is well proven that isoflavones can function as antioxidants 
probably due to the presence of the hydroxyl group of the phenolic ring in their 
structure which allows them to be good free radical scavengers, electron-hydrogen 
donors and reducing agents (Ponnusha et a l, 2011).
Genistin, a natural glycine isoflavone present in soybean, has free radical scavenging 
activity and reducing power (Chung et ah, 2006). Genistein, another isoflavone 
found in soybean, is proven to have in vitro and in vivo antioxidant effect. For 
instance, it was able to inhibit copper-dependent LDL oxidation in cells and cell-free 
systems (Polkowski and Mazurek, 2000). Studies have found that genistein is 
effective against oxidative DNA damage (Wei et al., 1996). Daidzein has inhibitory 
effect against lipid peroxidation (Dwiecki et al., 2009). Although the quantity of the 
isoflavones detected by HPLC in tested samples was very low (daidzin: 0.88-15.43, 
daidzein: 5.25-35.83, genistein: 6.50-36.37, genistin: 42.37-288.27 pg/ 71.4 mg), 
their role as antioxidants must be considered. Therefore, the antioxidant activity of 
the SPH and its fractions might be the sum of the antioxidant activity of the 
predominant peptides and minor isoflavones components.
2.4.4. Antioxidant activity of peptides purified by gel filtration 
chromatography
In order to separate active peptides showing higher antioxidant activity, the 2 kD 
fraction of SPH was loaded on a size exclusion Sephadex G-25 column. Thirty four 
fractions numbered 3, 4, 5, 6,7, 8, 9, 17, 18, 19, 35, 36, 37, 38, 39, 40, 49, 50, 51, 52, 
53, 54, 55, 56, 57, 58, 59, 79, 80, 81, 82, 84, 85, 86 showed higher absorbance at 215 
nm and were collected (figure 2.9), lyophilized and evaluated individually for 
antioxidant activity using the FTC and TBARS methods.
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Figure 2.7. FPLC chromatogram of three separate runs of the 2 kD (40 mg/ml) 
fraction on a Sephadex gel filtration column and detected at 215 nm. The flow rate 
was 1 mPmin. The volume of each fraction was 5 ml.
The results from the FTC method showed that all the 34 selected fractions from gel 
filtration had strong antioxidant activity and could inhibit peroxide formation in the 
linoleic acid model system. After 7 days of storage, the antioxidant activity and 
peroxide value were compared with each other and with BHT, to select the most 
effective fraction. The results showed that the peroxide value with BHT after 7 days 
of storage was 0.35 Meq./kg of oil. Any fraction which had a similar value to that of 
BHT was evaluated. The peroxide value in the tubes containing fractions 17, 19, 35, 
36, 37, 38 and 39 was 0.41, 0.44, 0.33, 0.40, 0.40, 0.44, and 0.35 Meq. /kg of oil 
respectively. These peroxide values were significantly lower compared to that of 
control (4.29 Meq./kg of oil) (figure 2.9). The absorbance of the fraction 36 (GFF 
36) on the chromatogram was higher at 215 nm compared to other fractions, which 
might be due to higher protein content, therefore it was selected for further 
purification by HPLC. The GFF 36 showed a very similar pattern of antioxidant 
activity and inhibition of peroxide formation to BHT during 7 days of storage (figure 
2 .8).
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Figure 2.8. Inhibitory effect of GFF 36 (2.4 mg/ml)on peroxide formation compared 
to BHT (100 ppm) (positive control) and the negative control with no peptides 
(CNT) during 7 days of storage in a linoleic acid model system incubated at 40° C in 
the dark. The results are averages of three replicates.
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Figure 2.9. Inhibitory effects of 34 gel filtration fractions (2.4 mg/ml), BHT (100 
ppm) and control (CNT) on production of peroxides after 5 days of storage in a 
linoleic acid model system incubated at 40° C in the dark. The results are averages of 
three replicates.
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All the gel filtration fractions were efficient antioxidants and minimised TBARS 
formation except GFF 3 (figure 2.11). After 7 days of storage, TBARS values in the 
linoleic acid model system in which BHT was used was 0.02 pg/ml. Fractions 9, 17, 
19, 35, and 36 had the same TBARS values as BHT. Gel filtration fraction number 
36 (GFF 36) had a similar antioxidant pattern as BHT (figure 2.10). TBARS values 
produced in the presence of GFF 36 were lower than the control (1.15 pg/ml) (figure 
2.10) and the 2 kD fraction (0.11 pg/ml) (figure 2.6).
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Figure 2.10. Inhibitory effect of the GFF 36 (2.4 mg/ml) against production of 
TBARS compared to BHT(100 ppm) (positive control) and negative control (CNT) 
during 7 days of storage in a linoleic acid model system in cubated at 40° C in the 
dark. The results are averages of three replicates.
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Figure 2.11. Inhibitory effects of gel filtration fractions (2.4 mg/ml), BHT(100 ppm) 
and control against production of TEARS after 7 days of storage in a linoleic acid 
model system incubated at 40° C in the dark. The results are averages of three 
replicates.
GFF 36 had significant antioxidant activity against production of TEARS compared 
to 2 kD fraction and lower molecular weight peptides might have a role (Eougatef et 
al., 2009). Peptides with low MW are thought to be adsorbed or to localize at 
oil/water interfaces more easily, which results in reducing lipid peroxidation (Sun et 
a/., 2011).
According to table 2.7, GFF 36 is rich in Phe and Trp. Phe could be converted to Tyr 
which is a potent radical scavenger (Park et al., 2010). Moreover, it is proven that 
tryptophan is a good antioxidant due to the presence of an indole ring which acts as a 
hydrogen donor (Pihlanto, 2006). Moreover, GFF 36 has significantly higher genistin 
content (288.27 pg/71.4 mg of sample) compared to the 2 kD fraction (126.14 
pg/71.4 mg of sample) which could be another explanation for its higher antioxidant 
activity compared to the 2 kD fraction. The higher genistin content of the GFF 36 
could probably be due to the fact that isoflavones are bound to proteins (Anderson 
and Garner, 1998) and, as the purer peptides with lower molecular weight are 
produced by sequential fractionation, genistin have been pooled by being bound to a 
specific peptide. However, it was not possible to identify any association of peptides
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with genistin either by HPLC or NMR spectroscopy. Gel filtration chromatography 
is a technique which separates molecules according to their molecular size (Wang 
and De Mejia, 2005; Beerman et al., 2009; Park et al., 2010). It has various 
applications including separation of substances based on the molecular size, desalting 
of proteins and group separation of protein hydrolysates (You et al., 2010).
Amino acid % composition (GFF 36)
Asp 2.4 ± 0.90
Glu 2.935 + 1.75
h.pro 0.96 + 0.02
Ser 2.11+0.81
Gly 3.68 + 1.53
His 1.23 + 0.92
Arg 2.56 + 0.22
Thr 0.77 + 0.68
Ala 2.23 + 0.14
Pro 2.27 + 0.15
Tyr 2.45 + 1.28
Val 1.37 + 1.14
Met 3.50 + 0.89
Cys 1.08 + 0.48
lieu 0.88 + 0.60
Leu 2.35 + 1.08
Phe 27.14+1.18
Trp 48.48 + 6.57
Lys 2.42+1.56
Table 2.7. Amino acid composition of the GFF36. The results are averages of four 
replicates.
Amino acid analysis of GFF 36 by NMR could detect Phe but not Trp. The rest of 
the amino acids were detected in low quantities or were not detected. A 
representative NMR spectrum is shown (figure 2.12). The spectra shown in the 
figure 2.12 represents the following: from the bottom SPH, 10 kD, 5 kD, 2 kD, GFF 
36, alanine, phenylalanine, glutamic acid , asparagine, cysteine, and glycine.,
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Figure 2.12. NMR spectra of the soy protein fractions analysed for detection of
amino acids. From the bottom upwards, the spectrum represents SPH, 10 kD, 5 kD,
2 kD, GFF 36, alanine, phenylalanine, glutamic acid, asparagine, cysteine, and 
glycine.
2.4.5. Isoflavone content of soy protein isolate and the related fractions
Isoflavone content of SPI, SPH, 10, 5, 2 kD and gel filtration fractions (GFF 36) 
were analysed using HPLC. The oneentration of daidzin, daidzein and genistein was 
not significantly different in SPI, SPH, 10 kD and 5 kD.The daidzin peak was below 
the detection limit in the 5 kD fraction. The concentration of genistin was 
significantly higher in all the samples compared to other isoflavones. Sequential 
fractionation from the 10 kD fraction to GFF 36, increased the concentration of 
genistin (figure 2.13).
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Figure 2.13. Isoflavone content of SPH and its related fractions (2.4 mg/ml). The 
results are averages of three replicates.
The genistin content of gel filtration fraction (GFF 36) was significantly higher 
(288.27 pg/71.4 mg of sample) compared to other samples. Genistin concentration in 
SPI, SPH, 10, 5 and 2 kD was 87.17, 72.61, 42.37, 74.34 and 126.14 pg/71.4 mg of 
sample respectively. Furthermore, all the samples were tested for the presence of 
isoflavones by NMR spectroscopy. Surprisingly, no isoflavone peaks were detected 
by NMR probably due to the low concentration of isoflavones in the samples. As it 
was mentioned with previous samples, NMR failed to detect isoflavones in GFF 36 
due to their low concentrations.
2.4.6. Reverse phase high performance liquid chromatography
The GFF 36 fraction was fractionated using reverse-phase high performance liquid 
chromatography (RP-HPLC) to check if its antioxidant activity could be improved. 
Reverse phase high performance chromatography (RP-HPLC) has been used to 
purify and identify peptides (Hu, 2012; Kasase, 2009). Nine fractions were collected 
each in 2 ml portions. The fraction numbers were designated HPLC fraction (HPF) 
15-23 (figure 2.14). The flow rate was 1 ml/min. In order to collect enough sample to 
do the antioxidant tests, individual fractions were collected from 55 runs, pooled and 
freeze dried.
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Figure 2.14. RP-HPLC of three runs out of a total of 55 runs of GFF 36 (10 mg/ml). 
The flow rate was 1 ml/min. Eaeh fraction was collected in 2 ml portions.
The antioxidant activity of RP-HPLC fractions were measured by evaluating 
peroxide and TEARS values using the FTC and TEARS methods. Using FTC 
method, HPF 21 and 22 did not exhibit activity; therefore these two fractions were 
not included. After 7 days of storage HPF 19 and HPF 23 could inhibit peroxide 
formation better than the control (figure 2.15). The remaining fractions inhibited 
peroxide formation by varying degrees (figure 2.16). Among the HPLC fractions, 
HPF 23 and HPF 19 were more effective than other fractions in preventing the 
formation of peroxides after 7 days of storage compared to the control (p < 0.05) 
(figure 2.16), and the peroxide values in linoleic acid model system containing HPF 
19 and HPF 23 were 2.63 and 1.57 Meq/kg oil, respectively (figure 2.16).
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Figure 2.15. Peroxide values of the two RP-HPLC fractions (HPF 19, HPF 23) (2.4 
mg/ml), BHT (100 ppm; synthetic antioxidant) and control. The results are averages 
of three replicates.
The amount of TEARS produced was lower in those containing BHT and HPF 23 
(figure 2.16).
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Figure 2.16. Comparison between antioxidant activities of HPF 19, HPF 23 (2.4 
mg/ml), BHT (100 ppm) and control in linoleic acid model systems incubates in the 
dark at 40 ° C after 7 days of storage. Values are averages of three repliocates.
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The amino acid analysis of the HPLC fractions showed that the amino acids His, 
Arg, Val, Met and Trp were present in high quantities in all HPLC fractions. HPF 19 
contained more Arg than the other fractions whereas HPF 23 had high quantities of 
Phe and Trp (table 2.8).
The Arg and Trp content of HPF 19 were high. Besides, amino acids His, Met and 
Val were present in higher quantities compared to HPFs 15, 16, 17, and 18. It was 
reported that the peptide Met-His-Ile-Arg-Leu had high radical scavenging activity 
due to the presence of Met (Pihlanto, 2006). This might give higher antioxidant 
activity of HPF 19. In the case of HPF 23, Trp and Phe are present in high amounts 
and the determining amino acid might be Phe since the per cent composition of Phe 
in HPF 23 is significantly higher compared to other fractions and it can convert to 
tyrosine which is an efficient hydroxyl radical scavenger (Guo et al., 2009; Saeed et 
al., 2006). Phe-containing peptides donate hydrogen to electron-deficient radicals 
and help to maintain their stability (Girjal et al., 2012). Contrary to expectation, the 
antioxidant activity of the GFF 36 was not improved by further purification. The 
reason might lie in the amino acid sequence and composition of these fractions. 
Another explanation is that combination of peptides might have better antioxidant 
activity rather than purified ones (Correa et al., 2011). The quantity of HPLC 
fractions was not enough to determine the isoflavone content. Therefore, it cannot be 
concluded that all the antioxidant activity obtained is due to the presence of amino 
acids and peptides.
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Amino
acid HPF 15 HPF 16 HPF 17 HPF 18 HPF 19 HPF 23
Asp 0.75 + 0.19 0.84 + 0.23 1.71+0.44 0.86 + 0.20 0.75 1.31+0.55
Glu 1.17 + 0.33 1.39 + 0.40 3.45 + 0.22 2.83 + 0.42 2.19 + 0.70 2.39 + 1.25
H.pro 0.59 + 0.01 0.58 + 0.40 0.36 0.40 + 0.10 0.42 + 0.21 0.20
Ser 0.92 + 0.16 1.44 + 0.64 2.76 + 1.86 1.09 + 0.14 1.06 + 0.08 1.67 + 0.34
Gly 1.56 + 0.57 2.43 + 0.72 4.41 + 2.63 1.34 + 0.27 1.67 + 0.11 3.40 + 0.07
His 0.00 0.00 0.61+0.14 1.84 + 0.45 3.76 + 0.53 0.67 + 0.65
Arg 0.52 + 0.04 0.00 1.30 + 0.64 9.65 + 1.74 25.44 + 2.83 2.36 + 0.38
Thr 0.00 0.60 + 0.14 2.62 + 0.96 0.00 1.45 + 0.97 0.89 + 0.04
Ala 0.00 1.46 + 0.42 6.01 + 1.81 1.54 + 0.27 0.85 + 0.21 1.56 + 0.08
Pro 0.89 + 0.02 0.00 0.34 + 0.02 0.00 0.00 1.79 + 1.89
Tyr 2.74 + 0.74 1.85 + 0.54 2.13 + 0.80 1.84 + 0.92 0.97 1.54 + 0.11
Val 6.11 + 3.50 0.00 0.00 2.69 + 0.67 6.21 + 1.15 1.12 + 0.14
Met 1.65 + 0.03 0.00 0.00 1.37 + 0.72 4.19 + 0.73 2.11+0.32
Cys 1.08 + 0.09 2.02 + 0.56 1.53 + 0.39 0.84 + 0.09 0.70 + 0.16 0.71+0.34
Heu 0.00 0.00 0.00 0.00 0.00 0.71+0.43
Leu 1.00 + 0.04 0.86 + 0.14 1.50 + 1.03 0.87 + 0.05 0.95 + 0.11 1.30
Phe 4.22+1.08 1.22 + 0.07 0.00 0.00 2.65 + 1.67 56.59 + 0.37
Trp 78.05 + 3.93 85.27 + 2.76 67.34 + 4.97 71.75 + 4.84 46.00+ 5.73 61.23 + 0.01
Lys 1.06 + 0.23 1.37 + 0.55 4.-49 + 2.95 1.74 + 0.44 1.98 + 0.95 3.93+4.04
Table 2.8. Amino acid composition of the fractions purified with RP-HPLC. The 
results are averages of four replicates.
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2.4.7. Antioxidant activity of 7S, 7S hydrolysate, the 2 kD fraction from  
7S hydrolysate and IIS
To compare the antioxidant activities of protein fractions of soya bean (7S and IIS) 
and their hydrolysates with SPI and SPH, the IS  and 11S fractions of soya protein 
were isolated by a sequential change in pH and centrifugation. Figure 2.19 is the 
electerophoresis pattern of 7S and 1 IS fractions from soy beans. The 7S fraction was 
hydrolysed using pepsin and pancreatin and the hydrolysate (7Sh) was fractionated to 
a 2 kD fraction by membrane filtration. The IIS fraction yield was not enough to 
carry out the hydrolysis and fractionation. The inhibitory effect of the samples 
against peroxide formation was evaluated using FTC method.
It is clearly demonstrated in figure 2.17 and 2.18 that the soya protein fractions have 
a profound effect on decreasing the peroxide value in linoleic acid model systems 
compared with the control. All the fractions reduced peroxide formation, particularly 
7Sh and 7Sh 2 kD. (figure 2.17). There was no significant difference between 7S and 
l i s  in inhibiting peroxide formation during storage for 7 days (p > 0.05). 7Sh and 
7Sh 2 kD fractions were not significantly different from each other in terms of 
peroxide formation but both showed lower values than the 78 and 118 fractions (p < 
0.05).
7sh  2 KD7sh con tro l
days
Figure 2.17. Peroxide value in linoleic acid model systems incubated using different 
protein fractions of soya protein (2.4 mg/ml). Thetubes were incubated at 40 ° C in 
the dark for 7 days. The values are averages of three replicates. BHT (100 ppm) was 
used as positive control.
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Figure 2.18. Comparison between the antioxidant activity and peroxide value in 
linoleic acid model systems using soya protein fractions and their hydrolysates (2.4 
mg/ml) as antioxidants measured after 2 days of storage. The values are averages of 
three replicates. BHT (100 ppm) was used a positive control.
Glycinin (IIS) and p-conglycinin (7S) are two major protein fractions of soya 
protein (Bian et al., 2003) and their antioxidant activity has been reported (Romijn et 
aA,1991^
Hydrolysis enhanced the activity of 7S probably by degrading the structure of the 
protein and producing bioactive peptides which enhance the antioxidant activity 
(Bamdad et at., 2011). The 2 kD fraction of 7Sh did not show any significant 
difference in antioxidant activity when compared with 7Sh, probably due to the 
presence of a combination of peptides in 7Sh and lower peptide content of 7Sh 2 kD. 
Since the 1 IS and 7S fractions were purified from the soya bean in the laboratory, it 
is clear that these two fractions contained more isoflavones than the fractions isolated 
after hydrolysing the commercial SPI. Therefore, the antioxidant activity of the 7S, 
l i s  and their hydrolysate may be due to the presence of both isoflavones and 
peptides, although it has to be reiterated that the amount of isoflavones detected was 
very small (table 2.9).
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Figure 2.19 shows gel electrophoresis profile of the 7S and IIS protein fractions of 
soy beans.The gel separation showed that the compositions of the 7 and 1 IS fractions 
were similar although the amount of the low MW protein bands (36,000 -  55,000D) 
was more predominant in the 1 IS fraction whereas the 66,000 -  200,000D MW 
bands were more prominent in the 7S fraction. These results indicate that a clear 
separation of 7 and 1 IS fractions was not possible by the fractionation method used.
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Figure 2.19. Electrophoresis pattern of 7S and 1 IS fraction isolated from soya 
bean.
SPI SPH 10 kD 5kD 2kD GFF 36
daidzin 15.43 9.95 OjW 7A2 2.99
daidzein 13.24 10.87 5 j# 8.94 21.56 35^3
genistein 19.26 13.25 6.50 11.50 29.10 3C37
genistin 87.17 72.61 4237 74.34 126.14 288.27
Table 2.9. Isoflavone content of the soy protein fractions analysed by HPLC. 
Values are averages of three replicates measured as pg/ 71.4 mg of the sample.
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2.5. Conclusion
In this study bioactive peptides were obtained from pepsin/pancreatin hydrolysis of 
soya protein isolate with sequential chromatography including gel filtration and high 
performance liquid chromatography. It was revealed that hydrolysis increased 
antioxidant activity. Antioxidant activity of all fractions was determined in linoleic 
acid model systems and it was found that the peptide fraction, purified by gel 
filtration (GFF 36), had higher antioxidant activity compared to the fractions purified 
by membrane filtration. Small quantities of isoflavones (table 2.9) were also detected 
by HPLC but not by NMR spectroscopy, which may have some antioxidant effect. 
The results revealed that further fractionation with RP-HPLC did not improve 
antioxidant activity, indicating that the antioxidant activity is enhanced by a mixture 
of peptides.
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CHAPTER 3
3.0 MECHANISM OF ANTIOXIDANT ACTIVITY OF SOY 
PROTEIN HYDROLYSATE (SPH) AND ITS LOW MOLECULAR 
WEIGHT FRACTION IN DIFFERENT SYSTEMS
3.1. Introduction
More than 2.5 billion years ago, oxygen appeared in the earth’s atmosphere. This 
resulted in the formation of the ozone layer and protection of organisms from 
ultraviolet radiation. With the massive rise in the atmospheric oxygen, the primitive 
organisms which could not adapt to this condition died, and only those that evolved 
mechanisms to protect themselves from the toxicity of oxygen survived. This process 
continued till multicellular organisms, evolved to control and use oxygen in their 
systems and eukaryotic cells developed systems to use oxygen in aerobic metabolism 
(Wilcox et al., 2004).
Reactive oxygen species (ROS) and free radicals are species with unpaired electrons. 
They are very unstable and need another electron to become stable. When one 
electron is added to the molecular oxygen, it is activated and generates the 
superoxide radical (O2") (Willcox et al., 2004). The free radicals generated form 
oxygen, called reactive oxygen species (ROS) and they are unstable molecules, ions 
or atoms, capable of oxidizing other molecules. Examples of ROS are superoxide 
anion radical, hydroxyl radical and the singlet oxygen. Free radicals and ROS attack 
biological molecules (Ray et al., 2012), which can cause chronic diseases such as 
cardiovascular diseases (Chanda and Dave, 2009).
Cells have developed mechanisms to protect themselves against free radicals 
including antioxidant enzymes to maintain the redox homeostasis of the cells (Luo et 
al., 2008; Chanda and Dave, 2009). Antioxidants derived from different food 
sources, including (3-carotene, vitamins C and E, natural phenols and some minerals
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can protect the cell from destructive free radicals (Rodriguez-Martinez et al., 2004; 
Willcox et al., 2004).0xidation of lipids and proteins in food systems is also a 
serious concern since it results in deterioration of food quality. Food processing 
results in an increase in oxygen content and pro-oxidative factors and a decrease in 
natural and endogenous antioxidants, which enhances oxidation reactions (Elias et 
al., 2008).
The inherent ability of proteins and peptides to react with free radicals has made 
them a suitable candidate to inhibit oxidation reactions (Saeed et al., 2006). By 
taking advantage of this fact, there are attempts to manufacture natural antioxidants 
including peptides from proteins (Elias et al., 2008). The previous chapter shows the 
potential antioxidant activity of soya protein hydrolysates and the purified fractions 
and the possible role of hydrophobic amino acids Trp and Phe. Moreover, studies 
have found that soy isoflavones that were detected in very low quantities may exert 
antioxidant activity (Park et al., 2008) in lipophilic and hydrophilic systems through 
different mechanisms (Larkin et al., 2008).
In this study, the mechanisms of antioxidant activity for crude soy protein 
hydrolysate and its fraction with molecular weight of <2 kD were investigated using 
various antioxidant tests.
3.2. Materials
Soy protein isolate was purchased from Kerry Ingredients, Bristol, UK. Pyrogallol, 
HCl, ascorbic acid (L ascorbate), butylated hydroxylanisole (BHA), 2-deoxy-D- 
erythro-pentose (deoxyribose), ferrous sulphate (FeS04), hydrogen peroxide, 
ethylenediaminetetraaceticacid (EDTA), thiobarbituric acid (TBA), trichloroacetic 
aid (TCA), 1,1 -Diphenyl-2-picryl-hydrazyl (DPPH), Ferrous chloride (FeCl2), (3-(2- 
pyiidyl)-5.6-diphenyl-1,2,4-triazine (ferrozine), ferrous chloride (FeCl2), 6 -hydroxy- 
2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox) genistein, daidzein, genistin, 
daidzin and formononetin, formic acid, zinc acetate and potassium ferrocyanide, all 
were products of Sigma-Aldrich, Dorset, UK. Tris-HCl was purchased from Fisher 
Scientific, Loughborough, UK.
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3.3. Methods
3.3.1. Preparation of soy protein hydrolysate: refer to 2.3.2
3.3.2. Fractionation of SPH to 2 kD fraction using ultrafiltration: refer to 
2.3.5
3.3.3. Amino acid analysis of SPH and 2 kD fraction: refer to 2.3.9
3.3.4. Determining the isoflavone concentration in the SPH and the 2 kD 
fraction: refer to 2.3.11.
3.3.5. Superoxide anion scavenging activity
The superoxide scavenging activity of soy protein hydrolysate (SPH) and the 2 kD 
fraction was determined (Tang et al., 2010). One ml of sample (0.35-7 mg/ml) was 
mixed with 1.8ml of 50 mM Tris-HCl (pH 8.2). The mixture was vortexed and kept 
at 25°C for 10 min. Then 0.1 ml of 10 mM pyrogallol solution (dissolved in 10 mM 
HCl) was added to the mixture, vortexed and the oxidation rate of pyrogallol was 
measured using a spectrophotometer (Uvikon 860) at 320 nm up to 4 min. For the 
negative control, Tric-HCl was added instead of the sample. Ascorbic acid and BHA 
were used as positive control.
The superoxide scavenging activity was measured using the following formula: 
Superoxide scavenging activity = [AAq- AAi) / AAq] x  100 
Where AAoand AAi are:
AAo = change in the absorbance of the control, AAi = change in the absorbance of 
the sample.
3.3.6. Deoxyribose degradation assay [Hydroxyl radical (*OH) scavenging 
assay (HRSA)]
The chemicals were mixed in the following order: 0.1 ml 10 mM ferrous sulphate,
0.1 ml 10 mM ethylenediaminetetraaceticacid (EDTA), 0.5 ml 10 mM a- 
deoxyribose, 0.9 ml 0.1 M sodium phosphate buffer, and 0.2 ml of the sample in 
different concentrations (0.005-2 mg/ml) were mixed thoroughly in a tube. Then 0.2 
ml of hydrogen peroxide (10 mM) was added to the mixture and vortexed. The 
mixture was incubated at 37°C for 1 h after which 1 ml of TCA was added to stop
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the reaction. Then, 1 ml of TBA in 0.05 M NaOH was added, vortexed and the 
mixture was incubated at 100°C for 15 min. After cooling the mixture, the 
absorbance was measured on a spectrophotometer (Uvikon 860) at 532 nm (Batool et 
al., 2010). Trolox was used as a positive control. The hydroxyl radical scavenging 
activity was measured according to the following formula:
'OH scavenging activity^ [(Absorbance control- absorbance sample) /Absorbance control] x 
100
3.3.7. Scavenging of hydrogen peroxide
Sample (0.2 ml) at different concentrations (0.06-1.3 mg/ml) was mixed with 2.8 ml 
of 4 mM hydrogen peroxide solution. The mixture was incubated for 10 min at room 
temperature. The absorbance was measured on a spectrophotometer (Uvikon 860) at 
230 nm (Zhuang, 2009). The percent inhibition was measured using the following 
formula:
H2O2 scavenging activity =
[(Absorbance control- Absorbance sample) /Absorbance control] x 100
3.3.8. DPPH radical scavenging activity
Scavenging ability of soy protein hydrolysate was measured according to (Liu et al., 
2010). One ml of sample (0.5-10 mg/ml) was mixed with 1 ml of 1 mM DPPH in 
methanol. The mixture was mixed thoroughly and allowed to stand in the dark at 
22°C for 60 min. The samples were centrifuged at 4500 rpm for 10 min at 22°C. The 
absorbance was measured at 517 nm using a spectrophotometer (Uvikon 860). 
Ascorbic acid (0.05 mg/ml) was used as a positive control.
DPPH scavenging activity =
[(Absorbance control- Absorbance sample) /Absorbance control] x 100
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3.3.9. Metal chelating activity
Deionized water (1.6 ml) was mixed with 0.5 ml of sample at different 
concentrations (0.1- 8.8 mg/ml), 2 mM Ferrous chloride (0.05 ml) was added to the 
mixture and vortexed. After 30 s, 0.1 ml of 5 mM ferrozine was added, mixed and 
incubated for 10 min at room temperature. EDTA (0.1 mg/ml) was used as the 
positive control. The absorbance was measured at 562 nm on a spectrophotometer 
(Uvikon 860). The ferrous chelating activity was measured according to the 
following formula:
Ferrous ion chelating activity =
[(Absorbance control- Absorbance sample) /Absorbance control] x 100
3.4. Results and discussion
3.4.1. Superoxide scavenging activity
Pyrogallol (1, 2, 3-benzenetriol), is an autooxidizable chemical specifically at high 
pH and in alkaline solutions. Oxygen possesses two unpaired electrons with parallel 
spins and a great tendency to be reduced. The superoxide anion O2' is the product of 
this reduction. The superoxide anion is involved in autoxidation of pyrogallol. Due 
to the formation of several intermediate products during auotoxidation of pyrogallol, 
the colour of the solution varies from the beginning of the reaction to the end and can 
be measured spectrophotometrically (Marklund et ah, 1974). At the beginning of 
autoxidation, the solution is colourless and changes to a yellow-brown colour in a 
few minutes. After that the colour turns to green, and after a few hours, it becomes 
yellow. Any substance capable of scavenging superoxide anion will inhibit the 
pyrogallol oxidation and the formation of oxidation intermediate products, which 
will be viewed as a reduction in colour and lower absorbance.
Soy protein hydrolysate (SPH) scavenged superoxide anion and decreased the 
oxidation of pyrogallol. The superoxide scavenging activity of the SPH at 0.35, 1.7,
3.5, 5, and 7 mg/ml was 5.85, 17.38, 39.70, 49.87, and 58.75 % respectively (figure
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3.1). Antioxidant activity of the SPH at 7 mg/ml was significantly higher compared 
to other concentrations. At 5 mg/ml the antioxidant activity of SPH was significantly 
higher than 1.7 and 0.35 mg/ml. The IC50 value of SPH was 5.4 mg/ml. A low IC50 
indicates a high radical scavenging activity. BHA did not show any superoxide 
scavenging activity. In contrast, ascorbic acid had scavenging activity (39.96 %) at a 
very low concentration (0.03 mg/ml) (figure 3.1). These results showed that ascorbic 
acid is a stronger superoxide scavenger even at low concentration compared to SPH.
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Figure 3.1. Superoxide scavenging activity of the soy protein hydrolysate (0.035-7 
mg/ml) calculated from rate of pyrogallol oxidation. Ascorbic acid (0.03 mg/ml) and 
BHA (0.03 mg/ml) were used as positive control. The results are averages of three 
independent experiments.
The 2 kD fraction was also capable of decreasing pyrogallol autoxidation by 
scavenging superoxide radical in the same way as SPH. The superoxide scavenging 
activity of the 2 kD fraction was dose-dependent. The 2 kD fraction had strong 
significant inhibitory effect on pyrogallol oxidation at all concentrations (p < 0.05).
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The superoxide scavenging activity of the 2 kD fraction improved with an increase in 
concentration as at 1.7, 3.5 and 7mg/ml the activity was and 26.38, 39.94 and 
51.39%. Ascorbic acid exhibited 98.84% scavenging activity. The IC50 value for 
inhibiting pyrogallol oxidation was 6.4 mg/ml for the 2 kD fraction.
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Figure 3.2. Superoxide scavenging activity of the 2 kD fraction (1.7, 3.5 and 7 
mg/ml) calculated from rate of pyrogallol oxidation. Ascorbic acid (0.03 mg/ml) was 
used as a positive control. The values are averages of three replicates.
Peptides and protein hydrolysates have attracted researchers because of their 
potential antioxidant activity. The results of this experiment clearly demonstrated 
that both SPH and the 2 kD fraction scavenge superoxide radical and their activity. 
SPH and the 2 kD fraction are a mixture of bioactive peptides. It has been proved 
that bioactive peptides can decrease the rate of pyrogallol oxidation (Lin, 2007).The 
amino acid content and sequence of the peptides defines their free readical 
scavenging activity. Several low molecular weight peptides with ability to scavenge 
the superoxide anion have been identified (Tang et al., 2010).
Furthermore, the analysis of the SPH and the 2 kD fraction by HPLC showed that 
they contain isoflavones in very minute quantities including daidzin, daidzein, 
genistein and genistin (figure 3.11). The concentration of daidzein, genistein and 
genistin were significantly higher in the 2 kD fraction compared to SPH. Studies
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have revealed that genistein and daidzein and their metabolites have scavenging 
effect on superoxide anion (Rimbach et al., 2003). Besides, genisting and daidzin are 
shown to be protective agaist DNA damage by having a superoxide dismutase -like 
effect (Russo gr ah, 2006).
3.4.2. Hydroxyl radical (*OH) scavenging assay
In this experiment, the hydroxyl radical was produced in a Fenton reaction. The 
reaction of ferrous ions with hydrogen peroxide led to production of the hydroxyl 
radical. The a-deoxyribose sugar was attacked by the hydroxyl radical which led to 
the formation of several oxidation products. The reaction of thiobarbituric acid with 
oxidation products of deoxyribose results in formation of a thiobarbituric acid -  
malondialdehyde (TBA-MDA) adduct. The production of this adduct is evident by 
the appearance of a pink colour in the reaction solution which can be measured at 
532 nm (Gutteridge and Halliwell, 1988). Trolox (6-hydroxy-2, 5, 7, 8- 
tetramethylchromane-2-carboxylic acid) is an analogue of vitamin E which prevents 
oxidative damage (Hamad et al., 2010).
The soy protein hydrolysate had a dose-dependent hydroxyl radical scavenging 
activity. At 0.5 mg/ml, SPH exhibited 26.99% activity and at 2 mg/ml the scavenging 
activity was 53.26 mg/ml and the IC50 value was 1.73 mg/ml. There was a significant 
difference between the activity of trolox (73.46 %) and SPH (53.26 %) (P <0.05) 
(figure.3.3). Moreover there was a significant difference between all SPH 
concentrations (p <0.05) except 1.5 and 2 mg/ml.
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Figure 3.3.Hydroxyl radical scavenging activity of soy protein hydrolysate (0.005- 
2 mg/ml) measured as antioxidant activity against production of TEARS in a Fenton 
reaction system using a- deoxy ribose as oxidizable substance. Trolox (0.1 mg/ml) 
was used as positive control. The values are averages of three replicates.
The 2 kD fraction exhibited similar results to SPH. Below 0.5 mg/ml, it did not show 
any scavenging activity and there was a significant difference between the activity of 
trolox as positive control (74.3 %) and the 2 kD fraction at all concentrations. The 
scavenging activity of the 2 kD fraction was concentration dependent (figure. 3.4). 
The IC50 value was 1.85 mg/ml.
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Figure 3.4. Hydroxyl radical scavenging of the 2 kD fraction (0.005-2 mg/ml) 
fraction of soy protein hydrolysates measured as antioxidant activity against 
productionof TEARS in a Fenton reaction system using a-deoxy ribose as oxidizable 
substance. The results are averages of three replicates.
The hydroxyl radical is a strong free radical which can be generated either from 
superoxide anion or from the reaction of hydrogen peroxide with metal ions. The 
hydroxyl radical causes severe damage to all biomolecules including proteins, amino 
acids and DNA since it can easily react with what it comes into contact. The 
consequence of its reaction with biomolecules is severe cell damage which leads to 
several medical conditions including premature ageing and cancer (Ajibola et al., 
2011 ; Sheih et al., 2009).
In this study, A Fenton system was used to generate hydroxyl radicals. The 
following scheme can clearly demonstrates the reactions happening in this system 
(Gomes, et al. 2001):
1) Fe^+-EDTA + O2 -^Fe^+ EDTA -F O2
2) 2O2 -F 2H+ ^  H2O2 +O2
3) Fe^^-EDTA -F H202-> OH + 'OH + Fe^+ -EDTA
4) 'OH + deoxyribose oxidation products
5) Oxidation products —>heat treatment -^TBA+ acid MDA
6) 2TB A + MDA chromogen
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The hydroxyl radical scavenging activity of SPH and its low molecular weight 
fraction (2 kD) lies in the presence of amino acids and peptides in the protein 
hydrolysate (Ramakrishna et al., 2012). The hydroxyl radical scavenging activity of 
protein hydrolysates and peptides from various protein sources has been reported. 
(Pan et al., 2012; Zhuang and Sun, 2011). Protein hydrolysates and peptides exert 
their antioxidant and scavenging activity by donating protons from their amino acids 
to the radicals and the radical scavenging activity of a protein hydrolysate or peptide 
depends on its amino acid constituent. For example peptides containing amino acids 
Tyr, Phe and Try are excellent proton donors and free radical scavengers 
(Ramakrishna, 2012).
In a reported study, it was shown that daidzein reacts with hydroxyl radicals with 
both OH functional groups and forms daidzin radical (Chakraborty and Biswas, 
2012). In another study the methanolic extract of soya bean leaves which contains 
isoflavones was investigated for its hydroxyl radical scavenging activity and it was 
shown that it had scavenging effect in a dose-dependent manner (Ponnusha et al., 
2011).
3.4.3. Scavenging of hydrogen peroxide
SPH showed hydrogen peroxide scavenging activity which was dose-dependent. The 
IC50 value was 0.65 mg/ml. Even at the lowest concentration (0.06 mg/ml), soy 
protein hydrolysate exhibited some scavenging effect on hydrogen peroxide (2.54%). 
The scavenging activity increased dramatically to 87.08% at SPH concentration of 1 
mg/ml. Although the SPH exhibited high scavenging effect at 1 and 1.3 mg/ml, 
ascorbic acid and BHT were much stronger scavengers at low concentration (0.006 
mg/ml) (figure. 3.5).
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Figure 3.5. Hydrogen peroxide scavenging activity of soy protein hydrolysate 
(0.06-1.3 mg/ml) and its comparison with positive controls ascorbic acid and 
BHT (0.006 mg/ml). The results are averages of three replicates.
Hydrogen peroxide is generated in vivo from the action of enzymes including 
superoxide dismutase. The instability of hydrogen peroxide results in production of 
hydroxyl radical and singlet oxygen from hydrogen peroxide in a Fenton reaction. 
Hydroxyl radicals and singlet oxygen are toxic since they can start oxidation 
reactions such as lipid oxidation reactions. Therefore, it is vital to remove hydrogen 
peroxide from biological systems (Song et al., 2008).
In this study, the soy protein hydrolysate (SPH) exhibited scavenging effect on 
hydrogen peroxide. The scavenging effect could be due to the electron donating 
ability of SPH. Hydrogen peroxide scavenging activity of protein hydrolysates has 
been reported in other studies (Je et al., 2009; Zhuang et al., 2009). Furthermore, the 
isoflavones detected in SPH might have a role in the scavenging of hydrogen 
peroxide. It was revealed that genistein had a scavenging effect on exogenously- 
added hydrogen peroxide in HL-60 cell line (Wei et al., 1993).
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3.4.4. DPPH radical scavenging activity
The 1, 1-diphenyl-2-picryl hydrazyl DPPH is a stable free radical, capable of 
reacting with suitable reducing agents. DPPH is used vastly in investigating 
antioxidant activities of different compounds. The scavenging of DPPH by 
antioxidants occurs via proton donation. When DPPH reacts with an antioxidant, the 
colour of the solution decreases which can be measured spectrophotometrically at 
517 nm. A rapid decrease in the absorbance is a sign of a strong antioxidant activity 
(Pan et al., 2011; Nikhat et al., 2009). DPPH radical scavenging activity of SPH and 
2 kD increased with increased concentration. The IC50 for SPH and the 2 kD fraction 
was 15.25 mg/ml and 4.64 mg/ml respectively.
At the highest concentration (10 mg/ml), antioxidant activity of SPH was 35.61%. 
Ascorbic acid (0.05 mg/ml) showed 47.05 % scavenging activity at a very low 
concentration compared to SPH. There was a significant difference between 
scavenging activity of ascorbic acid and SPH at 10 mg/ml as the highest 
concentration (P<0.05) (figure 3.6).
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Figure 3.6. DPPH radical scavenging activity of soy protein hydrolysate at 
various concentrations (2.5-10 mg/ml) and its comparison with ascorbic acid 
( 0.05 mg/ml) as a positive control. The results are averages of three replicates.
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The radical scavenging activity of the 2 kD fraction at 10 mg/ml was 93.68 %; 
although it was significantly higher compared to ascorbic acid, ascorbic acid was 
more effective since it showed 51.51% scavenging activity at 0.05 mg/ml. This 
concentration is much lower compared to the concentrations used in the study for the 
2 kD fraction. At 0.5 mg/ml, 2 kD exhibited just 2.80% scavenging activity, whereas, 
ascorbic acid had 51.51 % at 0.05 mg/ml, which is a concentration lower than the 
minimum concentration used for the 2 kD fraction (figure 3.7).
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Figure 3.7. DPPH radical scavenging activity of the 2 kD fraction purified 
from soy protein hydrolysate (0.5-10 mg/ml) and its comparison with ascorbic 
acid (0.05 mg/ml). The IC50 value was 4.64 mg/ml. The results are averages of three 
replicates.
When antioxidant activity of SPH and the 2 kD fraction were compared a significant 
difference observed between them (P <0.05). Except for the low concentration (2.5 
mg/ml), the DPPH radical scavenging activity of 2 kD fraction was higher than SPH 
at 5, 7.5 and 10 mg/ml.
SPH and the 2 kD fraction used in this study were protein hydrolysate which contain 
peptides, amino acids and traces of isoflavones responsible for radical scavenging 
activity. After fractionation, the 2 kD fraction, which is a fraction containing lower 
molecular weight peptides showed higher DPPH radical scavenging activity. 
Fractionation with membrane ultrafiltration results in production of more potent
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peptides in terms of antioxidant activity (Park et ak, 2008) and it has been proved in 
other studies (Zhong et al., 2011; Sun et al., 2011).
Since the radical scavenging activity of the soy protein hydrolysate and the 2 kD 
fraction was significantly different probably due to the difference in amino acid 
structure, composition and length of the peptides might be the reason (Hwang et al., 
2010). The DPPH radical scavenging activity could not be due to the presence of 
peptides only since isoflavones daidzein and genistein have been found to have 
DPPH radical scavenging activity (Liang et al., 2010; Kim et al., 2012).
3.4.5. Metal chelating activity
The metal chelating activity of a substance can be measured via the reaction of 
ferrous iron with 3-(2-pyridyl)-5, 6-bis (4-phenyl-sulfonic acid)-l, 2, 4-triazine 
(ferrozine) that results in an oxidation-resistant purple complex (Amax=562 nm) [Fe 
(II) Fzs] being formed (Berlett et a l, 2001).
As shown in figure 3.8, the chelating activity increased in a dose-dependent manner 
(from 0.1 to 8.8 mg/ml). FDTA, a known chelator, showed chelating activity of 
93.54 %. The difference between the chelating activities of FDTA and SPH at all 
concentrations were statistically significant (p<0.05). The metal chelating activity of 
SPH at 0.1, 0.2, 4.4, 6.6 and 8.8 mg/ml was 3.50, 4.14, 67.06, 74.27 and 85.04 % 
respectively. There was a significant difference between the chelating activity of 
SPH at 0.1 and 0.2 mg/ml with the chelating activity at higher concentrations. 
Although the activity at 8.8 mg/ml was higher than at 6.6 mg/ml, the difference was 
not significant (P > 0.05). FDTA was used at a very low concentration (0.02 mg/ml) 
compared to SPH, but it showed much higher chelating activity.
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Figure 3.8. Ferrous ion chelating activity of SPH (0.1-8.8 mg/ml) and its comparison 
with FDTA (0.02 mg/ml) as a positive co ntrol. The results are averages of three 
independent experiments. SPH was tested in triplicate.
Different concentrations of the 2 kD fraction (0.1, 0.2, 3.3, 4.4, 6.6, 8.8 mg/ml) 
showed iron chelating activity (figure 3.9) which was significantly different between 
concentrations (P <0.05) except between 8.8 and 6.6 mg/ml, and 3.3 and 0.2 mg/ml. 
There was a significant difference between the chelating activity of FDTA and the 2 
kD fraction at 0.1, 0.2, 3.3, and 4.4 mg/ml.
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Figure 3.9. Ferrous ion chelating activity of the 2 kD fraction (0.1-8.8 mg/ml) and its 
comparison with FDTA (0.02 mg/ml) a a positive control. The results are averages of 
three independent experiments and the tubes were tested in triplicate.
When SPH and the 2 kD fraction were compared for iron chelating activity, there 
was no difference between their activities except at concentration of 4.4 mg/ml and 
SPH exhibited more than twice (67.06%) the activity of the 2 kD fraction (32.26 %) 
(figure 3.10).
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Figure 3.10. Comparison between ferrous ion chelating activities of soy 
protein hydrolyste (SPH) and the 2 kD fraction (0.1-8.8 mg/ml) purified from SPH 
and EDTA (0.02 mg/ml) as a positive control. The results atre averages of three 
independent experiments.
Lipid oxidation reactions require an initiator to start the reactions and the most well- 
known and common initiators are reactive oxygen species (ROS). The most reactive 
ROS is the hydroxyl radical ("OH). Generation of "OH may occur via the action of a 
metal ion during the Fenton reaction. Besides, other free radicals such as peroxyl 
radicals can be generated by the decomposition of lipid hydroperoxides via the action 
of metal ions. Therefore, it is crucial to remove the metal ions from biological 
systems. Chelating agents stabilize the metal ions in an oxidized form since they 
decrease the redox potential (Benedet et al., 2008; Cheng et al, 2006)
In this study, SPH and the 2 kD fraction inhibited formation of ferrous-ferrozin 
complex, implying that they have chelating activity and can capture the ferrous ion 
before it reacts with ferrozine and form the complex which is due to the presence of 
peptides and amino acids. Hydrophobic peptides are strong chelators of iron (Wang 
et al., 2009). In addition, peptides with a high content of Glu and Asp might be 
crucial for binding with iron and iron chelation (Lv et al., 2009). Genistein, genistin, 
daidzein and daidzin have metal chelating activity (Wang et al., 2012) and it is
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accepted that the metal chelating activities of flavonoids are influential in their 
antioxidant activity (Symonowic and Kolanek, 2012).
The antioxidant activity of SPH and the 2 kD fractions lies in their amino acid(table 
2.6) and isoflavone contents (figure 2.13 and table 2.9). Soy protein hydrolysate 
(SPH) has higher amounts of Asp, Glu, Pro and Gly, whereas the 2 kD fraction is 
rich in Arg, Ala, Tyr, Leu, Met, Leu, Phe, Trp and Lys. In the antioxidant 
experiments, both SPH and the 2 kD fraction showed activity which is apparently 
due to the presence of high total amino acid content, but, in three tests, the 2 kD 
fraction had either higher IC50 value (superoxide scavenging test, hydroxyl radical 
scavenging experiment) or higher activity (DPPH radical scavenging test). This 
could be due to the presence of more hydrophobic amino acids in the 2 kD fraction. 
Several studies have pointed out that the radical scavenging activity of peptides lies 
in the presence of hydrophobic amino acids in their structure (table 2.6) (Wang et al., 
2009; Li et al., 2008; Nalinanon gf a/., 2011).
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Figure 3.11. Isoflavone content of SPH and the 2 kD fraction detected by 
HPLC. The results are averages of three replicates.
The results obtained from HPLC showed that the 2 kD fraction and SPH contain 
minute quantities of isoflavones (table 3.11). The presence of isoflavones and amino 
acids was further investigated by NMR spectroscopy. No isoflavones were detected 
in the samples using NMR due to their low concentration (figure 3.12). Figure 3.12 
shows the NMR spectra of the samples and standard isoflavones. As it is clear no
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isoflavones were detected in the samples when their spectra were cpmpared with 
that of standard isoflavone. Amino acids Tyr, Lys, Phe, Gin, Ala and Ser were 
detected with NMR and appendices 2-4)
8 « 4 2 [ppm]
Figure 3.12. Analysis of soy protein fractions for presence of isoflavones. From the
bottom the spectra represent the following fractions; SPH (A), 10 kD (B), 5 kD (C),
2 kD (D), OFF 36 (E), and standards daidzein (F), genistein (G), daidzin (H), 
genistin (I), formononetin (J).
3.5. Conclusion
In this study it was proved that SPH and its low molecular weight fraction possess 
antioxidant activity against different free radicals. Peptides, protein hydrolysates and 
the presence of trace quantities of isoflavones exhibit different antioxidant activities 
in different model systems. Therefore, more than one method must be used to 
determine their free radical scavenging and antioxidant activity. The free radical 
scavenging activity of the peptides depends on their amino acid composition and the 
way they are arranged next to each other in a sequence. Besides, the hydrophobicity 
of the peptides plays an important role in their activity and hydrophobic peptides
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have been shown to be better antioxidants. Moreover, the activity of the peptides 
depends on the enzyme used to hydrolyse the proteins. It was also found that all 
fractions had antioxidant activity indicating that a combination of soya peptides 
produced better antioxidant peptides compared to specific fraction using hydrolysis 
with a single enzyme. Furthermore, peptide sequence and amino acid composition 
depends on the original protein source in terms of being a plant protein or an animal 
protein. The antioxidant activity of the isoflavones depends on their structure. The 
antioxidant activity of the fractions in this study may not be due to the presence of 
peptides only since the fractions contained isoflavones in minute quantities.
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CHAPTER 4
4.0 ANTIOXIDANT ACTIVITY OF SOY PROTEIN 
HYDROLYSATE FRACTIONS IN THE PRESENCE OF COPPER
4.1. Introduction
In food systems, metal ions can decompose primary lipid peroxides and generate free 
radicals which decrease food quality and safety specifically during cooking and 
storage (Maraschiello et ah, 1999). Furthermore, there is a relationship between lipid 
peroxidation, deficiency of amino acids, cardiovascular disease and atherosclerosis 
(Rumley et al., 2004).
In all forms of cardiovascular disease, formation of an atheroma (atherosclerotic 
plaque), occlusion of small blood vessels and disruption of blood flow is common. 
The plaque may rupture, cause a thrombus and may occlude the blood vessels in a 
site away from the initial site (Fearon and Faux, 2009).
LDL oxidation is an important factor in atherosclerotic plaque formation and 
initiation of atherosclerosis. Oxidation of LDL occurs via enzymatic and non- 
enzymatic pathways and mechanisms (Young and McEneny, 2001). Different arterial 
wall cells such as smooth muscle cells and endothelial cells are capable of oxidizing 
LDL (Lynch and Erei, 1993) involving lipoxygenases, peroxidases and heme 
proteins and transition metal ions (Ghaffari and Mojab, 2008). Copper ions are 
reported to initiate lipid peroxidation in different model systems using various lipids 
such as linoleic acid and LDL (Ueda et al., 1999).
Oxidized LDL promotes atherosclerosis since it has several chemoattractant 
properties. It attracts monocytes and T-cells and differentiates monocytes to 
macrophages. Therefore, the atherosclerotic plaque contains monocytes and T cells 
and it is immunogenic. During transformation of LDL to oxidized LDL
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lysophosphatidylcholine is generated which is responsible for the chemoattractant 
activity of oxidized LDL. Since oxidised LDL is cytotoxic for cells, it causes 
endothelial injury in the arterial wall (Young and McEneny, 2001). Based on results 
from cell culture studies, oxidation of LDL depends on the presence of metals such 
as copper. Moreover, in vitro LDL oxidation can be initiated by copper ions. Briefly, 
copper ions bind to apolipoprotein B-lOO (apo B) in the structure of LDL and start 
the oxidation process.
Half of the molecules found in low density lipoprotein (LDL) are polyunsaturated 
fatty acids (PUEAs). The main component of unsaturated fatty acids in LDL is 
linoleic acid. The LDL particle is protected against oxidation by its endogenous 
antioxidants including a-tocopherol and P-carotene. LDL oxidation is mediated 
through free radicals and many structural changes occur in the LDL particle both in 
the fatty acid and protein moiety. Transition metals such as copper are essential for 
LDL oxidation in cell cultures. In the absence of cells, metal ions are capable of 
oxidizing LDL as well. Oxidized LDL produced by copper has similar characteristics 
to LDL oxidized by cells. Copper ions can initiate the redox cycling reactions with 
endogenous lipid hydroperoxides of LDL.
The oxidation process has three phases including lag phase, propagation phase and 
decomposition phase.
1. Lag phase
During the lag phase copper ions react with endogenous lipid hydroperoxides 
(LOOH) which results in the formation of peroxyl (LOO’) and alkoxyl (LO’) radicals 
that initiate oxidation reactions by abstracting a hydrogen atom from a PUFA. 
Following intermolecular rearrangements, conjugated dienes are formed.
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The series of reactions can be indicated as follow:
Cu^+ + LOOH Cu^ + LOO’ + H+
Cu+ + LOOH + LO’ + OH
LOO’ and LO’ + PUFA —> -H* + molecular rearrangements —> Conjugated dienes
During the lag phase, minimum LDL oxidation occurs and oxidation is delayed due 
to the presence of endogenous antioxidants. In other words endogenous antioxidants 
of LDL are consumed during this initial phase and PUFAs are protected against 
oxidation (figure 4.20).
2. Propagation phase
When the amount of antioxidants in the LDL structure is decreased, the alkoxyl and 
peroxyl radicals abstract another hydrogen atom and generate lipid peroxides. This 
stage is propagated by oxygenation. The reaction is as follows:
LOO’ + LH (PUFA)-> LOOH + L’
LO’ + L H ^ L O H  + L’
L’ +O2 LOO’
3. Decomposition or degradation phase
Lipid hydroperoxides are transient products and their concentration increases up to 
the point that their rate of formation exceeds their rate of decomposition. Decrease 
in lipid hydroperoxides becomes dominant when about 80% of the PUFAs have been 
consumed within LDL.
During this phase, lipid hydroperoxides are decomposed to aldehydes by P-cleavage 
and the main aldehydes produced are malondialdehyde (MDA), 4-hydroxynonenal
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(HNE) and hexanal. Furthermore the oxidative modification in LDL causes changes 
in the tertiary structure of the apoB-100. In other words, the generated aldehydes can 
form a Schiff base with positively charged amino acids such as lysine residues of 
apoB-100 and these results in occurrence of negative charge on the LDL particle. 
The change in the structure of the apoB-100 and charge of the LDL can promote 
LDL binding to the putative receptors and/or accumulation of cholesterol (Roland et 
al., 2001; Burkitt, 2001; Chehin et al., 2001; Jialal and Devaraj, 1996; Esterbauer et 
a l, 1991).
The histidine residue on apo B may be a copper binding site (Retsky et ah, 1999). 
Epidemiological studies have shown a link between the deficiency of antioxidants 
and cardiovascular disease (Young and McEneny, 2001). Many studies report the 
metal chelating and antioxidant properties of protein hydrolysates and peptides. For 
example, (Chen et a l, 1998) proved the metal chelating property of histidine 
containing peptides designed, based on peptides in soy bean protein digests. 
Camosine, a dipeptide (p-alanylhistidine) reduces copper-dependent LDL oxidation 
possibly by chelating of copper ions (Bogardus and Boissonneault, 2000). The amino 
acid histidine has been proved as an inhibitor of LDL oxidation (Retsky et a l, 1999). 
In addition, isoflavones have been found to be effective against LDL oxidation. For 
instance, genistein is capable of inhibiting copper-dependent LDL oxidation 
(Kapiotis et al., 1997; Kerry and Abbey, 1998). In another study, daidzein was 
combined with a-tocopherol and their synergistic effect against LDL oxidation was 
evaluated. It was revealed that combination of daidzein and a-tocopherol can inhibit 
LDL oxidation better than daidzein alone (Wang et a l, 2010). Therefore, in this 
study, the copper chelating properties of soy protein hydrolysate and its lower 
molecular weight fractions was investigated in different model systems using linoleic 
acid and LDL. In addition, the chelating property was also examined in-oil free 
systems.
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4.2. Materials
Soy protein isolate was purchased from Kerry Ingredients, Bristol, UK. Linoleic 
acid, butylated hydroxytoluene (BHT), copper sulphate, L-ascorbic acid, copper 
chloride, sodium dihydrogen orthophosphate, disodium hydrogen orthophosphate, 
pyrocatechol, ethylenediaminetetraacetic acid (EDTA), sodium bromide and bovine 
serum albumin, genistein, daidzein, genistin, daidzin and formononetin, formic acid, 
zinc acetate and potassium ferrocyanide were purchased from Sigma-Aldrich, 
Dorset, UK. Potassium dihydrogen orthophosphate (KH2P04), Tris-HCl, sodium 
chloride and phosphate buffer saline (PBS) tablets were purchased from Fisher 
Scientific, Loughborough, UK F. PD Midi Trap G-10 column and HiPrepTM IMAC 
FF 16/10 were obtained from GE Healthcare. Pyridine was kindly donated by the 
Department of Chemistry, University of Surrey. All the reagents were of analytical 
grades.
4.3. Methods
4.3.1. Preparation of soy protein hydrolysate: refer to 2.3.2.
4.3.2. Fractionation of soy protein hydrolysate using ultrafiltration: refer 
to 2.3.5.
4.3.3. Antioxidant activity of SPH in the linoleic acid system in the 
presence of copper
4.3.3.1. Preparation of linoleic acid model systems
Soy protein hydrolysate (250 mg) was mixed with 4.87 ml distilled water, 0.13 ml 
linoleic acid, 10 ml ethanol 99.5%, and 10 ml 50 mM phosphate buffer (pH 7.0). The 
samples flasks were kept at 40°C in the dark. BHT was used as positive control and a 
negative control was prepared without the hydrolysate. In order to evaluate the 
copper-binding activity, CUSO4 was added to the linoleic acid model systems. The 
final concentration of copper sulphate in the linoleic acid model system was 10'  ^M. 
The production of primary and secondary products was evaluated for 7 days.
4.3.3.2. Assessing peroxide value: refer to 2.3.8.1
4.3.3.3. Assessing TEARS value: refer to 2.3.S.2
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4.3.4. Determination of copper chelating activity using ascorbic acid
Following solutions were mixed: 20 mM Tris-HCl (pH 7.5), CuCli, ascorbic acid and 
soy protein hydrolysate and its fractions with different molecular weight at different 
concentrations. Oxidation of ascorbic acid was measured spectrophotometrically at 
265 nm at room temperature (Nishikawa et al., 1997).
4.3.5. Fractionation of SPH using affinity chromatography
In order to purify peptides with copper chelating activity, affinity chromatography 
with a HiPrepTM IMAC FF 16/10, ready-to-use column, pre-packed with uncharged 
IMAC Sepharose™ 6 Fast Flow resin, was used. Deionized water was used to remove 
the 20% ethanol (the storage solution) from the column. The column was charged 
with 10 ml of 0.1 M copper chloride in distilled water. Then it was washed with 100 
ml of distilled water and equilibrated with 100 ml of binding buffer at pH 7.4 ( 0.02 
M sodium phosphate buffer containing 1 M NaCl). SPH (5 ml, 20 mg/ml) was 
injected to the column and peptide fractions were eluted using the equilibration 
buffer. After 90 min, another 5 ml of SPH was injected on to the column and the 
fraction was collected with equilibration buffer at pH 4 for 90 min. The procedure 
was repeated with equilibration buffer at pH 3. Altogether, 3 peptide fractions were 
collected separately after 270 min and labelled P7.4, P4, and P3 (P= peptide, number 
= pH of the equilibration buffer). Fractions from six chromatography runs of each 
fraction were collected, pooled and freeze dried. The absorbance of fractions was 
determined using a spectrophotometer at 215 nm (Lo and Li-Chan, 2005). The dried 
peptides were desalted prior to use by PD MidiTrap G-10 columns according to the 
instructions provided by the company.
4.3.5.I. Determination of copper content by Atomic Absorption Assay
The copper content of the fraction obtained from affinity chromatography after the 
desalting procedure was assessed using atomic absorption assay. A series of dilutions 
(0.5-5 ppm) of copper nitrate was prepared and the concentration of the copper in the 
sample was calculated based on the standard curve obtained for copper nitrate with 
atomic absorption assay.
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4.3.6. Copper chelating property with pyrocatechol violet and pyridine
One ml of 2 mM CUSO4 was mixed with pyridine (1 ml, 10 %, w/v) and 20 pi of 
pyrocatechol violet (0.1 % w/v). In the next step, 1 ml of sample (SPH and its 
fractions obtained by membrane fractionation and affinity chromatography) was 
mixed with the rest of the solution and, after 5 min; the absorbance of the solution 
was measured at 632 nm on a spectrophotometer. Deionized water was used instead 
of the sample for the negative control (Zhang, 2011). Ascorbic acid was used as 
positive control. The following formula was used to calculate the copper chelating 
activity:
Copper chelating activity= (Absorbance Absorbance x 100
Absorbance control
4.3.7. Antioxidant activity of the GFF 36 against LDL oxidation
4 3.7.1. Purification of low density lipoprotein from blood
LDL was purified from 50 ml of blood provided by a healthy, non-smoker male 
individual. Blood was centrifuged using a bench centrifuge at 2000 rpm (1750 % g) 
for 20 min at 10°C. The recovered plasma was pooled and the volume was measured. 
Then the plasma density was adjusted to 0.45 g/ml by the addition of solid sodium 
bromide (mass of sodium bromide to adjust the density = the volume of plasma x 
0.45). The density-adjusted plasma was layered under saline (100 pM EDTA, 154 
mM sodium chloride). The under-layered plasma was centrifuged for 2 h at 45000 
rpm (10°C) (Centrifuge XL-100 Beckman ultracentrifuge, Ti60 rotor). After 
centrifugation, the LDL, which was located half way down the centrifuge tube, was 
collected and concentrated by a second centrifuge step according to the following 
instructions: The high density solution (5 ml, 1.75 M sodium bromide containing 
100 pM EDTA) was placed into the tube, followed by 7 ml of LDL and 10 ml of 
low density solution (0.78 M sodium bromide containing 100 pM EDTA). The 
solutions were transferred with extra care in order to prevent them from mixing. The 
LDL was centrifuged (140,000 x g, 16 h, and 10°C). At the end, the floating orange 
layer (LDL) on top of the tube was collected and kept at 4°C for up to one month 
(Spence, 2005).
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Phosphate buffer saline (PBS, pH 7.4) was prepared with 10 mM potassium 
dihydrogen orthophosphate and 154 mM sodium chloride and 10 pM EDTA. LDL 
was dialysed using the mentioned buffer in order to remove all the salts which might 
be problematic during LDL oxidation. LDL was dialysed using a semi-permeable 
membrane. In order to have uniform pore size in the membrane and to remove any 
possible contamination, the dialysis membranes were boiled in water for 15 min 
before dialysis. The LDL sample (2-3 ml) was dialysed at 4°C, 40 min. A fresh 
dialysis solution was used every 40 min and the whole process was repeated 5 times. 
The LDL fraction recovered after dialysis was kept at 4°C and was used within 5 
days (Spence, 2005).
4.3.7. 2. Determination of LDL protein concentration
The protein concentration of LDL was calculated using the Lowry method. Two 
dilutions of LDL sample (1:50 and 1:100) were used to determine protein 
concentration. The standard solution was bovine serum albumin. A volume of LDL 
containing 62.5 pg/ml (concentration) proteins was needed for oxidation reactions 
and it was calculated from the BSA standard curve (Spence, 2005).
4.3.7.3. LDL oxidation and measurement of copper chelating activity of the 
samples
Copper sulphate solution was used to initiate LDL oxidation. The copper 
concentration required for LDL oxidation was 1.66 pM. The volume representing 
this concentration depends on the LDL protein content. Therefore, the volume of 
copper required was calculated after each LDL dialysis. A volume of LDL solution 
containing 62.5 pg/ml of protein was incubated with 30 pi of P4 sample (150 and 
300 pg/ml) and GFF 36 (10, 30 and 50 pg/ml) and a volume of copper sulphate 
solution containing 1.66 pM directly in a quartz cuvette. The final volume of the 
reaction mixture was 1 ml after adding PBS. The LDL was added first followed by 
sample, PBS and finally the copper sulphate solution. The LDL oxidation and 
formation of conjugated dienes were monitored on a Unicam UVl 
spectrophotometer equipped with temperature control at 234 nm, 30°C, every 10 
min, for at least 20 h (Spence, 2005).
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4.3.8. Determination of amino acid content: refer to 2.3.9.
4.3.9. Determination of isoflavone content of soy protein isolate and 
related fractions: refer to 2.3.11.
4.3.10. Determination of isoflavones and amino acids using NMR 
spectroscopy: refer to 2.3.12
4.4. Results and discussion
4.4.1. Copper binding activity of SPH and its fractions using ascorbic acid 
as an oxidation indicator
The copper chelating property of the soy protein hydrolysate (SPH) and fractions 
with different molecular weights was determined by oxidizing ascorbic acid (50pM) 
using copper chloride. The ability of the SPH and its fractions towards chelating of 
copper was determined by reading the absorbance of ascorbic acid at 265 nm. It was 
assumed that a higher absorbance indicated higher concentration of ascorbic acid 
remaining in the reaction solution.
In the first step, the oxidation of ascorbic acid was evaluated using different 
concentrations of copper chloride. The selected concentration for copper was within 
the physiological range (2-24 pM). The oxidation reaction was monitored within 2- 
min for all copper concentrations. As shown in figure 4.1, copper-dependent ascorbic 
acid oxidation was dose-dependent and, as the copper concentration increased the 
ascorbic acid oxidation increased (P < 0.05), resulting in a decrease in the absorbance 
of the remaining ascorbic acid in the reaction solution. Moreover, it is clear from the 
figure that oxidation of ascorbic acid increased with time. For example, at copper 
concentration of 2 pM, the absorbance of ascorbic acid in the beginning (0 time) was
0.623 whereas, after 2 min, it decreased significantly (P < 0.05) to 0.457, indicating 
the presence of less ascorbic acid in the solution. At higher copper concentrations, 
the decrease in absorbance of ascorbic acid was greater. For instance, at 23 pM, there 
was no significant difference between the absorbance of ascorbic acid from the 
beginning of the experiment to the end (P < 0.05) (0 -2 min).
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Figure 4.1. Decrease in ascorbic acid (50 pM) absorbance with an increase in 
copper concentration (2-23 pM) and with time. The results are averages of three 
replicates.
In the next experiment, SPH and its fractions (200 pg) were incubated with copper 
and ascorbic acid to assess their ability towards copper chelating. EDTA, a known 
metal chelator, was used as a positive control. Figure 4.2 shows that the absorbance 
of ascorbic acid in the presence of copper and SPH fractions was significantly lower 
(P < 0.05) than the control (copper + ascorbic acid, Cu + AA) except for the 5 kD 
and 2 kD fractions, indicating greater oxidation of ascorbic acid. As the molecular 
weight of the fractions decreased, the absorbance of ascorbic acid increased showing 
reduced oxidation of ascorbic acid, but the absorbance was still lower compared to 
control (Cu + AA). Although there was no significant difference between the 
absorbance of ascorbic acid in the control (Cu + AA) and with the 2 kD fraction, the 
absorbance of ascorbic acid increased significantly (P <0.05) in the order SPH, 10, 5 
and 2 kD indicating an increasing preventive effect of ascorbic acid oxidation with 
purification of the fractions. When EDTA was used as a chelator, the absorbance of 
ascorbic acid was 0.682 which was significantly (P<0.05) higher than that of control 
(0.603). Absorbance of unoxidized ascorbic acid (without any copper and protein 
hydrolysate) was significantly higher (P<0.05) compared to control (Cu 4- AA) 
indicating that copper had a positive effect on the oxidation of ascorbic acid. There 
was no significant difference between absorbance of ascorbic acid alone and in the
96
EDTA tube, indicating that EDTA had effectively chelated copper and inhibited 
ascorbic acid oxidation.
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Figure 4.2. Inhibitory effect of soy protein hydrolysate (200 pg/ml) fractions 
on oxidation of ascorbic acid (50 pM) incubated with copper (2pM), measured 
as absorbance of remaining ascorbic acid in the solution after 2 min. All the 
absorbance values were compared with Cu+AA (negative control) which did not 
contain any antioxidant. EDTA was (0.01%) used as a positive control. The values 
are averages of three replicates.
In a separate experiment (figure 4.3), SPH and the fractions were tested at a higher 
concentration (600 pg/ml). The results showed that the absorbance of ascorbic acid 
in the presence of SPH and fractions at higher concentration (600 pg) was lower 
compared to a low SPH concentration (200 pg/ml). This result proved that higher 
concentrations of SPH and its fractions were more oxidising.
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Figure 4.3. Inhibitory effect of soy protein hydrolysate (600 pg/ml) fractions 
on the oxidation of ascorbic acid (50 pM) incubated with copper (2 pM), measured 
as absorbance of remaining ascorbic acid in the solution after 2 min. All the 
absorbance values were compared with Cu+AA (negative control) which did not 
contain any antioxidant. EDTA (0.01%) was used as a positive control. The values 
are averages of three replicates.
Ascorbic acid is an antioxidant which exists in oxidized and reduced forms in nature. 
It is a very unstable compound which degrades by air, oxygen, light, transitional 
metals and some other oxidants. Autoxidation of ascorbic acid can be catalysed by 
metal ions such as Cu (H) and Ee(III) (Ogata et al., 1969). Complexation of copper 
ions by ligands such as EDTA and amino acids modifies its catalytic activity in 
oxidation reactions. In other words, the copper-ligand complex becomes more stable 
and this affects the oxidation reactions (Imer et al., 2008). Amino acids and peptides 
can form complexes with metal ions including copper (Sovago et ah, 2003).
Oxidation of ascorbic acid by copper increased two-fold by complexation with
histidine oligopeptides. Ueda et al. demonstrated that the molecular weight of the 
peptide and number of histidyl residues are important factors in their potential for 
oxidizing ascorbic acid after forming a complex with free copper ions. They
concluded that the peptides with higher molecular weight can bind to more copper
atoms resulting in formation of more effective complexes with copper with higher
98
oxidizing capability towards ascorbic acid (Ueda et aL, 2000). SPH and its fractions 
can bind to copper ions due to the presence of peptides capable of forming 
complexes with transition metals. The complex formed by the peptide and copper 
ions is more potent than free copper ions towards ascorbic acid oxidation. Thw 
absorbance of ascorbic acid in the reaction mixtures containing SPH + copper was 
lower compared to the control (copper ions only). It means that the rate of ascorbic 
acid oxidation in the solution containing SPH + copper complex was higher 
compared to the control. Peptides with high molecular weight might be responsible 
since they might have strong copper chelating activity and probably higher oxidizing 
activity of their copper complexes compared to control (free copper ions only). This 
finding was observed in other studies as well (Ueda et aL, 2000).
Decrease in ascorbic acid oxidation with presence of SPH which had been 
fractionated into lower molecular weight fractions might be due to this fact that 
higher molecular weight peptides bind to more copper atoms (Zhang et aL, 2010) and 
form stronger complexes. Apart from histidine, basic or acidic amino acids in a 
protein hydrolysate or peptide play a significant role in metal chelation (Zhang et aL, 
2009). According to tables 2.6 and 2.7, all the fractions have acidic and basic amino 
acids Asp, Glu, Arg, Lys and some His. The per cent compositions of Asp and Glu 
were higher in SPH and in the 10 kD fraction, which indicates why SPH and the 10 
kD fraction decreased ascorbic acid absorbance more than the 5 kD fraction and the 
2 kD fraction. SPH and the 10 kD fraction formed strong complexes with copper ions 
and oxidized ascorbic acid; therefore, they are good chelators. Glutamic acid has 
strong metal chelating activity (Dundar et aL, 2012).
The inhibitory effect of the 2 kD fraction in a range of concentrations was checked 
in separate experiments. Figure 4.4 clearly demonstrates that the protective effect of 
2 kD fraction against copper-dependent oxidation of ascorbic acid is dose-dependent. 
As the concentration of the 2 kD fraction decreased, the absorbance at 265 nm of 
ascorbic acid decreased indicating more oxidation with free copper ions. As it is 
demonstrated in figure 4.4, conversely, the ascorbic acid absorbance and chelating 
activity increased when the concentration of the 2 kD fraction increased from 1 
pg/ml to 600 pg/ml.
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Figure 4.4. Decrease in absorbance of ascorbic acid (50 pM) oxidized by copper (2 
pM), incubated with and without the 2 kD fraction at different concentrations (1-600 
pg/ml). The values are averages of three replicates. Ascorbic acid (AA) was used as 
a positive control.
Compared to SPH, the 2 kD fraction has lower peptide content with lower molecular 
weight. It was mentioned above that higher molecular weight peptides have higher 
chelating activity (Ueda et aL, 2000). The higher absorbance of ascorbic acid in the 2 
kD fraction + copper might be due to the presence of peptides with lower molecular 
weight and lower chelating activity which results in the formation of less effective 
complexes towards ascorbic acid oxidation. On the other hand, the 2 kD fraction 
concentration and amino acid content seems to be a more effective factor in ascorbic 
acid oxidation.
For example, at 1 pg/ml, the amino acid content is too low to chelate the copper ions, 
so ascorbic acid will be oxidized by copper ions only rather than the amino acid + 
copper complex. An increase in concentration of the 2 kD fraction will increase 
amino acid content and improve the chelating properties of this fraction and prevent
1 0 0
ascorbic acid oxidation by copper. The effect of the 2 kD fraction on oxidation of 
ascorbic acid is dose dependent.
Figure 4.5 shows that incubation of copper (at different concentrations) and ascorbic 
acid with the 2 kD fraction at a high concentration (0.5 mg/ml) increased ascorbic 
acid oxidation. Absorbance of ascorbic acid in the reaction mixture containing 
copper ions at different concentrations was significantly higher (P < 0.05) compared 
to the reaction mixtures containing copper ions and the 2 kD fraction.
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Figure 4.5. Effect of copper ions (2-23 pM) and the 2kD fraction 4- copper ions (Cu) 
on ascorbic acid (AA, 50 pM)) oxidation after 2 minutes of incubation. The values 
are averages of three replicates.
4.4.2. Copper-binding activity of soy protein hydrolysate (SPH) in a 
linoleic acid model system
As it is illustrated in figure 4.6, after three days of storage, TEARS concentration in 
all the linoleic acid-containing-systems reached the highest point except for tubes 
containing BHT which reached the highest point after 2 days. Copper had a positive 
effect on linoleic acid oxidation. When the two linoleic acid model systems without 
any added antioxidant (two negative controls) were compared, a significant 
difference between the concentrations of TEARS was observed between them on
1 0 1
days 3, 4 and 6 (P <0.05). After 3 days of storage, the concentration of TEARS in the 
linoleic acid model systems containing copper and oil was 1.03 pg/ml whereas this 
value for linoleic acid model systems containing linoleic acid alone was 0.45 pg/ml. 
It was clearly proved that copper enhanced the oxidation of linoleic acid (fig. 4.6).
There was no significant difference between the TEARS value of two linoleic acid- 
containing systems in which SPH was used as antioxidant during 7 days of storage 
(P < 0.05). In one of the systems, copper and heat was used to oxidize the oil and, in 
the other system, linoleic acid was oxidized by heating. The results indicated that 
although copper enhanced linoleic acid oxidation (evident from results of two 
controls), SPH prevented copper-dependent and temperature-dependent oxidation of 
linoleic acid in two systems containing SPH. There was no statistical difference 
between the TEARS value in two tubes containing SPH as antioxidant (p >0.05). 
Even on the third day of storage, when the TEARS value was at the highest point, 
there was no significant difference between the system containing soy protein 
hydrolysate (p > 0.05) (figure 4.7). Moreover, TEARS values were significantly 
lower (P <0.05) (figures 4.6 & 4.7) in the system containing SPH, copper and oil 
compared with its negative control (copper + oil), indicating that SPH was a very 
effective antioxidant.
From the second day of storage, EHT as positive control, significantly inhibited 
linoleic acid oxidation, compared with the system containing linoleic acid only 
(P<0.05) (figure 4.6). Thus, the TEARS value on the third day for the system 
containing EHT was 0.26 pg/ml compared with 0.45 pg/ml for the system containing 
linoleic acid. Oxidation of linoleic acid by copper in the presence of EHT was not 
checked.
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Figure 4.6. Inhibitory effect of SPH (10 mg/ml) against linoleic acid oxidation in the 
presence and absence of copper (lO'^M) during 7 days of storage at 40 °C in the dark. 
BHT (100 ppm) was used as a positive control. The values are averages of three 
replicates.
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Figure 4.7. Comparison between TBARS concentrations in linoleic acid model 
systems containing copper (lO'^M) as an oxidizing agent and SPH (10 mg/ml) as 
antioxidant after 3 days of storage at 40 °C in the dark. The values are averages of 
three replicates.
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The antioxidant activity of SPH against copper-dependent and temperature- 
dependent oxidation of linoleic acid is due to the presence of peptides and amino 
acids in the SPH. Proteolytic treatment of soy protein isolate resulted in the 
formation of products which bind to copper (copper chelating agents) and prevent 
methyl linoleate oxidation (Yee et a\., 1980). Bioactive peptides in the protein 
hydrolysates have been shown to be responsible for chelating activity (Carrasco- 
Castilla et al., 2012).
The antioxidant and chelating activity of bioactive peptides depend on the amino 
acid sequence and content. Histidine-containing dipeptides, anserine and camosine, 
have been reported to be effective antioxidant and chelating agents as the imidazole 
group in histidine has biological activity (Wu et ah, 2003). Amino acids like 
tyrosine, phenylalanine and tryptophan donate protons to free radicals which results 
in antioxidant activity, whereas aspartic acid, glutamic acid and lysine are good 
metal chelators. In this study, soy protein hydrolysate SPH had a reasonable content 
of Asp (7.9 ± 0.4), Glu (13.9 ± 0.59) and Lys (8.05 ±0.15) which are good metal 
chelators.
4.4.3 Copper-chelating activity using the pyrocatechol and pyridine 
method
4.4.3.1 Copper-chelating activity of soy protein hydrolysate and its fractions
The copper chelating property of the samples was evaluated using the pyridine and 
pyrocatechol method. In this method, when all the chemicals are added, the reaction 
solution shows a deep blue colour. If the sample has copper chelating activity, the 
blue colour of the solution fades due to dissociation of copper. The disappearance of 
blue colour can be detected at 632 nm on a spectrophotometer. Lower absorbance 
proves high chelating activity (Amadou et ah, 2010).
SPH and its fractions showed remarkable copper chelating activity. There was no 
significant difference between the chelating activities of the fractions. The copper 
chelating activity of SPH, 10 kD, 5 kD, and 2 kD fractions was 77.34, 74.56, 75.43, 
and 84.98% respectively (figure. 4.8). Ascorbic acid showed 100.78 % chelating 
activity which was statistically different compared to the fractions. These results
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showed that SPH hydrolysates had copper binding activity, and molecular weight did 
not play any role in their activity.
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Figure 4.8. Copper chelating activities of SPH (10 mg/ml) and its 
fractions with lower molecular weight. Ascorbic acid (0.01%)had 
significantly higher activity compared to the SPH. The values are 
averages of three replicates.
Soy protein hydrolysate and its ultrafiltered fractions showed copper chelating 
activity. Therefore, it was decided to fractionate the SPH and its 2 kD fraction using 
different methods and assess their chelating and antioxidant activity in different 
systems.
4.4.3.2. Copper chelating activity of the peptides purified with affinity 
chromatography
Combinations of chromatographic techniques have been used to purify bioactive 
peptides from the original protein hydrolysate. A different method, namely affinity 
chromatography, can purify peptides based on the formation of a complex between 
the peptide and a ligand. At first, the solution containing the molecule to be purified 
is loaded on the column and incubated with the affinity adsorbent. Then, the unbound
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molecules are washed with an elution buffer and the bound molecules are eluted with 
a second elution buffer (Megias et al., 2007).
Copper chelating activity of SPH was determined using three different methods 
(using ascorbic acid, linoleic acid model system and complex of copper with pyridine 
and pyrocatechol). Since it was proved that SPH has copper chelating activity, 
further purification of SPH with affinity chromatography was performed to purify the 
most potent peptide fractions of SPH.
Three fractions were separated on the affinity column using sodium phosphate buffer 
which contained 1 M NaCl at different pHs (7.4, 4 and 3) and named as P7.4, P4 and 
P3. After 6 runs, the absorbance of the fractions was measured at 215 nm using a 
spectrophotometer. P7.4 showed higher absorbance (1.289) followed by P4 (0.577) 
and P3 (0.192).
Since the elution buffer contained high amounts of salt (including NaCl and free 
copper ions), the eluent was desalted using PD MidiTrap G-10 columns. The copper 
content was measured by atomic absorption assay before and after desalting. Results 
from atomic absorption assay showed that desalting significantly reduced the copper 
content of fractions but it was not completely removed from the sample. The copper 
chelating property was measured with pyridine method.
Figure 4.9 demonstrates the copper chelating activity of fractions purified using 
affinity chromatography before and after desalting. There was no significant 
difference between the activities of the fractions prior to desalting (P >0.05). The 
copper chelating activity decreased after desalting for all the fractions. P7.4 did not 
show any activity (-10.52 %). The activity of P4 before desalting was 6.64 % which 
reduced significantly to 1.58 % after desalting (P <0.05). The activity of P3 was 8.26 
% before desalting which decreased significantly (P <0.05) to 3.99 % after desalting.
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Figure 4.9. Copper chelating activities of SPH fractions (10 mg/ml) purified using 
affinity chromatography after and before desalting measured by pyridine and 
pyrocatechol violet method. The values are averages of three replicates.
Protein hydrolysates contain peptides with variable amino acid sequence and 
structure. Specific peptide structures may chelate of transition metals such as copper 
(Decker et a l, 1992). Peptides containing histidine have high antioxidant activity 
since they can bind metal ions via their imidazole group (Rajapakse et al., 2005). 
The presence of two amino acid residues of histidine at the C terminal might have 
synergistic effects in combination with other antioxidants (Seo et al., 2010). The 
histidine content of SPH fractions in this study was negligible, but they have 
moderate amount of Arg which could be a reason for their copper-chelating 
properties (Megias et al., 2008). Besides, SPH fractions are rich in aspartic acid, 
glutamic acid, glycine and also contain alanine and phenylalanine which chelate 
copper ions (Imer et al., 2008).
Peroxide value was measured in linoleic acid model systems containing linoleic acid 
and the P4 fraction before and after desalting using the FTC method. Before 
desalting, there was no significant difference between the peroxide value of the 
control (CNT) and the P4 fraction during 5 days of storage indicating presence of 
copper in the fraction which caused more oxidation of linoleic acid. The atomic
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absorption assay confirmed that 1.231 mg/L of copper was present in the P4 fraction 
prior to desalting. There was a significant difference between the peroxide values of 
model systems containing BHT and the P4 fraction (figure 4.10).
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Figure 4.10. Peroxide value in the linoleic acid model system using
the P4 (6 mg/ml) fraction obtained by affinity chromatography of 
the linoleic acid model systems were einubated in the dark at 
40 ° C in the dark. The values are averages of three replicates.
The difference between the peroxide value of the control and P4 fraction after 
desalting was significant (P < 0.05) (figure 4.11) indicating presence of antioxidant 
peptides in the P4 fraction and lower copper content. Results from atomie absorption 
assay proved that, after desalting, copper the content of P4 fraction decreased but 
minute quantities of copper were still present (0.319 mg/L).
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Figure 4.11. Antioxidant activity of the desalted P4 fraction (6 mg/ml). The P4 
fraction was dissolved in linoleic acid model system and incubated at 40 ° C in the 
dark for 7 days. The values are averages of three replicates.
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Figure 4.12. Comparison of the peroxide value in the model systems
using the P4 fraction before and after desalting. The values are averages of three
replicates.
The decrease in chelating activity of the peptides purified using affinity 
chromatography might be due to loss of peptides during desalting and the presence of 
minute quantities of copper in the samples which gives low activities. Since the
109
pyrocatechol method uses copper to measure the chelating activity, it was decided to 
check the antioxidant activity of the sample in a copper-free system.
When the peroxide value of the P4 fraction before and after desalting was compared, 
it was clear that, after desalting, the peroxide value increased although the copper- 
content was lower (figure 4.12). It seems that peptide-content decreased after 
desalting due to a loss of peptides during the desalting process. Despite losing 
peptides and having copper in the sample, the P4 fraction showed antioxidant and 
chelating property. The amino acid composition of the P4 fraction was not 
determined. Since the results showed that the P4 fraction had some antioxidant and 
chelating activity towards copper, it was decided to test the P4 fraction against LDL 
oxidation. Moreover, the 2 kD fraction was purified using gel filtration 
chromatography and its antioxidant activity against LDL oxidation was also tested.
4.4.4. Protective effect of the GFF 36 fraction purified from soy protein 
hydrolysate on copper-dependent LDL oxidation
Development of atherosclerosis is dependent on the level of plasma low density 
lipoprotein. Most studies have indicated that the modified, mainly oxidized LDL is 
the agent necessary for the development of atherosclerosis (Steinbrecher ,., 1990; 
Witztum, 1993; Witztum, 1994; Berliner and Heinecke, 1996). Results from in vitro 
and animal studies reveal that there is a relationship between oxidized LDL and 
atherosclerosis, but there is little convincing data from human studies probably due 
to the inability to measure the oxidized LDL directly in the plasma (Jialal and 
Devaraj, 1996). Measurement of autoantibodies to oxidized LDL in the plasma might 
seem like a good method but due to the necessity of production of antigens (oxidized 
LDL) in vitro, there is a large variability between the results produced in different 
laboratories (Jialal and Devaraj, 1996; Yla-Herttuala, 1998).
There are several methods available to measure lipid peroxidation. Determination of 
conjugated dienes is a popular and convenient method, first introduced by Esterbauer 
and has been used to prove in vitro accumulation of conjugated dienes in LDL 
oxidation (Esterbauer et al., 1992; Jialal and Devaraj, 1996). When LDL oxidation is 
studied in vitro, the oxidation phase is divided into 3 phases namely, the lag phase
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which is the period before onset of LDL oxidation, the propagation phase and the 
decomposition phase. This assay is a very suitable way of measuring the effect of 
different oxidizing agents as well as antioxidants on LDL oxidation {Esterbauer et 
al., 1992; Esterbauer et al., 1991; Kleinveld et al., 1992; Stocker et al., 1991). Based 
on the information from ex vivo measurement of conjugated dienes in LDL 
oxidation, the LDL-base line diene conjugation method has been developed to 
monitor in vivo LDL oxidation (Ahotupa et al., 1996; Ahotupa et al., 1998).
In this study, the LDL sample was incubated with copper and the antioxidant of 
choice, and LDL oxidation was continuously routinely checked at 234 nm using a 
UV spectrophotometer. At 234 nm, production of lipid hydroperoxides from 
polyunsaturated fatty acids (PUFAs) with conjugated double bonds was measured 
(Kleinveld et al., 1992). Figure 4.13 shows a typical graph of copper-dependent LDL 
oxidation in the absence of exogenous antioxidants.
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Figure 4.13. A typical graph of copper dependent oxidation of LDL sample, purified 
from the blood of a healthy, normolipidemic male. To solutions of 1 ml LDL in PBS 
in a 1 cm quartz cuvette, quantities of copper sulphate were added so that the final 
concentration of copper reached 1.66 pM. The oxidation was monitored and recorded 
at 234 nm in a UV spectrophotometer equipped with a water bath at 30°C. The 
oxidation resistance was defined as the length of the lag phase. In this experiment, 
the oxidation resistant or the lag phase was 180 min. 1 = lag phase, 2= propagation 
phase, 3 = decomposition phase.
The P4 and GFF 36 fractions were tested for their antioxidant activity against 
copper-dependent LDL oxidation. To measure the resistance of LDL particles to 
oxidation in the presence of the fractions, two different parameters were measured:
1. The ability of the potential antioxidant to extend the lag phase, (time before the 
point at which propagation phase starts, i.e. where the absorbance of the curve 
starts to increase).
2. The absorbance difference (AD), i.e. the ability of a compound to inhibit the 
formation of conjugated dienes compared to a control sample without any 
antioxidant, at a point where the absorbance of the control reaches its highest 
value.
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Figure 4.14 shows different stages of LDL oxidation, when the P4 fraction was used 
as an antioxidant to inhibit LDL oxidation. LDL oxidation was measured by 
determining the production of conjugated dienes at 234 nm.
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Figure 4.14. Comparison between two concentrations (150 and 300 pg/ml) of P4 
sample and the negative control (with no antioxidant) in preventing the formation of 
conjugated dienes during copper-dependent LDL oxidation. The values are averages 
of three replicates
According to figure 4.15, the lag phase for the prevention of the conjugated diened in 
the control and in the P4 fraction at 300 pg/ml was 90 and 130 min, respectively, and 
the P4 fraction (300 pg/ml) could lengthen the lag phase significantly compared to 
the control (P<0.05). The lag phase of LDL oxidation with added P4 at 150 pg/ml 
was 105 min. These results showed that higher concentrations of the P4 fraction (300 
pg/ml) can delay the lag phase significantly.
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Figure 4.15. Comparison between two concentrations of P4 (150 and 300 pg/ml) in 
delaying the lag phase of copper-dependent LDL oxidation. The effect of P4 is 
measured in terms of time (minutes) compared to the control. The values are 
averages of three replicates.
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Figure 4.16. Comparison between antioxidant activities of P4 fractions at 
two concentrations (150 and 300 pg/ml) when the propagation phase reaches 
the maximum point.
The antioxidant activity of the P4 fraction at two concentrations was determined 
using the absorbance difference measurement at the highest point of the propagation
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phase which is the point when all the polyunsaturated fatty aeids (PUFAs) are 
consumed within the LDL particle. The P4 fraction at higher concentration 
(300pg/ml) showed a significantly higher antioxidant activity compared to the lower 
concentration (150 pg/ml) (figure 4.16).
In another experiment, the inhibitive effect of the P4 fraction at 300 pg/ml against 
production of conjugated dienes in the LDL particle was compared with that of 
ascorbic acid and a control sample without antioxidant. Figure 4.15 shows that 
ascorbic acid could significantly (P<0.05) delay the lag time (305 min) compared to 
the control (95 min) and the P4 fraction (140 min). There was also a significant 
difference (P<0.05) between the lag time of control and P4 fraction, indicating the 
beneficial effect of P4 fraction as an antioxidant (figure 4.17).
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Figure 4.17. Comparison between the lag time for oxidation in the presence of 
ascorbic acid, P4 (300 pg/ml) fraction and for the control. The P4 fraction was 
effective in delaying the start of LDL oxidation compared to the control (P<0.05) and 
ascorbic acid (0.1 mg/ml) was better than the P4 fraction.
The absorbance of conjugated dienes at their highest point (t nm) in the control 
sample was compared with that when ascorbic acid and the P4 fraction were present 
and the results were exhibited as antioxidant activity (figure 4.18). Ascorbic acid had
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a significantly higher 102.35% antioxidant activity than the P4 fractions (54.57%) 
(P<0.05).
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Figure 4.18. Comparison between the antioxidant activities of the P4 fraction at 
300 pg/ml and ascorbic acid (0.1 mg/ml) calculated from absorbance difference of 
conjugated dienes at maximum point of the control (tmax) and when the potential 
antioxidants were used. The values are averages of duplicate.
The inhibitory effect of soy protein against LDL oxidation was further tested using 
another fraction of soy protein hydrolysate (GFF 36). The 2 kD fraction was 
fractionated using gel filtration and the most potent fraction (GFF 36) was selected 
based on its antioxidant activity in linoleic acid model system (refer to chapter 2). 
The effect of different concentrations of GFF 36 against copper-dependent LDL 
oxidation was tested.
Figure 4.19 shows the difference between the lag phases of copper-dependent LDL 
oxidation when GFF 36 was used as antioxidant at different concentrations. Histidine 
was used as a known copper chelator and positive control. Except for the lowest 
concentration (lOpg/ml), GFF 36 at all concentrations significantly delayed the lag 
phase compared to the control (P<0.05) and the lag phase value for control, histidine-
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containing tubes and GFF 36 at 10, 30 and 50pg/ml were 160, 1400, 205, 490, and 
690 min respectively. In these experiments, histidine was used at a very low 
concentration, much lower than that present in the plasma (90 pg/ml). Using 
histidine as a copper chelator, it was found that LDL oxidation did not start and no 
propagation phase was seen when histidine was used. Histidine significantly delayed 
the lag phase compared to control and when GFF 36 fractions were present at 
concentrations of 10 and 30 pg/ml (P<0.05).
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Figure 4.19. Comparison between the lag phase of copper-dependent LDL
oxidation using different concentrations of GFF 36 (10,30 and
50pg/ml ) and histidine (His, 25 pM). The results are averages of two replicates.
The antioxidant activity of GFF 36 at 10, 30 and 50 pg/ml was 56.84, 72.93 and 
72.02 % respectively. There was a significant difference between the antioxidant 
activity in the presence of GFF 36 at 10 and 30 pg/ml (P<0.05) but not between the 
activity when present at 30 and 50 pg/ml (figure 4.20).
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Figure 4.20. Antioxidant activity of GFF 36 at three concentrations (10, 30 and 
50pg/ml) against production of conjugated dienes calculated from absorbance 
difference of control and that of potential anti oxidants. The results are averages of 
two replicates.
The results from this study indicated that the P4 fraction which was purified from 
SPH had significant antioxidant activity at a high concentration (300pg/ml) and 
could delay the lag phase and formation of conjugated dienes. Since this fraction had 
been purified using affinity chromatography, it was assumed that it could have 
copper chelating peptides or amino acids. Compared to the P4 fraction, ascorbic acid 
had a significantly higher inhibitory activity towards LDL oxidation. Plasma is rich 
in ascorbic acid (10-50 pM) which protects vitamin E against oxidation. Therefore 
oxidation of LDL does not occur in plasma in the presence of ascorbic acid and other 
water-soluble antioxidants (Esterbauer et al., 1991). Moreover, in the presence of 
ascorbic acid, the LDL particle is not depleted from a-tocopherol and is not oxidized 
since ascorbic acid is oxidized instead (Esterbauer et al., 1991).
GEE 36, purified from 2 kD using gel filtration chromatography, was tested for its 
potential protective effect on copper-dependent LDL oxidation. It was found that 
GFF 36 had an inhibitory effect at a much lower concentration compared to the P4 
fraction. The GFF 36 fraction was tested at 10, 30, and 50 pg/ml and proved to be 
effective in delaying the lag phase and preventing conjugated diene formation. The 
reason behind the better antioxidant activity of GFF 36 versus P4 might be the 
presence of minute quantities of copper in the P4 fraction which could not be
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completely removed using desalting PD-10 Sephadex columns, or due to differences 
in amino acid residue content. Histidine was used as a known copper chelator due to 
its imidazole ring. In conclusion, it can be mentioned that the two fractions could 
delay LDL oxidation by getting oxidized instead of the endogenous antioxidants of 
LDL, saving the endogenous antioxidants and delaying the oxidation process. The 
protective effect of P4 fraction and GFF 36 is due to the presence of antioxidant and 
chelating peptides (Sheih et al. 2010; Elias et al., 2008).
The GFF 36 is a mixture of amino acid residues. The per cent composition of 
tryptophan and phenylalanine in GFF 36 is high, whereas the other amino acids are 
present at a much lower concentration (table 2.7). The per cent compositions of Met, 
His, Arg, Lys, Asp, Glu, Gly, Ala and Ser are 3.5, 1.23 ,2.56 ,2.42 ,2.39 ,2.94 ,3.98 , 
2.23 and 2.1 1 %, respectively. The antioxidant activity of the GFF 36 against copper 
dependent LDL oxidation might be due to the total effect of these amino acids in the 
fraction (Thomas, 1992; Santanam and Parthasarathy, 1995; Murase, et al., 1993; Je 
et al., 2005).
The effectiveness of a variety of natural antioxidants in minimising LDL oxidation 
has been described in the literature. Some of these antioxidants are of nutritive value 
such as protein hydrolysates and peptides and some are not. Phenolic compounds and 
catechins have antioxidant activity against LDL oxidation (Pearson et al., 1997; 
Yang and Koo, 2000). The dipeptide camosine (P-alanine-L-histidine), which is 
found in many tissues, is present in diets containing meat and muscle and can prevent 
LDL oxidation (Bogardus and Boissonneault, 2000). Since camosine is absorbed 
intact into the plasma, it is assumed that it might be an important bioactive 
component (Decker et al., 2001). The peptide Tyr-Ala-Glu-Glu-Arg-Tyr-Pro-De-Leu 
was isolated from cmde egg white hydrolysate and was effective in preventing 
copper-dependent LDL oxidation (Davalos et al., 2004).
NMR spectroscopy confirmed the presence of some amino acids in the gel filtration 
fraction e.g., Phe was detected in good quantities, which was in line with HPLC 
results that showed that Phe was present in high quantities. The rest of the amino 
acids were detected in small quantities or were not detected since NMR does not
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have the sensitivity for detection at very low concentrations. Amino acids, Lys, Gin, 
Ala, Phe and Ser were detected in SPH, 10, 5 and 2 kD fractions. Tyrosine was 
detected in GFF 36 at lower levels,
4.4.5. Determining the isoflavone content of the SPH and related fractions
Isoflavones have metal chelating and antioxidant activity; metal chelation by 
flavonoids has been discussed by many researchers. Interaction of flavonoids with 
metal ions is very important for preventing radical formation and contributing to 
their antioxidant activity (Symonowic and Kolanek, 2012). Dowling et al, showed 
that genistein can chelate copper ions and the genistein-copper chelate is a much 
stronger antioxidant in terms of DPPH radical scavenging activity than free genistein 
alone (Dowling et al., 2010). Shizuo et al reported that both daidzein and daidzin 
have copper-chelating properties with daidzein being a stronger chelator compared to 
daidzin (Toda and Shirataki, 2001). In vivo and in vitro studies have proved that soy 
isoflavones have inhibitory effect on copper-induced LDL oxidation (Yan et al., 
2001). Genistein has been shown to prevent LDL oxidation induced by copper ions 
(Kerry and Abbey, 1998). Since isoflavones were detected in the test samples by 
HPLC (figure 2.13 and table 2.9) (although in low picogram quantities) the 
properties which were discussed in this chapter may not be due to the presence of 
protein hydrolysates and peptides alone. It is possible that peptides and isoflavones 
may have synergistic behaviour with respect to copper chelation, antioxidant and 
inhibition of LDL oxidation.Although HLPC could detect isoflavones in the tested 
samples, NMR failed to show the presence of isoflavones in the samples due to the 
minute quantities of isoflavones. The NMR spectra are shown in figure 3.11.
4.5. Conclusion
Copper chelating and antioxidant activity of several fractions purified from soy 
protein hydrolysate was determined in this study. The crude soy protein hydrolysate 
showed antioxidant activity in the linoleic acid model systems containing copper. 
The 10 kD, 5 kD, and 2 kD fractions purified from soy protein hydrolysate using 
ultra filtration showed copper-chelating properties in a copper-pyridine pyrocatechol
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system. The 2 kD fraction was tested in another system using copper and ascorbic 
acid and it was revealed that it can form complexes with copper and catalyse the 
ascorbic acid oxidation.
The gel filtration fraction, GFF 36, showed inhibitory effects on LDL oxidation. 
Another fraction from soy protein hydrolysate which was purified using affinity 
chromatography, the P4 fraction, showed some copper-chelating properties in the 
copper-pyridine-pyrocatechol system. Besides it was found that at high concentration 
(300 pg/ml), the P4 fraction was able to inhibit copper-dependent LDL oxidation. 
However, the P4 fraction was less effective than the GFF 36 fraction, probably due 
to the presence of minute quantities of copper in the sample even after desalting.
These results show that a combination of peptides with specific amino acid content 
and sequence and probably traces of isoflavones in these fractions are capable of 
stopping or delaying the oxidation reactions in different systems. These peptides 
could be potential chelators (comprising acidic and basic amino acids and/or radical 
scavenger (comprising mainly hydrophobic Tip and Phe). Therefore, further studies 
and experiments are needed to assess the potential in vivo capability of bioactive 
peptides and isoflavones towards prevention of oxidation reactions, specifically, 
LDL oxidation and development of atherosclerosis.
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CHAPTERS
5.0 ACE INHIBITORY PROPERTIES OF SOY PROTEIN 
HYDROLYSATE AND THE RELATED FRACTIONS WITH 
DIFFERENT MOLECULAR WEIGHTS
5.1. Introduction
Despite the high worldwide prevalence of hypertension, there is little social 
awareness about this problem. Hypertension is a public health problem in many 
industrialised and developed countries. The “silent killer” may remain asymptomatic 
and untreated for years and become obvious only when a fatal heart attack occurs. 
Untreated hypertension can lead to other heart problems including peripheral 
vascular disease. Early detection and control of hypertension can prevent these 
degenerative diseases (Mahan, 2004).
Blood pressure regulation is achieved by different mechanisms including the renin 
angiotensin system (RAS), the renin-chymase system (RCS), the kinin-nitric oxide 
system (KNOS), and the neutral endopeptidase system (NEPS) (Mine and Shahidi, 
2005).
The renin angiotensin system has a vital role in controlling blood pressure. In this 
system, renin which is released from kidneys, cleaves angiotensinogen (produced 
primarily by the liver) to the decapeptide angiotensin I (Ang I). The angiotensin 
converting enzyme (ACE), converts Ang I to Ang II (the active form), a potent 
vasoconstrictor. ACE activates Ang I by cleaving the dipeptide His-Leu from the C- 
terminal of angiotensin I. The Ang II binds to the Ang II receptor and causes 
vasoconstriction in the vessel wall. The renin angiotensin system occurs in 
circulatory blood system, brain, lungs, kidneys and aorta. To prevent or treat elevated 
blood pressure, prevention of Ang II production through ACE inhibition could be of 
importance (Qian et al., 2007).
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Synthetic ACE inhibitors such as enalapril, captopril and lisinopril are used to treat 
high blood pressure (Qian et al., 2007). Despite their efficacy, several side effects 
have been reported in patients taking ACE-inhibitors as the treatments. For instance, 
coughing has been reported in patients taking captopril, enalapril, lisinopril and 
perindopril (Yesil et al., 1994). Dizziness is another common side effect (Nileeka 
Balasuriya, 2011). A more severe consequence of ACE inhibitors in some patients 
could be angioedema, a fatal condition and the symptoms are swelling of the lips, 
mouth, tongue and airways, in the absence of any other clinically identifiable cause 
(Gibbs et al., 1999). The mentioned side effects are a good reason for researchers to 
search for safer options for the benefit of hypertensive patients.
Manipulation of the diet is an important non-pharmacological treatment for 
hypertension. There are several studies which report the positive effect of dietary 
protein, such as fish protein, or soy protein on reducing blood pressure. The 
mechanism by which dietary protein reduces blood pressure is vast (Martin, 2003). 
Food is not only a source of basic compounds and energy, but also a source of 
compounds which could have extra benefit.
In recent years, proteins have been evaluated for the presence of biologically active 
components known as bioactive peptides (Parris et al., 2008). The blood pressure 
lowering effect of dietary protein could be related to the presence of bioactive 
peptides (Qian et al., 2007). These active fragments are inactive in the protein 
structure and are activated either by the action of the enzymes in the gut or by food 
processing (Contreras et al., 2009). Bioactive peptides have been purified from 
different protein sources, such as soy protein isolate. Bioactive peptides have 
variable biological effects such as angiotensin I-converting (ACE) enzyme inhibitory 
activities. Some of these peptides exert their biological action by inhibiting the 
angiotensin converting enzyme, which consequently results in vasodilation. ACE- 
inhibitory peptides have been purified from different protein sources including 
gelatin hydrolysates (Oshima et a l, 1979), fish proteins (Yokoyama et al., 1992) and 
milk casein (Maruyama et al., 1987), which have been digested with different types 
of enzymes (Megias et al., 2004). Moreover, since soy protein contains isoflavones.
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the blood pressure lowering effect of isoflavones has been studied by several 
researchers (Wu and Muir, 2008; Guerrero et al., 2012),
The aim of this study was to purify ACE-inhibitory peptides from soy protein isolate 
using digestive enzymes, pepsin and pancreatine. It was hypothesized that hydrolysis 
of the soy protein using pepsin and pancreatine would produce peptides resembling 
those produced naturally in the digestive tract. Eurthermore, the isoflavone contents 
of the soya protein fractions were determined.
5.2. Materials
Soy protein isolate was obtained from Kerry Ingredients, Bristol, UK. Chemicals for 
the experiments were obtained from Eisher Scientific, Loughborough, UK. 
Triethylamine (TEA), amino acid standards, and phenylisothiocyanate (PITC), 
Angiotensin converting enzyme from rabbit lungs, pepsin from porcine mucosa and 
pancreatin, genistein, daidzein, genistin, daidzin and formononetin, formic acid, zinc 
acetate and potassium ferrocyanide were purchased from Sigma-Aldrich, Dorset 
UK.
5.3. Methods
5.3.1. Preparation of soy protein hydrolysate (refer to 2.3.2).
5.3.2. Fractionation of soy protein hydrolysate to 2, 5 and 10 kD fractions 
using ultrafiltration (refer to 2.3.5).
5.3.3. Fractionation of the 2 kD fraction by gel filtration chromatography 
(refer to 2.3.6).
5.3.4. Purification of the gel filtration fraction with high performance 
liquid chromatography (refer to 2.3.7).
5.3.5. Determining a method to evaluate ACE inhibitory activity.
Different methods exist to quantify the ACE inhibitory activity of peptides. In all the 
methods used by researchers, the hydrolysis of a substrate by the enzyme and the 
formation of a product is measured. The extent of interference by the peptides is a 
good measure of their ACE inhibitory activity. One of the most famous methods was 
developed by Cushman and Cheung in which Hippuryl-L-Histydyl-L-Leucine (Hip-
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His-Leu, HHL) reacts with ACE resulting in the formation of two products, Hippuric 
acid (HA) and L-His-L-Leu (HE) that are measured spectrophotometrically at 228 
nm. Several modifications to the original method of Cushman and Cheung exist. For 
instance, release of HA has been measured on a spectrophotometer following its 
reaction with 2, 4, 6-trichloro-s-triazine (TT) in dioxane. In another modification, HL 
was quantified by its reaction with 0-phthaldialdehyde, the fluorescent adduct 
(Guang and Phillips, 2009). Cushman and Ondetti introduced captopril as the best 
ACE inhibitor after evaluating the ACE inhibitory activity of several compounds. 
After captopril, several other ACE inhibitors were introduced such as enalapril, and 
ramipiril which reduce the mortality rate in patients (Erdos, 2006).
Some researchers have used the same principle but with a different detection method. 
For instance, in capillary electrophoresis, the mixture of the enzyme and substrate is 
injected directly on to a capillary electrophoresis system comprising a high voltage 
power and a UV detector which monitors HA and HHL at 228 nm. All of the 
methods used have drawbacks and weak points. For instance, in capillary 
electrophoresis, high salt concentrations broaden the peaks and reduce the detection 
sensitivity. Therefore, it is necessary to work with specific buffers with low salt 
concentrations (Chiang et a\., 2005). The Cushman and Cheung method itself has 
drawbacks including involvement of several steps. Moreover, unhydrolyzed substrate 
(HHL) is extracted with ethyl acetate and its absorbance interferes with that of HA at 
228 nm, which all together results in overestimation of ACE activity (Sarbon, 2011); 
this error can be overcome by HPLC analysis as discussed below.
53.5.1 ACE Inhibitory activity assay
The ACE inhibitory activity of the soy protein hydrolysate and its related peptides 
was determined through detection of the HA peak in a reverse phase HPLC system 
equipped with a UV detector at 228 nm. The assay used to measure ACE inhibitory 
activity of enzymatically hydrolysed soy protein and its purified fractions was a 
modification of the method reported by Kasase (2009).
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The reaction volume was 70 pi. Briefly, 50 pi of 2.17 mM HHL dissolved in sodium 
borate buffer (pH 8.3) was mixed with 10 pi of the sample to be tested in 2 ml 
polyethylene microcentrifuge tubes, vortexed and incubated at 37° C for 10 min. 
Angiotensin converting enzyme (2 mU) was also incubated at 37°C for 10 min. 
Then, the mixture of HHL and the sample was mixed with 10 pi of the ACE, 
vortexed thoroughly and incubated at 37°C for 30 min with continuous agitation, 
after 30 min. To stop the reaction, 85 pi of 1 M HCl was added and vortexed to 
terminate the reaction. Two controls (HHL + enzyme, HHL + buffer) were prepared 
in the same way. Captopril is used as a known ACE inhibitor and a positive control.
5.3.S.2. High performance liquid chromatography
Reverse phase high performance liquid chromatography (RP-HPLC) separates 
molecules based on polarity. In RP-HPLC, the column contains bonded 
octadecylsilyl-coated silica. These columns are known as C-18 columns and are very 
non-polar. Organic solvents, including propanol, methanol or acetonitiile are used, 
with a gradient elution and a gradual increase in concentration to elute the required 
compound. As a result, the molecules which elute first are the most polar ones and 
the molecules eluting last are non-polar. In order to have well-shaped peaks, 
trifluroacetic acid is usually added to the solvents (Guang and Phillips, 2009). HPLC 
analysis was performed on a liquid chromatography system equipped with a pump, 
an autosampler and a UV detector (Dionex, Hemel Hempstead, UK). Samples were 
injected into a C-18 column (3.0 x 150 mm, 5 pm, phenomenex). The HA and HHL 
peaks were detected at 228 nm. The flow rate was 1 ml/min. Two solvents were 
used: (A) 0.05% (v/v) TEA in water and (B) 0.05 % (v/v) TEA in acetonitiile, with a 
5-60% acetonitrile gradient for the first 10 min, hold for 2 min at 60% acetonitirile, 
then returned to 5% acetonitirile for 1 min. This continued with isocratic elution for 4 
min. The ACE inhibitory activity was calculated as follows:
ACE inhibitory activity= [(S-C) /C] x 100
S = peak area of the sample + the enzyme 
C= Peak area of the HHL +enzyme
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The IC50 was determined by regression analysis of ACE inhibition (%) versus 
inhibitor concentration.
5.3.6. Determination of the amino acid composition of ACE inhibitory 
peptides (refer to 2.3.9)
5.3.7. Statistical analysis
Statistical analysis was undertaken by using Microsoft Excel 2010. One way analysis 
of variance (ANOVA) was used.
5.3.8. Determination of isoflavone content of soy protein isolate and 
related fractions: refer to 2.3.11
5.3.9. Determination of isoflavone and amino acid content of the tested 
samples with NMR spectroscopy: refer to 2.3.12
5.4. Results
5.4.1. ACE inhibitory activity of soya protein hydrolysate (SPH) and 
its fractions with different molecular weights
Soy protein isolate was hydrolysed with pepsin and pancreatine to yield a protein 
hydrolysate. The soy protein hydrolysate was fractionated sequentially using 10, 5 
and 2 kD molecular weight cut-off (MWCO) ultrafiltration membrane cartridges. 
The ACE inhibitory activities of soy protein hydrolysate (SPH) and the related 
fractions were measured. The ACE inhibitory activities of the tested fractions varied 
with the molecular weight (MW) distribution and increased by fractionation of soy 
protein hydrolysate (figure 5.1). The 2 kD fraction showed highest ACE inhibitory 
activity. The ACE inhibitory activity of SPH and the 10, 5, and 2 kD fractions were 
17.70, 29.5, 43.66 and 58.87 % respectively. Captopril which is a known synthetic 
ACE inhibitor showed 93.72 % activity. There was a significant difference between 
the activities of SPH with that of the 5 kD and the 2 kD fraction (p < 0.05). Also, the 
difference between the activity of the 10 kD and the 2 kD fractions was significant (p 
< 0.05). These results proved that ultrafiltration is a reliable technique to increase 
ACE inhibitory activity of soy protein hydrolysate. The IC50 value of the 2 kD 
fraction was 1.24 mg/ml.
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The ACE inhibitory activity of pepsin-pancreatin digests of proteins has been 
determined in several studies. Yang et al proved that pepsin-pancreatin digests of 
spinach Rubisco had ACE inhibitory activity (Yang et al., 2003). Lo et al., isolated 
ACE inhibitory bioactive peptides from pepsin-pancreatin digest of soy protein 
isolate with sequential fractionation (Lo and Li-Chan, 2005). Moreover, it has been 
found by several researchers that low molecular weight peptides have better ACE 
inhibitory activity (Zhao et al., 2007; Rho et al., 2009; Kasase, 2009; Sarbon, 2011).
In this study, the 2 kD fraction was rich in hydrophobic amino acids specifically 
leucine and phenylalanine (table 2.6) as well as moderate amounts of alanine, valine 
and isoleucine. The tyrosine and arginine content of the 2 kD fraction was higher 
compared to SPH and the 5 and 10 kD fractions. A small amount, of proline was also 
present in the 2 kD fraction. Hydrophobic amino acids (both aromatic and branched 
chain) such as tyrosine, phenylalanine, tryptophan and proline enhance binding of the 
substrate to the ACE enzyme (FitzGerald and Meisel, 2000; Clare and Swaisgood, 
2000). The presence of valine, lysine, isoleucine and leucine, as well as that of 
arginine, in the penultimate position was linked to significant ACE inhibitory activity 
(Murray and FitzGerald, 2007; Kumada et al., 2007). Thus, these amino acids in the 
2 kD fraction may have contributed to a significantly higher ACE inhibitory activity 
compared with SPH and the 5 and 10 kD fractions.
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Figure 5.1. Comparison between ACE inhibitory activities of different fractions 
of soy protein hydrolysate with different molecular weight at concentration of 2 
mg/ml and captopril (2 mg/ml) as a positive control. Results are averages of three 
replicates.
5.4.2. ACE inhibitory activity of the fractions purified with gel filtration
The 2 kD fraction which showed highest ACE inhibitory activity was 
chromatographed using gel filtration to separate the active peptides based on their 
size. The column was washed with 50 mM sodium phosphate buffer and the fractions 
were collected. The absorbance of the fractions was monitored at 215 nm (figure 
5.2).
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Figure 5.2. Chromatogram of three separate runs of the 2 kD fraction on the 
Sephadex G-25 column detected at 215 nm. Fractions were collected at a flow rate of 
1 ml/min in 5 ml portions.
Twenty six fractions showing absorbance grater than other fractions at 215 nm were 
collected. The ACE inhibitory activity of the 26 fractions was measured and 
compared with captopril (figure 5.3). All the fractions showed a degree of inhibition 
ranging from 6.52% to 84.68%. Among the gel filtration fractions, fraction number 
57 (GFF 57), eluted after 285 min, was a strong ACE inhibitor (84.68%), close to 
that of captopril (CPT) (94.6%). The IC50 value was 0.46 mg/ml.
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Figure 5.3. ACE inhibitory activity of the gel filtration fractions (2 mg/ml). Fraction 
number 57 showed highest ACE inhibitory activity. The results are averages of three 
replicates. Captopril (CPT) was used as a positive control (2 mg/ml).
Use of gel filtration as a tool for further purification yielded fractions with different 
ACE inhibitory activity. Some of the fractions had lower activity compared to the 2- 
kD fraction, but ACE inhibition was higher in some other fractions, particularly GEE 
57. This could be attributed to the molecular size of the peptides and their amino acid 
content and sequence. Not only was the ACE inhibitory activity of the GEE 57 
higher than that of the 2 kD fraction, but also the IC50 value was lower compared to 2 
kD fraction (p<0.05). The GFF 57 has hydrophobic amino acids but to a lesser extent 
compared to 2 kD fraction (tables 2.6 and 5.1).
Consumption of soy protein, soy milk and soy-based diets has been reported to be 
effective in controlling blood pressure (Martin et ah, 2001; Nevala et al., 2000). 
These studies attributed the hypotensive effect of soy diets to presence of 
isoflavones, but the nature of amino acids in a diet might determine the blood 
lowering effect in humans. HPLC analysis of GFF 57 for detecting amino acids 
showed that only the Trp content of the GFF 57 is significantly higher than that of 
the 2 kD fraction. In addition, NMR spectroscopy could detect only Trp in GFF 57
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due to its higher content compared to the other amino acids (Appendix 5). However, 
amino acids Tyr, Lys, Gin, Ala, Phe and Ser were detected in SPH, and in the 10, 5 
and the 2 kD fractions by NMR.
The presence of hydrophobic amino acids is important for ACE inhibitory activity 
since they might act as the binding site with ACE (Chen et al., 2002). The C-terminal 
amino acid can strongly influence the ACE inhibitory activity of a peptide. The 
presence of Trp, Phe, Pro and Tyr at the C-terminus of the peptides resulted in a very 
strong ACE inhibitory activity (Sharma et ah, 2011). Peptides containing branched 
chain amino acids (He, Leu and valine) have been reported to be strong ACE 
inhibitors. Jiun-Rong Chen et al. purified four leucine and one isoleucine ACE 
inhibitory peptides from pepsin digests of soybean. All of the purified peptides had 
branched-chain amino acids in their structure. They also proved the antihypertensive 
effect of these peptides in SHRs. Branched chain amino acids were also present in 
GFF 57. Good ACE inhibitors have tryptophan, tyrosine, proline or phenylalanine at 
the C-terminus and a branched chain aliphatic amino acid at their N-terminus. 
Jenfeng Fan et al. isolated an ACE inhibitory peptide from douchi, a fermented 
soybean product. The identified peptide had a proline at its C-terminus (Yang et al., 
2003) and Histidine at the N-terminus (Fan et al., 2009). Therefore, the higher ACE 
inhibitory activity of the GFF 57 might be due to the presence of peptides with Trp at 
their C-terminus in combination with other hydrophobic and branched chain amino 
acids. Several studies have reported presence of Trp in the structure of identified 
peptides with ACE inhibitory activity (either at the C-terminus or the N-terminus). 
The peptides Pyr-WPRPTPNIPP and Pyr-NWPHPNIPP have been extracted from 
snake venom (Ondetti et al., 1971). In another study, TTMPLW has been purified 
from as 1-Casein by hydrolysis with trypsin (Kohmura et al. 1989). Trp containing 
peptides with high ACE inhibitory activity have also been synthesized (Matsumura et 
a l, 1993).
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5.4.3 Reverse-phase high performance liquid chromatography
In order to evaluate if the ACE inhibitory activity of GFF 57 improved by further 
fractionation, it was purified by high performance liquid chromatography. Figure 5.4 
shows HPLC chromatograms of three separate runs of GFF 57. Two major peaks and 
a small peak were observed on the chromatograph each time. Each point plotted on 
the chrpmatograms was considered as individual fractions (individual tubes were 
taken). Ten tubes were selected in total including tubes number 12, 13, 14, 15, 16, 
17, 23, 24, 25 and 26. After 30 chromatography runs, only three fractions (15, 16, 
and 17) could be collected in the quantities which were required to do the ACE 
inhibitory assay.
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Figure 5.4. Chromatogram of three separate runs of GFF 57 on the 
HPLC column and detected at 215 nm. Fractions were collected 
at a flow rate of 1 ml/min in 2 ml portions.
Figure 5.5 shows that HPLC 16 had highest activity (44.07%). The activity of HPLC 
15 and HPLC 17 were 32.18 and 20.86% respectively. The values were statistically 
different (P<0.05). None of the HPLC fractions showed higher activity compared to 
GFF 57. The results indicated that purification with HPLC did not improve the ACE 
inhibitory activity compared to ultrafiltration and gel filtration. This is in contrast to 
studies reported by Kasase (2009) and Sarbon (2011).
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Figure 5.5. ACE inhibitory activity of HPLC fractions (2 mg/ml). Fraction number 
16 (HPLC 16) showed highest ACE inhibitory activity. The results are averages of 
three replicates.
The following amino acids were not present in the selected fractions: Thr and Ala in 
fraction 15, Glu, His, Thr, Ala, Val, Lys in fraction 16 and Asp, Glu, Thr, Arg, His, 
Val, lie and Lys in fraction 17 (table 5.1). Absence of these amino acids might be the 
reason for lower activity of these HPLC fractions compared to GFF 57. The lowest 
ACE inhibitory activity of HPLC 17 among the three HPLC fractions might be due 
to lack of mentioned amino acids. Casein-derived ACE inhibitory peptides have Pro, 
Lys or Arg at their C-terminus, (FitzGerald and Meisel, 2000). The higher ACE 
inhibitory activity of HPLC 16 might be specifically due to the presence of 
phenylalanine in high quantities, the amino acid which is present in low quantities in 
HPLC 15 and much lower in HPLC 17. Phenylalanine at the C-terminal position of 
peptides has been reported to be a favourable amino acid for ACE inhibition (Zhao et 
al., 2007). Several ACE-inhibitor peptides with Phe at their C-terminal have been 
reported: Phe-Phe-Val-Ara-Pro (Maruyama and Suzuki, 1982), Phe-Gln-Pro 
(Kohama et a i, 1988), Phe-Asn-Phe (Matsui et al., 2002). Besides, Met is present in 
good quantities in HPLC 16. A peptide with sequence of Met-Phe has been isolated 
from wheat germ (Matsufuji et a i, 1994). Therefore, there might be peptides in the
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HPLC 16 with Phe at their C-terminal and Met in their structure which gives their 
higher ACE inhibitory activity.
Amino acid Fraction 15 
(%)
Fraction 16 
(%)
Fraction 17 
(%)
GFF 57 
(%)
Asp 3.58 ± 0.03 0.42 + 0.002 0.00 5.82 + 3.51
Glu 1.48+1.53 0.00 0.00 8.82 + 5.10
h.pro 3.26 + 0.03 0.37 + 0.002 0.63 + 0.01 0.12 + 0.14
Ser 0.60 ± 0.04 0.60 + 0.20 0.70 + 0.12 4.41+2.35
Gly 1.41+0.58 1.27 + 0.71 1.14 + 0.22 5.89+1.94
His 0.95 + 0.03 0.00 0.00 0.27 + 0.31
Arg 0.63 + 0.02 0.48 + 0.002 0.00 4.21 + 2.46
Thr 0.00 0.00 0.00 2.55 +1.57
Ala 0.00 0.00 3.48 + 2.69 4.02 + 2.52
Pro 1.92 + 0.07 0.89 + 0.008 0.79 + 0.01 1.33 + 1.34
Tyr 6.84 + 4.94 3.51+0.63 4.94 + 0.69 2.32+1.64
Val 1.17 + 0.00 0.00 0.00 3.22 + 2.22
Met 14.07 + 9.70 8.87 + 6.51 3.00 + 0.61 0.69 + 0.73
Cys 1.22 + 0.35 1.93 + 0.69 1.34 + 0.18 0.63 + 0.67
lieu 4.91+0.04 1.27 + 0.02 0.00 2.82 + 2.14
Leu 1.93 + 1.28 1.84+1.35 3.39+1.58 6.08 + 3.78
Phe 15.10 ±0.06 29.14 0.79 + 0.05 3.50 + 2.14
Trp 57.67 + 15.09 74.92 84.36 + 4.18 65.59 + 0.06
Lys 0.88 + 0.00 0.00 0.00 6.83 + 3.57
Table 5.1. Amino acid analysis of HPLC fractions. The values are averages of 
four replicates
5.4.4. Determination of isoflavones in soy protein hdyrolysate and its 
related fractions
Since isoflavones are tightly bound to the proteins, the amount of four isoflavones in 
the soy protein fractions was quantified using HPLC. As it is shown in figure 5.8 the 
isoflavone content of the soy protein fractions was calculated in 71.4 mg of the test 
samples. All our isoflavones were detected in test samples except daidzin that was 
under detection limit in the 5 kD fraction. The amount of daidzin, daidzein and
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genistein was not significantly different among SPI, SPH and the 10 kD and 5 kD 
fractions. The concentration of daidzein and genistein and genistin were significantly 
higher (p<0.05) in the 2 kD fraction and GFF 36 compared to SPI, SPH and the 10 
kD and 5 kD fraction (table 2.9).
Several studies report the effect of isoflavones on reducing of blood pressure. For 
instance, genistein can reduce NaCl-sensitive hypertension in spontaneously 
hypertensive rates (SHR) (Cho et al., 2007). In another study, genistein was effective 
in decreasing ACE activity in aortic endothelial cells of rat (Xu et al., 2006). 
Although the hypotensive properties of genistein were demonstrated in in vivo 
studies on hypertensive Wistar rats (Montenegro et al., 2009), ACE inhibitory 
peptides containing isoflavones in soy bean did not show enhanced ACE inhibition 
effect when compared to the same fractions without isoflavones (Nileeka Balasuiiya, 
2011). Wu and Muir (2008) revealed that adding isoflavones to soya flour 
hydrolysate and ACE-inhibitory peptides of soya flour by 31.5% (w/w) did not have 
any effect on ACE inhibitory property of the mentioned samples. Besides, they 
mentioned that hydrolysing the soya flour decreases the quantity of isoflavones by 
40 %. Based on these studies and since the amount of the detected isoflavones are 
very low (picogram levels) in the test samples it is unlikely that peptide-bound 
isolavones in this study had any ACE inhibitory effect.
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According to NMR spectroscopy, no isoflavones were detected in the tested samples 
probably due to the very low concentrations (figure 5.6).
2
Figure 5.6. Analysis of soy protein fractions for presence of isoflavones. From the 
bottom upeards the spectra represent the following fractions: SPH (A), 10 kD (B), 5 
kD (C), 2 kD (D), GFF 36 (E), and the standards daidzein (F), genistein (G), daidzin 
(H), genistin (I), formononetin (J).
5.5. Conclusion
All the peptide fractions purified in this study had ACE inhibitory activity. 
Fractionation of soy protein hydrolysate to smaller peptides by ultrafiltration and gel 
filtration improved the ACE inhibitory activity at each level of fractionation. The gel 
filtration fraction was carried out using RP-HPLC and 10 fractions were obtained. 
The amount of all peptide fractions purified with RP-HPLC was not enough to be 
tested for ACE inhibition. The ACE inhibitory activity of three fractions (15, 16 and 
17) was evaluated; however all three HPLC fractions tested showed less ACE 
inhibitory activity compared to the parent gel filtration fraction (GFF 57). Soybeans 
and their products have been consumed since ancient times, therefore, these are
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considered to be safe. Although the peptide fractions purified in this study were 
weaker than captopril, which is used as a medical treatment, consumption of soya 
bean products particularly the purified GFF 57 fraction could be beneficial in 
maintaining blood pressure at a healthy level.
Four isoflavones were detected in the soy protein fractions in very low picogram 
quantities. Since these isoflavones are bound to the protein hydrolysates and peptide 
fractions, it is very difficult to conclude on their effect on ACE inhibitory activity. 
Isoflavones and peptides might have synergistic effects when it comes to ACE 
inhibiton. In order to clarify this matter, the isoflavones must be detached from the 
fractions and ACE inhibitory activity of isoEavone-free fractions and isoflavone- 
bound fractions must be measured and compared. The effect of genistin in the 
GFF57 fraction may have had an effect and this isoflavone could be tested further in 
the presence and absence of soya peptide fractions. Further in vivo research is 
necessary in order to prove the antihypertensive properties of these purified fractions.
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CHAPTER 6
6.0 ANTICANCER AND ANTIOXIDANT ACTIVITY OF THE 
LOWER MOLECULAR WEIGHT FRACTION OF SOY 
PROTEIN HYDROLYSATE IN CELLS
6.1. Introduction
In cells, reactive oxygen species are removed by different factors such as superoxide 
dismutase, glutathione peroxidase and ascorbic acid. When there is over production 
of reactive oxygen species, the resulting oxidative stress could lead to development 
of various pathophysiological conditions including cancer, arthritis, and 
cardiovascular diseases (Sheih et a l, 2009). Free radicals are capable of oxidizing 
polyunsaturated fatty acids in cell membranes. Lipid peroxidation products affect cell 
growth in a deleterious way. Both free radicals and lipid oxidation products can 
cause cell death (Alghazeer et al., 2008). Oxidative stress resulting from free radicals 
has an important role in development of life-threatening disease including 
atherosclerosis (Chacko and Rajamohan, 2011). The most effective way to prevent 
the onset of oxidative reactions in the body is to remove the excess reactive oxygen 
species (Sheih et ah, 2009). Protein hydrolysates and bioactive peptides have shown 
antioxidant properties in cultured cells (Samaranayaka et ah, 2010).
A gelatin radical-scavenging peptide exhibited antioxidant effects in cultured human 
hepatoma cells (Hep 3B) by increasing the level of superoxide dismutase, glutathione 
peroxidase and catalase (Mendis et ah, 2005). In another study, whey protein 
hydrolysate demonstrated a protective effect on the viability of rat 
pheochromocytoma line 12 (PC 12) cells, previously treated with hydrogen peroxide 
(Zhang et ah, 2012). Furthermore, research has shown that three peptide fractions 
isolated from rapeseed inhibited red blood cell autohemolysis and membrane 
destruction caused by oxidation (Xue et ah, 2009).
The most effective way to study the bioactivity of a compound is by animal studies 
or human clinical trials. Since these methods are not fast and cheap, in vitro cell
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culture studies provide invaluable information regarding bioactivity of a compound. 
Cell culture models can be used to study antioxidant activity or cytotoxicity of a 
compound (Samaranayaka et al., 2010). Human adenocarcinoma colon cancer cell 
mono-layers (caco-2 cells) are a reliable in vitro model system extensively used to 
study the bioactivity of compounds (Samaranayaka et al., 2010). Caco-2 cells can 
differentiate to confluent monolayers when grown on semipermeable filters. 
Structurally and functionally, they are similar to the small intestine epithelium; 
therefore, they are a proper in vitro model to study absorption and metabolism in the 
small intestine (Hilgers et al., 1990).
Many of the cell models currently available to study the bioactivity of different 
components are of cancerous origin (Roig et al., 2010). Therefore, it is important to 
test the components with potential bioactivity on a normal cell line as well. In this 
study, the antioxidant and anticarcinogenic properties of the 2 kD fraction from soy 
protein hydrolysate was studied on caco-2 cell line. In addition, the antioxidant 
properties of the 2 kD fraction were tested on a normal colon cell line (HCEC line).
6.2. M aterials
Soy protein isolate was kindly supplied by Kerry Ingredients, Bristol, UK. 
Dulbecco’s Modified Eagle Media (DMEM), glutamine, penicillin, non-essential 
amino acids (NEAA), trypsin, 3-(4, 5-dimethylthiazole-2-yl)-2, 5- 
diphenyltetrazolioum bromide) and foetal bovine serum (FBS), were purchased from 
Invitrogen (Paisley, UK). (MTT), dimethyl sulfoxide (DMSO), tert-butyl 
hydroperoxide (tBHP), propidium iodide, RNAse, 2’,7’-dichlorofiuorescein 
diacetate (DCFDA) were obtained from Sigma-Aldrich, Dorset UK. Ethanol, 
chloroform, phosphate buffer saline (PBS) were purchased from Fisher Scientific, 
Loughborough, UK.
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6.3. Methods
6.3.1. Enzymatic hydrolysis of soy protein isolate: refer to 2.3.2
6.3.2. Isolation of a 2 kD fraction from soy protein hydrolysate by 
ultrafiltration: refer to 2.3.5
6.3.3. Amino acid analysis of the 2 kD fraction: refer to 2.3.9
6.3.4. Determining cell viability of caco-2 cells
6.3.5. Cell culture
Caco-2 cells were removed from liquid nitrogen (-196 ° C), defrosted in a water bath 
at 37 ° C and centrifuged at 352 x g for 3 min. The cell precipitate was homogenised 
using Dulbecco’s Modified Eagle Media (DMEM) containing 5% glutamine, 5% 
penicillin/streptomycin, 5% non-essential amino acids (NEAA) and 20% heat- 
inactivated foetal bovine serum (FBS). Cells were cultured in the 25 cm^ tissue 
culture flask at 37° C in 5% C02/95% air in an incubator. When the cells were 100% 
confluent, they were detached by adding 5 ml of trypsin to the flask followed by 
incubation for 4 min at 37 °C. In order to inactivate the trypsin, 5 ml of culture 
medium was added to the trypsinized cells. After centrifugation at 1500 rpm for 3 
min, trypsin was removed and cells were subcultured in larger flasks (75 cm^). 
(Karamustafa et a l, 2009).
Human colonal epithelial cell line (HCEC) was grown in high glucose DMEM 
containing 10% FBS. All flasks were pre-coated with a coating media for 15 min. 
The coating solution contained 50 ml of the Dulbecco’s Modified Eagle Media 
(DMEM) with no FBS, 65 pi bovine serum albumin (BSA) (100 mg BSA in 2ml 
H2O), 0.5 ml collagen (250 pi stock + 9.75 ml H20) and 125 pi fibronectin. Cells 
were cultured in the 25 cm^ tissue culture flask at 37° C in 5% C02/95% air in an 
incubator. When the cells were 100% confluent, they were detached by adding 5 ml 
of trypsin to the flask followed by incubation for 2 min at 37 °C. In order to 
inactivate the trypsin, 5 ml of culture medium was added to the trypsinized cells. 
After centrifugation at 1500 rpm for 3 min, trypsin was removed and cells were 
subcultured in larger flasks (75 cm^) (Karamustafa et a l, 2009).
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6.3.6. MTT assay
When the cells were 80-100 % confluent, cells were removed by trypsinization. Cells 
were washed with 5 ml of PBS, counted with a hemocytometer and seeded in a 96- 
well plate at 20 x 10"^  cells/well. After 24 h, cells were washed with PBS and 5 pi of 
MTT dye (10 mg/ml in PBS) was added to each well. Following incubation for 4 h at 
37 ° C, the MTT dye was aspirated, and cells were washed with PBS. Then, 150 pi 
of dimethyl sulfoxide (DMSO) was added to each well and the cells were shaken at 
37 ° C for 10 min. The absorbance was read using a plate reader, at 492 nm 
(Mosmann 1983; Kasase, 2009). The MTT assay is a sensitive colorimetric method 
to determine cell viability and cell proliferation. In live active cells, the yellow MTT 
salt [3-(4, 5-dimethylthiazole-2-yl)-2, 5-diphenyltetrazolioum bromide)] is reduced 
to purple formazan dye by mitochondrial succinate dehydrogenase. The formazan 
dye is soluble in DMSO and its absorbance is measured using a spectrophotometer. 
A high absorbance value reflects greater viability (Karamustafa et al., 2009; Kasase, 
2009).
6.3.7. Cell viability of tbe caco-2 cells treated witb 2 kD fraction
Cells were cultured at 20 x 10"^  cells/well in 96-well plates, according to the 
instructions given in section 6.3.5. A. After 24 h, cells were treated with different 
concentrations of the 2 kD fraction which was dissolved in DMEM medium. After 
removing media from wells, cells were washed with PBS and their viability was 
assessed using the MTT assay.
6.3.8. Oxidizing metbyl linoleate and determination of peroxide value in 
tbe oxidized oil
Methyl linoleate was heated for 24 h at 120 ° C in the oven. Using nitrogen gas, air 
was expelled from the flask. Methyl linoleate was weighed into the flask and 10 ml 
chloroform was added followed by 15 ml acetic acid. The flask was sealed with 
nescofilm and the solutions were mixed thoroughly for 1 min after which it was 
placed in a dark place for 1 min. After the incubation time, starch solution (1 ml) was 
added and the solution was titrated with sodium thiosulfate solution (0.002 N). A
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control sample without methyl linoleate was prepared in the same way. Peroxide 
value was calculated according the following formula:
PV = [(PV titre - PV control) x N x 1000] / weight of methyl linoleate 
PV titre is the volume (ml) of sodium thiosulfate solution used to titrate the coloured 
solution, PV control is the volume (ml) of sodium thiosulfate solution used to titrate 
the control, N is normality of the sodium thiosulfate solution (Alghazeer et al.,
2008).
6.3.9. Cell viability of tbe cells treated witb fresb and 24-b oxidized metbyl 
linoleate
To determine the effect of methyl linoleate and on cells, cells were seeded in 96-well 
plates at 20 x 10"^  per well. After 24 h, they were washed with PBS and treated with 
different concentrations of methyl linoleate and tert-butyl hydroperoxide for 2.5 h. 
Methyl linoleate was dissolved in DMSO first as is not water-soluble. The final 
concentration of DMSO did not exceed 0.1%. Tert-butyl hydroperoxide was directly 
dissolved into the cell culture media. After the incubation time, methyl linoleate was 
removed and cells were washed with PBS and cell viability was determined by the 
MTT assay described in section 6.3.6 (Kasase, 2009).
6.3.10. Effect of metbyl linoleate and tBHP on cells pre-treated witb tbe 2- 
kD fraction.
Cells were seeded in 96-well plates at 20 x 10"^ . After 24 h treatment with the 2 kD 
fraction, the cells were exposed to methyl linoleate for 24 h. The cells were exposed 
to tBHP only for 2.5 h. The viability of cells was determined by MTT assay.
6.3.11. Flow cytometric analysis of cell cycle arrest of caco-2 cells exposed 
to tbe 2 kD fraction
Cell cycle arrest was analysed by measuring the DNA content of individual cells 
using flow cytometry. Caco-2 cells were seeded in 25 cm^ tissue culture flasks at a 
density of one million per flask. After 24 h, when the cells were 50% confluent, cells
143
were treated with the 2 kD fraction at different concentrations using phosphate buffer 
as the control. After 24 h of treatment, cells were washed and detached with trypsin. 
Cells were then centrifuged (352 x g, 3 min) and the media was aspirated. Cells were 
suspended in 200 pi of PBS and mixed well. Then, 1 ml of cold 70% ethanol was 
added to the cells and incubated for 24 h. After the incubation time, cells were 
centrifuged (352 x g, 3 min), the fixation solution was aspirated and 1 ml of PBS was 
added prior to adding 10 pi of RNAse. The cells were then incubated for 30 min at 
37°C. Just before analysing with flow cytometry (BD Facs Canto), 5 pi of propidium 
iodide (1 mg/ml) was added to the cells and the mixture was vortexed. Cell cycle 
arrest was assessed on a flow cytometer (BD Facs Canto) and data were analysed 
with BD FacsDiva software (Denkert et al., 2003).
6.3.12. Measurement of reactive oxygen species in cells
Cells were seeded at a density of 1 million in 25 cm^ tissue culture flasks. After 24 h, 
some cells were treated with different concentrations of the 2 kD fraction and some 
other cells with 10 pi of H2O2 (1%) and incubated at 37 ° C for another 24 h. After 
the incubation time, the media of each flask was collected and cells were washed 
with 5 ml of PBS and trypsinized. Cells were washed after trypsinization with PBS, 
centrifuged and suspended in 0.5 ml of PBS followed by the addition of 5 pi of 
Dichlorofluorescein diacetate (DCFDA). Cells were kept for 30 min at 37 ° C and 
kept in ice until reading on a flow cytometer (BD Facs Canto).
6.3.13. Morphological changes in cells treated with the 2 kD fraction
Caco-2 cells and HCEC line were seeded in 25 cm cell culture flasks. After reaching 
confluence (80%) the monolayer was treated with the 2 kD fraction at different 
concentrations for 24 h following treatment with tBHP (2.5 mM) for 150 min. tBHP 
was then removed and cells were washed with PBS. The morphological changes 
were investigated with a phase contrast microscope (Zeiss Telaval microscopy) fitted 
with a camera (Nikon, Japan).
144
6.3.14. Determination of isoflavone and amino acid content of the 2 kD 
fraction by NMR: refer to 2.3.12
6.4. Results
6.4.1. Antiproliferative effect of the 2 kD fraction on caco-2 cell line
Figure 6.1 shows the cell viability of different cell concentrations. The cell viability 
is defined as the percentage of live cells based on the control. As cell concentration 
increased, the formazan produced was higher and the absorbance of formazan 
increased. Caco-2 cells were treated with the 2 kD fraction to assess its effect on cell 
viability and cell proliferation. The results showed that, except at 0.006 mg/ml, the 2- 
kD fraction significantly decreased cell proliferation compared to control (p < 0.05) 
at tested concentrations. There was no significant decrease between the cell viability 
of the cells treated with the 2 kD fraction at 0.006 mg/ml and non-treated cells 
(control). At 0.002 mg/ml, 85 % of the cells were alive and 15% were dead. There 
was a significant difference between viability of the cells treated with the 2 kD 
fraction at 1 mg/ml and at 3,4 and 5 mg/ml (p<0.05) and also between treatment at 
2 mg/ml and 5 mg/ml (p<0.05). The lowest cell viability was 61% (4 mg/ml) and the 
highest was 101 % (0.006 mg/ml) (figure 6.2). These results clearly demonstrate that 
increasing the concentration reduced cell viability and cell proliferation.
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Figure 6.1. Absorbance of different concentrations of eaco-2 cells after 24 h of 
incubation at 37 ° C measured by MTT assay. The values are averages of atleast six 
replicates.
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Figure 6.2. Effect of the 2 kD fraction (0.002-5 mg/ml) on cell viability of the caeo- 
2 cell line after 24 h of incubation at 37 ° C measured by MTT assay. The values are 
averages of three independent experiments.
Several bioactive components from soya bean have health benefits (Barrett, 2006). 
Bioactive components in soybean include isoflavones, saponins, lunasin, Bowman-
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Birk inhibitor (BBI), soy proteins and peptides (Wang et al., 2008). The most 
abundant component of soybean is protein including 2, 7 and 11 S globulins 
(Nielsen, 1996). After enzymatic digestion in the gastrointestinal tract, these proteins 
release bioactive peptides with different biological properties including anticancer, 
antioxidant, immunomodulatory, antiobesity and antihypertensive properties 
(Panthee et al., 2004; Wang and De Mejia, 2005). Peptides and amino acids have 
shown to have antiproliferative properties (Hsu et al.,2Q l\).
In this study, the 2 kD fraction of soy protein hydrolysate was antiproliferative on 
caco-2 cells. The bioactive peptides released during simulated digestion might be 
responsible for this effect (Wang et ah, 2008). Lunasin, a peptide with 43 amino 
acids, and Bowman-Birk inhibitor, an acid protease inhibitor with 71 amino acids are 
present in soybeans and have been found to have antiproliferative, anticancer and 
chemopreventive properties (Armstrong et al, 2003; Galvez et al., 2001; Kim et al., 
2004). Lunasin and BBI are digested during simulated enzymatic digestion, but they 
are not completely eliminated during hydrolysis and some amounts remain active 
after hydrolysis (Wang et al., 2008). In this study the lunasin and BBI contents of 
soy protein hydrolysate were not checked but they might contain these anticancer 
peptides which are effective against (caco-2 cell line).
An anticancer peptide was purified from hydrolysed soy protein by gel filtration 
chromatography and HPLC and the sequence was found to be X-Met-Leu-Pro-Ser- 
Tyr-Ser-Pro-Tyr (Kim et al., 2000). Two peptides Leu-Pro-His-Val-Leu-the-Pro- 
Glu-Ala-Gly-Ala-Thr and Pro-Thr-Ala-Glu-Gly-Gly-Val-Tyr-Met-Val-Thr purified 
from Tuna dark muscle were found to have antiproliferative properties on human 
breast cancer cell line MCF-7 (Hsu, Li-Chan et al. 2011). As shown in table 2.6, the 
2 kD fraction has moderate quantities of Leu (9.86 % ± 0.38), Glu (9.44% ± 0.28), 
and followed by Ala (6.13% ± 1.24), Tyr (5.41 % ± 0.90) Ser (5.85 % ± 0.31) and 
Pro (3.20 % ± 1.41). The 2 kD fraction might contain peptides with similar amino 
acid sequence or content to the peptides mentioned above giving antiproliferative 
properties on the caco-2 cell line. NMR spectroscopy detected Tyr, Gin, Ala, Lys, 
Phe and Ser. The rest of the amino acids were not detected by NMR.
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6.4.2. Effect of fresh and oxidized methyl linoleate on caco-2 cells
In order to evaluate toxicity of peroxides on caco-2 cells, methyl linoleate was 
oxidized in an oven for 24 h and the amount of peroxide produced was measured 
(figure 6.3). Caco-2 cells were treated with fresh and oxidized methyl linoleate for 24 
h to compare the cytotoxicity and the amount of peroxide produced was measured. 
As illustrated in figure 6.3, the amount of peroxide produced in oxidized oil is 
significantly higher compared to the unheated oil (p<0.05). Figure 6.4 shows the 
viability of cells exposed to fresh and 24-h heated methyl linoleate at different 
concentrations. There was a significant difference between the viability of the cells 
treated with fresh and oxidized methyl linoleate at 0.5, 0.3 and 0.1 mg/ml (p < 0.05), 
but there was no significant difference between the viability of cells treated with 
fresh and oxidized oils at 0.05 and 0.01 mg/ml (p > 0.05). The toxicity of oxidized 
oil was significantly lower at two concentrations (0.05 and 0.01 mg/ml) compared to 
higher concentrations (0.5, 0.3 and 0.1 mg/ml).
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Figure 6.3. Peroxide values in fresh and oxidized methyl linoleate heated at 120 ° C 
in the oven. Peroxide value was measured by iodimetric titration method. The results 
are averages of two replicates.
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Figure 6.4. Effect of heated and unheated methyl linoleate on viability of caco-2 
cells. Cells were treated with different concentrations of methyl linoleate (0.01-0.5 
mg/ml) for 24 h. cell viability was determined by the MTT assay. The results are 
averages of three replicates.
6.4.3. Effect of tBHP on cell viability of Caco-2 cells
Peroxides, including tBHP, are known to have a cytotoxic effect on cells (Kasase,
2009). In this study, caco-2 cells treated with tBHP for 2.5 h confirmed the cytotoxic 
effect of tBHP by a reduction in cell viability. Viability of the cells treated with 2- 
mM tBHP was 96.60 %, which decreased significantly (p < 0.05) to 66.97 % for 4 
mM and 60.33 % for 6 mM tBHP above which there was no significant change 
(figure 6.5).
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Figure 6.5. Effect of tBHP at different concentrations (2-128 Mm) on caco-2 cell 
lines. Cells were incubated with tBHP for 2.5 h and the cell viability was assessed by 
MTT assay. The results are averages of three replicates.
One of the useful model compounds to study oxidative cell injury is tert-butyl 
hydroperoxide (t-BHP) (Lapshina et al., 2005). Reduction in GSH content, DNA 
strand breakages, oxidation of membrane lipids (Aheme and O'Brien, 2000; Baker 
and He, 1991), depletion of cellular ATP, alteration in calcium signalling pathways 
(Choi et al., 1997) and loss of mitochondrial potential (Sestili et al., 1999) are all 
reported proposed mechanisms of t-BHP cytotoxicity and cell death.
Both oxidised methyl linoleate and tBHP were toxic to caco-2 cells and decreased 
their proliferation and viability. Peroxidation of oils and fatty acids results in the 
production of free radicals which leads to production of the hydroperoxides and more 
stable products like hydroxides as well as secondary products like aldehydes 
including malonaldehyde, gluteraldehyde and hydroxynonenal (Alghazeer, 2008; 
Totani et al., 2008).
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6.4.4. Effect of oxidised methyl linoleate on caco-2 cells pre-treated with 
the 2 kD fraction
To determine if the 2 kD fraction has any protective effect against oxidized methyl 
linoleate cytotoxicity, caco-2 cells were treated with three different concentrations of 
the 2 kD fraction for 24 h prior to being exposed to 0.1 mg/ml oxidised methyl 
linoleate for 24 h. Surprisingly, the viability of the cells treated with oxidised methyl 
linoleate and the 2 kD fraction was lower than that of oxidised methyl linoleate on its 
own (figure 6.6). The decrease in cell viability can be due to the combined toxic 
effect of the 2 kD fraction and the oxidised oil. An increase in the 2 kD fraction 
resulted in a decrease in cell viability for both treatments the 2 kD fraction on its own 
and the 2 kD + methyl linoleate).
In a separate experiment, caco-2 cells were pre-treated with 1 mg/ml of the 2 kD 
fraction for 24 h followed by treatment with different concentrations of oxidized 
methyl linoleate. As observed in the previous experiment, the viability of cells 
treated with the 2 kD fraction and oxidised oil was lower than the viability of cells 
treated with the 2 kD fraction or oil alone. The viability of the cells treated with 2 
KD fraction and oil was expected to be lower than that of cells treated with 2 kD 
fraction alone and higher than that of cells treated with oil alone. The viability of the 
cells increased as the 2 kD concentration decreased in all groups, thus showing that 
the 2 kD fraction (1 mg/ml) had no protective effect against the cytoxicity of 
oxidised oil (0.01-0.5 mg/ml) (figure 6.7).
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Figure 6.6. Effect of oxidised methyl linoleate ( ML)(0.1 mg/ml) on viability of 
caco-2 cells. Cells were pretreated with the 2 kD (0.06-1 mg/ml) for 24 h fraction 
prior to treatment with ML . The results are averages of three replicates.
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Figure 6.7. Effect of oxidised methylinoleate (0.01-0.5 mg/ml) on viability of caco-2 
cell pre-treated with the 2 kD fraction (1 mg/ml) for 24 h prior to treatment with ML 
for 24 h. The results are averages of three replicates.
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6.4.5. Effect of tBHP on caco-2 cells pre-treated with the 2 kD fraction
After oxidizing the methyl linoleate, it was stored at -20°C for further use. Oxidation 
reactions continue to happen when methyl linoleate is stored in the freezer. 
Therefore, the peroxide concentration will not be the same each time the oil is used. 
Therefore, it was decided to use tBHP (synthetic peroxide), in which further 
oxidation reactions are not possible during storage. tBHP reduced cell viability 
compared to the control (un-treated cells) (p < 0.05). Similarly to the oxidised methyl 
linoleate results above, the 2 kD fraction did not inhibit the oxidative cell injury 
induced by tBHP (2.5 mM and 4 mM). Cell viability of the cells treated with the 2- 
kD fraction + tBHP was less compared to the cells treated with tBHP alone (figure
6.8 and 6.9). Figure 6.10 shows morphological changes in caco-2 cells treated with 
tBHP and two concentrations of the 2 kD fraction. It is clear that the 2 kD fraction 
did not have any protective effective against the destructive effects of tBHP in the 
caco-2 cell line (figure 6.10-D) since the cells were found to be detached from the 
flask. The 2 kD fraction did not show any toxicity at low concentration (figure 6.10 
C). At 5 mg/ml, the 2 kD fraction were found to be toxic since the ells were detached 
from the flask 9figure (6.10-E).
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Figure 6.8. Effect of tBHP (2.5 mM) on viability of caco-2 cell. Cells were treated 
with the 2 kD fraction (0.002-0.008 mg/ml) prior to treatment with tBHP (2.5 mM) 
for 2.5 h. The values are averages of three replicates.
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Figure 6.9. Cell viability of the caco-2 cell line treated the 2 kD fraction (0.002- 
0.008 mg/ml) for 24 h prior to treatment with tBHP (4 mM) for 2.5 h. The values are 
averages of three replicates.
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The main cell organelles that deal with the metabolism of reactive oxygen species are 
mitochondria (Baker and Baker, 1993). MTT conversion in the mitochondria of 
viable cells by dehydrogenase enzymes is an indirect marker of cell metabolism. 
Following exposure to oxidized methyl linoleate and tBHP, cell viability decreased 
significantly compared to the control, confirming impairment of mitochondrial 
enzyme activities. Pre-incubation with the 2 kD fraction failed to inhibit tBHP- and 
oxidized methyl linoleate cyto-toxicity. This may be due to the fact that the 2 kD 
fraction itself was toxic to caco-2 cells and the combined effect of the 2 kD fraction 
and oxidised oils reduced cell viability even further.
Cytotoxicity of the soy protein hydrolysate and its fractions has been observed in 
other cancer cell lines as well (Wang, 2005) and peptides released during simulated 
gastrointestinal digestion might be responsible for observed cytotoxicity (Wang et 
al, 2008). Besides, low molecular weight peptides generated from the germination of 
soybean seeds followed by hydrolysis with digestive enzymes has been shown to 
have cytotoxic effects on epidermoid cervical carcinoma cell lines. It is proved that 
hydrolysis degrade the alpha-fraction of beta-conglycinin and acid fraction of 
glycinin, which results in generation of anticancer low molecular weight peptides 
(Mora-Escobedo, Robles-Ramirez et a l 2009). Bioactive peptides produced after 
simulative gastrointestinal digestion of soy proteins were cytotoxic on L1210 
leukemia cell lines probably through G2/M cell cycle arrest (Wang, 2008).
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Figure 6.10. Morphological changes in caco-2 cell line treated with tBHP (2.5 mM, 
2.5 h) (A), control (B), 2 kD (0.006 mg/ml) (C) 2 kD (0.006 mg/ml) + tBHP (D), 2 
kD (5 mg/ml) (E), 2 kD (5 mg/ml) + tBHP (F).( Magnification x 200).
156
6.4.6. Effect of tBHP on caco-2 cells pre-treated with ascorbic acid
Caco-2 cells were pre-treated with ascorbic acid (AA) at different concentrations 
followed by treatment with tBHP (4 mM) in order to test if ascorbic acid had any 
protective effect at different concentrations against the cytotoxic effects of tBHP. It 
is evident from figure 6.11 that ascorbic acid at concentrations 0.1, 0.01, 0.001 and 
0.0001 mg/ml is not protective against oxidative injury induced by tBHP in caco-2 
cells. The viability of the cells treated with ascorbic acid and tBHP is not 
significantly different from cells treated with tBHP alone (p >0.05). When caco-2 
cells were treated with ascorbic acid alone, their viability decreased significantly 
(p < 0.05) as its concentration increased. Cytotoxic effects of ascorbic acid in cells 
may be due to ROS production via autoxidation of ascorbic acid (Schmidt et al., 
1993). Ascorbic acid is capable of killing leukaemia cells by oxidative stress 
mechanism, through production of reactive oxygen species and caspase activation 
pathway (Bonilla-Porras et a i, 2011). Ascorbic acid induces apoptosis in SW620 
human colon carcinoma cells (Casciari et al., 2001). In vivo animal studies and cell 
culture studies have shown that ascorbic acid at prooxidant concentrations (3-5 mM) 
has cytotoxic effects on oral neoplastic cells via induction of apoptosis, necrosis, 
DNA fragmentation, free radical formation and generation of hydrogen peroxide 
(Putchala et a l, 2013).
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Figure 6.11. Effect of tBHP (4 mM) on caco-2 cells pre-treated with ascorbic acid 
(AA) at different concentrations (0.0001-0.1 mg/ml). The values are averages of 
three replicates.
6.4.7. Anticancer properties of soy protein hydrolysate (2 kD fraction) on 
caco-2 cells assessed by flow cytometry
An intrinsic feature of cancer cells is a persistent pro-oxidative state. Production of 
reactive oxygen species is higher in cancer cells compared to normal cells, hi other 
words the cancer phenotype depends on high production of reactive oxygen species 
(Gibellini et al., 2010). The anticancer properties of the 2 kD fraction were analysed 
by determining ROS production and cell cycle arrest using a flow cytometer (BD 
Facs Canto).
Figure 6.12 demonstrates that ROS production in the control sample (untreated cells) 
was high (92.58 %) whereas, in cells treated with hydrogen peroxide, ROS 
production was significantly lower compared to the control which means that the 
cells were dead. When cells were treated with the 2 kD fraction, ROS production did 
not significantly decrease at three concentrations (0.4, 1 and 3 mg/ml) compared to 
the control but, compared to H2O2, their ROS production was higher which means 
that, at these concentrations, the 2 KD fraction toxicity is lower than that of H2O2. 
When the 2 kD fraction was used at 5 mg/ml, ROS production was significantly 
lower than the control and hydrogen peroxide which implies that the cells were dead.
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Comparison of cells treated with 5 mg/ml of the 2 kD fraction with those treated with 
H2O2 alone, shows that ROS production was significantly lower (p<0.05) in cells 
treated with the 2 kD fraction, which means that cells died due to the effect of the 2 
kD fraction. It demonstrates that the 2 kD fraction is very toxic at 5 mg/ml.
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Figure 6.12. Decrease in ROS production in Caco-2 cells treated with 
2 kD fraction (0.4-5 mg/ml) and hydrogen peroxide (1%) for 24 h. The 
values are averages of three replicates.
Figure 6.13-B clearly demonstrates that, compared to control (figure 6.13-A) 
addition of the 2 kD fraction shifted the cells to the left. In other words, addition of 
the 2 kD fraction increased the population of dead cells (P3) and decreased the live 
population (P2). The number of live cells in the control was significantly higher 
compared to the cells treated with 5 mg/ml of the 2 kD fraction. Comparison of 
figure 6.13-B and 6.13-C shows the toxic effect of the 2 kD fraction at 5 mg/ml since 
the P2 population was very low in the cells treated with the 2 kD fraction compared 
to the hydrogen peroxide treated cells in figure. 6.13 C.
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Figure 6.13. Measurement of ROS production in caco-2 cells in phosphate buffer 
saline (control) (A), treated with the 2 kD fraction (5 mg/ml) (B) and hydrogen 
peroxide (C) with flow cytometry.
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Figure 6.14. Cell cycle arrests at Gq/G i in Caco-2 cells treated with the 2 kD 
Fraction (0.4, 1 and 5 mg/ml) for 24 h. The values are averages of three replicates.
Cell cycle stages are referred to as Gi, S, G2 and M phase. Gq was used to indicate 
the cells that were not actively included in the cycle but had the potential to be 
divided. Gi and G2 are two gaps in the cell cycle where cells prepare for DNA 
synthesis and mitosis. In Gi, cells are getting prepared for DNA synthesis, at S phase 
cells are synthesizing DNA for mitosis and at G2 cells prepare for mitosis (Schafer, 
1998). The effect of the 2 kD fraction on cell cycle was detected by analysing 
propidium iodide-stained caco-2 cells using the flow cytometer. A significant arrest 
was observed with an increase in the proportion of cells in the Gq/Gi compartment 
and a decrease in the proportion of cells in the S phase and G2/M phase where treated 
with the 2 kD fraction for 24 h (p < 0.05) (figure 6.14).
The advantage of using a flow cytometer is that the intracellular fluorescence of cells 
in the culture media can be measured (not from culture media). The disadvantage is 
that the cells need to be in suspension which requires trypsinization or scraping 
which causes further oxidative stress (Halliwell and Whiteman, 2004). 
Dichlorofluorescin diacetate (DCFDA) is a perfect tool to detect the protective or 
destructive effect of potential antioxidants in cells (Zhang et a i, 2010). It is also a 
probe used to detect cellular peroxides. DCFDA is converted to dichlorofluorescin
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(DCFH) by esterase. Reactive species convert DCFH to DCF which can be measured 
using a flow cytometer (Halliwell and Whiteman, 2004).
Fruits and vegetables contain dietary constituents which are considered to be 
effective against cancer development in the digestive tract (Hudson et al., 2003). In 
addition, peptides generated from protein hydrolysis may also act as valuable 
anticancer agents. The most abundant component in soya bean is protein (~ 40%). 
Peptides from soy protein have been reported to have antiproliferative and tumour 
inhibitory activity (Bhutia and Maiti, 2008). Epidemiological studies have revealed 
the relationship between the consumption of soy products and the lower risk of 
breast, colon and prostate cancer. Soybeans contain various anticancer 
phytochemicals including soy isoflavones, BBI, and saponins that have shown 
anticancer capacity or in vitro chemopreventive effect.
Although soy protein produces bioactive peptides after enzymatic digestion in the 
gastrointestinal system, it is not easy to determine the contribution of every 
individual soy component to a health benefit. After gastrointestinal enzymatic 
digestion (simulated), lunasin (a unique cancer preventive peptide isolated from soy 
bean) (De Mejia et al., 2004) and BBI remain active in soy protein hydrolysate. 
Lunasin concentration is 4-6 mg/g of protein in 144 analyzed genotypes of soy bean. 
Although lunasin can be digested by pancreatin, BBI and Kunitz trypsin inhibitor 
protect lunasin from gastrointestinal digestion in humans and animals (de Lumen, 
2008). Soy protein hydrolysate has been shown to inhibit leukaemia cell lines (Fink 
and Cookson, 2005). The observed anti-proliferative properties in caco-2 cells might 
be due to the presence of a peptide with a specific sequence, BBI and/or lunasin.
6.4.8 Effect of the 2 kD fraction on HCEC line
Normal cell line, Human Colonal Epithelial Cell line (HCEC) were seeded in 96- 
well plates at different concentrations. After 24 h, their viability was determined by 
MTT assay. As expected, by increase in cell concentration, the absorbance of 
formazan increased (figure 6.15).
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Figure 6.15. Absorbance of the HCEC cells after 24 h of incubation at 
37° C measured by MTT assay.
Toxicity of the 2 kD fraction was tested in the HCEC line in the same way as caco-2 
cells. As illustrated in Eigure 6.16, the 2 kD fraction did not show any toxicity.
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Figure 6.16. Effect of the 2 kD fraction (200-0.2 jig/ml) on HCEC (Human 
colonic Epithelial Cell line) viability after 24 h of treatment. The values are 
average of triplicate.
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6.4.9. Cytotoxicity of tBHP and antioxidant activity of the 2 kD fraction in 
HCEC line
Figure 6.17 shows the cytotoxic effect of tBHP on the HCEC cell line. Cells were 
treated with tBHP for 2.5 h and their viability was determined. The viability of the 
cells significantly increased as the concentration of tBHP decreased (p < 0.05). At 70 
mM tBHP, cell viability was 36 %, whereas at 0.01 mM cell viability was 92 %. 
Eigure 6.18 describes morphological changes in the HCEC line treated with tBHP 
and the 2 kD fraction at three concentrations (0.0002, 0.006 and 0.2 mg/ml). Cells 
which have not been treated (control) show an uniform network with no 
morphological changes. The same uniform morphology is obvious in the cells treated 
with the 2 kD fraction at different concentration. Cells which were treated with tBHP 
and 2 kD + tBHP were swollen, detached and dead (figure 6.18). In another 
experiment, HCECs were treated with the 2 kD fraction for 24 h. Then they were 
exposed to tBHP (2.5 mM) for 2.5 h and their viability was determined by MTT 
assay. According to the MTT assay, three concentrations of the 2 kD fractionlO, 8 
and 5 pg/ml significantly (p < 0.05) prevented the cytotoxic effects of tBHP. Cell 
viability of the cells treated with tBHP was 84 %, in contrast to 112, 115 and 96 % in 
cells pretreated with 10, 8 and 5 pg/ml 2 kD fraction, respectively (figure 6.19).
The 2 kD fraction did not show any cytotoxic effect on HCEC cells, unlike caco-2 
cells, probably due to a difference in the metabolism of the peptides of the 2 kD 
fraction. It is possible that the 2 kD fraction, which does not affect HCEC cell 
viability, might be metabolized by HCEC to non-toxic products.
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Figure 6.17. Effect of tBHP on HCEC cells. Cells were treated with tBHP (70-0.01 
mM) for 2.5 h and their viability was determined by MTT assay. The values are 
averages of three replicates.
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Figure 6.18. Morphological changes in HCEC line treated with (A) tBHP, ( B) 
control, (c) 0.0002 mg/ml 2 Kd fraction, (D)0.0002 mg/ ml 2 kD fraction + tBHP, 
(E) 0.006 mg/ ml 2 kD fraction , (F) 0.006 mg/ml 2 kD fraction + tBHP, (G) 0.2 
mg/ml 2 kD fraction , (H) 0.2 mg/ml fraction + tBHP. (Magnification x 200).
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Figure 6.19. Cell viability of HCEC treated with 2.5 mM tBHP (2.5 h) 
pretreated with the 2 kD fraction (0.1- 10 pg/ml) for 24 h. The values are 
averages of three replicates.
6.4.10. Determining isoflavone content of the 2 kD fraction
The 2 kD fraction was analysed for the presence of four isoflavones. The methanol 
extract of the 2 kD fraction was used for determination of the isoflavone content by 
HPLC. According to figure 2.13 and table 2.9, the 2 kD fraction had four types of 
isoflavones and genistin constituted the highest concentration. Since the HPLC 
analysis has shown that the 2 kD fraction contains isoflavones (although in very low 
quantities) the anticancer and antiproliferative effects observed in this study might be 
due to a combining effect of peptides and isoflavoens. NMR spectroscopy did not 
show any isoflavones in the 2 kD fraction probably due to minute quantities of the 
isoflavones which cannot be detected by NMR spectroscopy.
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6.5. Conclusion
In this study, the effect of the 2 kD fraction of hydrolysed soya protein, in the 
presence and absence of peroxides was determined. It was revealed that the 2 kD 
fraction had antiproliferative properties in caco-2 cell lines but not in the HCEC line. 
Cytotoxicity of tBHP was observed in both cell lines and that of oxidized methyl 
linoleate in caco-2 cell line.
The 2 kD fraction did not show any antioxidant activity in the caco-2 cell line but 
was toxic and increased ROS production in caco-2 cells at high concentrations and 
blocked the cell cycle at the G q/G i phase at the tested concentrations. The 2 kD 
fractions showed antioxidant activity in the HCEC line at just two concentrations (5 
and 8 pg/ml) measured by MTT assay.
p-conglycinin and glycinin, which are the main proteins in the 7S and IIS  fractions 
have been shown to be toxic towards leukaemia cell line (Fink and Cookson, 2005). 
Soy protein extracts have been reported to have cytotoxicity against both cancer cell 
lines and normal cell lines. Soy protein extract is a combination of isoflavones and 
other bioactive compounds which could act synergistically on cell lines (Kingsley et 
al., 2011). Isoflavones in soy (genistein and genistin) are cytotoxic in cells due to 
inhibition of protein tyrosine kinase and DNA topoisomerase activities. All cell 
functions which depend on these enzymes can be impaired (Ji et al., 1999). In 
soybeans, isoflavones are associated with proteins (Wang and Murphy, 1996) and it 
is difficult to separate isoflavones from proteins (Coward et al., 1993). The amount 
of protein-bound isoflavones in soybean products can vary (Barnes et al., 1994; 
Franke et al., 1998). Therefore, the cytotoxic effects seen in this study might be a 
synergistic effect of isoflavones and peptides, although the quantity of isoflavones 
was very low.
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C H A PTER  7
7.0 E FFEC T  O F U L TR A FIL T ER E D  2 kD FR A C T IO N  FR O M  
SO Y A  ISO L A TE  ON A N TIO X ID A N T  PR O PER TIES A N D  C ELL  
V IA B ILIT Y  O F E N D O TH E L IA L  C A N C ER  C ELL L IN E  (EA.hy- 
926)
7.1. Introduction
Reactive oxygen species (ROS) can function as signalling molecules at low 
concentrations and are involved in cell activities including cell growth and cell 
adaptation responses. On the other hand, ROS can cause cell injury and cell death at 
high concentrations (Lum and Roebuck, 2001). Chronic or acute oxidative stress can 
cause endothelial dysfunction which has a main role in pathophysiology of vascular 
disease including atherosclerosis. Two critical factors in endothelial dysfunction are 
increased endothelial permeability and increased leukocyte adhesion to the 
endothelium (Lander, 1997; Natarajan, 1995). Several studies support the theory of 
increased endothelial permeability by reactive oxygen species (Barnard and Matalon, 
1992; Holman and Maier, 1990; Shasby et al., 1985). During inflammation and 
infection the endothelium is exposed to high levels of reactive oxygen species. A 
major source of ROS production is polymorphonuclear neutrophils or leukocytes 
which migrate to the site of inflammation and adhere to the endothelium through the 
effect of cytokines (Lum et al., 1994; Nathan, 1987; Tauber et al., 1982).
Nitric oxide is a free radical with vasodilatory properties. It protects the endothelial 
inner layer by preventing platelet aggregation, leukocyte adhesion, and migration of 
smooth muscle cells (de la Rosa et al., 2010). A diminished level of nitric oxide is a 
main factor in endothelial dysfunction; this may be due to a decrease in nitric oxide 
production or nitric oxide inactivation due to high production of reactive oxygen 
species (Russo et al., 2002).
Different purified food components have shown a scavenging effect of free radicals 
in cells. Phenolic acids and flavonoids purified from honey are reported to have 
antioxidant activity in EA.hy 926 cell line by reducing and removing ROS (Beretta et
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a l, 2007). Dehydrocaffeic acid showed antioxidant activity in EA.hy 926 cell line 
(Huang et al., 2004).
Transformed human umbilical vein endothelial cells (EA.hy 926) are a continuous 
cell line that show similar characteristics to normal vascular endothelial cells (Bauer 
et al., 1992). EA.hy 926 is a hybiidoma between human umblical endothelial cells 
(HUVECs) and the permanent human epithelial lung tumour cell line (A549). EA.hy- 
926 cell line displays most features of HUVECs (Edgell et al., 1983; Lai et al., 
2011).
7.2. M aterials
EA.hy 926 cell line was kindly donated by the Department of Microbial and Cellular 
Sciences. Pencillin, foetal bovine serum, trypsin and Griess reaction kit were 
purchased from Invitrogen (Paisley, UK). MTT dye and DMSO were obtained from 
Sigma-Aldrich, Dorset UK. PBS tablets were purchased from Fisher Scientific, 
Loughborough, UK. Soy protein isolate was kindly supplied by Kerry ingredients, 
Bristol, UK.
7.3. M ethods
7.3.1. Enzymatic hydrolysis of soy protein isolate (2.3.2)
7.3.2. Fractionation of 2 KD fraction from soy protein hydrolysate hy 
ultrafiltration (2.3.5)
7.3.3. Determining cell viability of caco-2 cells 
7.3.31. Cell culture
Transformed human umbilical vein endothelial cells (EA.hy 926) were removed 
from liquid nitrogen (-196 ° C), defrosted in a water bath at 37 ° C and centrifuged 
(352 X g, 3 nun). The cell precipitant was homogenised using high glucose 
Dulbecco’s Modified Eagle Media (DMEM) supplemented with 5 ml 
penicillin/streptomycin, and 10% heat-inactivated foetal bovine serum (FBS). Cells 
were cultured in the 25-cm^ tissue culture flask at 37° C in 5% C02/95% air in an
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incubator. When the cells were 100% confluent, they were detached by adding 2 ml 
of trypsin to the flask following by incubation for 2 min at 37 °C. In order to 
inactivate the trypsin, 5 ml of culture medium was added to the trypsinized cells. 
After centrifugation at 1500 rpm for 3 min, trypsin was removed and cells were 
subcultured in larger flasks (75 cm^) (Karamustafa et al., 2009).
13 .3.2. MTT assay
After the cells were 80-100 % confluent, they were removed by trypsinization, 
washed with 5 ml of PBS, counted with a hemocytometer and seeded in a 96-well 
plate at 20 x 104 cells/well. After 24 h of incubation cells were washed with PBS and 
5 pi of MTT dye (10 mg/ml in PBS) was added to each well. Following incubation 
for 4h at 37 ° C, the MTT dye was aspirated, and cells were washed with PBS. Then 
150 pi of dimethyl sulfoxide (DMSO) was added to each well and the cells were 
shaken at 37 ° C for 10 min. The absorbance was read using a plate reader, at 492 nm 
(Twentyman and Luscombe, 1987; Kasase 2009). The MTT assay is a sensitive 
colorimetric method to determine cell viability. In live active cells, the yellow MTT 
salt [3-(4, 5-dimethylthiazole-2-yl)-2, 5-diphenyltetrazolioum bromide) is reduced to 
purple formazan dye crystal by mitochondrial succinate dehydrogenase. The 
formazan dye is soluble in DMSO and its absorbance is measured using a 
spectrophotometer. A higher absorbance indicates a greater viability (Karamustafa et 
al., 2009; Kasase 2009).
7.3.4. Measurement of reactive oxygen species in cells
Cells were seeded at a density of 1 million in 25 cm^ tissue culture flasks. After 24 
h, cells were treated with different concentrations of the 2 kD fraction. After 24 h, 
cells were treated with tBHP (2.5 mM) and incubated at 37 ° C for 150 min. After 
incubation, the media from each flask was collected and cells were washed with 5 ml 
of PBS and trypsinized. Cells were washed after trypsinization with PBS, centrifuged 
and suspended in 0.5 ml of PBS followed by addition of 5 pi of DCFDA. Cells were 
kept for 30 min at 37 ° C and kept in ice until analysed by flow cytometry (BD Facs 
Canto).
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7.3.5. Morphological changes in cells treated with the 2 kD fraction
EA.hy 926 cell line was seeded in 25 cm cell culture flasks. After reaching 
confluence (80%) the monolayer was treated with the 2 kD fraction at different 
concentrations for 24 h following treatment with tBHP (2.5 mM) for 150 min. tBHP 
was then washed away with PBS. The morphological changes was investigated with 
a phase contrast microscope (Zeiss Telaval microscopy) fitted with a camera (Nikon, 
Japan).
7.3.6. Amino acid analysis of the 2 kD fraction refer to 2.3.9
7.3.7. Measurement of nitric oxide production in cells treated with the 2 
kD fraction
EA.hy 926 cell line was treated with the 2 kD fraction at different concentrations 
and NO* production was detected by measuring presence of nitrites in the culture 
medium by the Griess reaction according to the information provided by Sigma in 
the Griess reaction kit. The absorbance of the culture medium was read at 540 nm on 
a microplate reader.
7.3.8. Determination of isoflavone content of the 2 kD fraction by NMR  
spectroscopy: refer to 2.3.12
7.4. R esults
7.4.1. The linear relationship between cell concentration and cell 
absorbance
Cell suspensions of different concentration were prepared and the absorbance of the 
live cells was measured using MTT assay. Figure 7.1 demonstrates that there is a 
linear relationship between the cell concentration and cell absorbance. The highest 
cell concentration with the highest absorbance (50000 cell/ml) was selected for 
further studies.
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FigureT.l. Linear relationship between the cell concentration and the absorbance 
determined by MTT assay.
7.4.2. Effect o f the 2 kD fraction on EAhy 926 cell line
The effect of 2 kD fraction on endothelial cells was tested by MTT assay. As 
illustrated in figure 7.2, the 2 kD fraction induced significant toxic effects at 
concentrations exceeding 0.2 mg/ml on EA.hy 926 cell line. Major inhibition was 
observed at 1-5 mg/ml. The 2 kD fraction exerted toxic effects at lower 
concentrations as well and the viability of the cells were lower compared to the non­
treated cells. At 0.07 mg/ml the viability of the cells was 77 %.
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Figure 7.2. Cytotoxic effect of the 2 kD fraction (0.07-5 mg/ml) on 
EAhy 926 cell lines. The cells were incubated with the 2 kD fraction for 24 h. 
The viability was assessed with MTT assay. The values are averages of three 
replicates.
7.4.3. Effect of tert-butyl hydroperoxide (tBHP) on EA.hy 926 cell line
Endothelial cells were treated with tBHP at different concentrations to determine the 
cytotoxicity of tBHP on cells. Figure 7.3 clearly demonstrates that tBHP was toxic to 
endothelial cells and could induce death. The viability of the cells did not change 
when tBHP was used between the 5-70 mM, whereas the cytotoxicity of tBHP was 
found to be dose-dependent between 0.07-5 mM. As the concentration of tBHP 
decreased, cell viability increased. Reactive oxygen species produced by t-BHP and 
its related oxidative stress results in apoptosis and cell death (Lamari et al., 2007). 
Induction of oxidative stress in cells treated with t-BHP occurs due to several reasons 
including increased generation of hydroperoxide radical (Kasase, 2009) and the 
decrease in intracellular glutathione levels. Treatment of endothelial cells with tBHP 
induces a premature senescence, resembling natural senescence including growth 
arrest and apoptosis (Unterluggauer et al., 2003).
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Figure 7.3. Cytotoxic effect of tBHP (0.07-70 mM) on Eahy 926 cells after 
150 min measured by MTT assay. The values are averages of three replicates.
7.4.4. Determining antioxidant activity of the 2 kD fraction in EA.y 926 
cell line treated v^ith tBHP
The potential of the 2 kD fraction at very low concentrations to prevent oxidative 
damage resulting from treatment with tBHP (2.5mM) was assessed by the MTT 
assay to determine cell viability. Figure 7.4 demonstrates that at concentrations 
exceeding 0.01 mg/ml the viability of the cells treated with both compounds (2 kD + 
tBHP) was much lower compared to the cells treated with 2 kD fraction, tBHP or 
control. At some concentrations (0.01, 0.005, 0.0025, 0.0005 and 0.0001 mg/ml) the 
viability of the cells treated with both compounds seemed to be higher compared to 
tBHP-treated cells, but data analysis proved it not significant (p > 0.05). ROS 
production is high in cancer cell lines (Schumacker, 2006). ROS production was high 
in EA.hy 926 cell line because they are a hybridoma between human umbilical 
endothelial cells (HUVECs) and the permanent human epithelial lung tumour cell 
line (A549). Adding tBHP to the cells might have increased peroxide and reactive 
oxygen species to a level that 2 kD fraction was not potent enough to counter the 
toxic effect of tBHP. Moreover the 2 kD fraction itself was shown to kill the cells 
when the cells were treated with 2 kD fraction only (figure 7.4) and probably could 
not inhibit cell death by tBHP.
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Figure 7.4. Comparison of the cell viability of non-treated cells and the cells 
treated with 2 kD and 2 kD+tBHP. Cells were treated with the 2kD 
fraction ( 0.0001-0.1 mg/ml) for 24 h followed by treatment with 2.5 mM 
tBHP (2.5 h). The values are averages of two replicates.
7.4.5. Morphological changes in EA.hy 926 cell line treated with tBHP 
and 2 kD fraction
The effect of the 2 kD fraction and tBHP on cells was investigated by microscope. 
Figure 7.5 shows the morphological modification in EA.hy 926 treated with tBHP 
(A) where the cells are detached from the flask surface, indicating cell death due to 
the toxic effect of tBHP, compared to the control (B) where cells are attached to the 
surface of the flask. When the cells treated with the 2 kD fraction alone were 
compared to those treated with the 2 kD fraction and tBHP, it was obvious that more 
cells were detached from the surface of the flask when cells were treated with both 
compounds indicating that the 2 kD fraction did not show a protective effect against 
the toxic tBHP at the tested concentrations. When the cells treated with the 2 kD 
fraction compared to the control, it was obvious that some of the cells were detached 
from the flask, therefore, the 2 kD fraction was harmful.
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Figure 7.5. EAhy 926 cell line treated with tBHP (A), control (B), 2 kD fraction 
(0.005 mg/ml) + tBHP (C) 2 kD fraction (0.0025 mg/ml) + tBHP (D), 2 kD (0.0005 
mg/ml) + tBHP (E), 2 kD fraction 0.0005 mg/ml (E), 2 kD fraction 0.005 mg/ml (G) 
and 2 kD fraction 0.0025 mg/ml (H). (Magnification x 200).
7.4.6. Analysis of ROS production in EA.hy 926 treated with tBHP in the 
presence of 2 kD fraction
Eigure 7.6 demonstrates ROS generation in EA.hy 926 cell line detected by flow 
cytometry using DCFDA dye. ROS production in tBHP-treated cells were 
significantly lower (p< 0.05) compared to cells treated with 2 kD fraction, 2 kD 
fraction+tBHP and control. There was no significant difference between ROS 
production in 2 kD fraction and 2 kD fraction + tBHP treatments which might be due 
to the protective effect of the 2 kD fraction on cell in the presence of tBHP. There
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was no significant difference between ROS production in the control cells and cells 
treated with 2 kD fraction alone indicating that 2 kD fraction does not affect ROS 
production in the cells in the absence of tBHP. There was a significant difference in 
ROS production of the cells treated with 2 kD fraetion+tBHP (0.0025 mg/ml) and 
cells treated with the 2 kD fraction alone indicating that 2 kD fraction was not 
protective at this concentration. Figure 7.7 illustrates ROS production in the cells 
treated with tBHP, 2 kD fraction+ tBHP and control. It is well demonstrated that 
tBHP decreased ROS production in cells and the 2 kD fraction was protective at 
tested concentrations except 0.0025 mg/ml.
2KDA ■2KDa+tBHP BtBHP 
90.6
control
ln.85 90.4 94.6 91.95 92.2
0.005 0.0025 0.0005 0.0001
concentration (mg/ml)
87.25
Figure 7.6. Determination of ROS productions in EA.hy 926 cell line. The cells 
were treated with the 2 kD fraction (0.0001-0.005 mg/ml). The values are averages 
of three replicates.
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Figure 7.7. ROS production in EA.hy 926 cell line treated with tBHP (2.5 mM) and 
2 kD fraction (0.0005-0.005 mg/ml) at different concentrations.
7.4.7. Effect of ascorbic acid on EA.hy 926 cell line treated with tBHP
Figure 7.8 illustrates the effect of ascorbic acid at different concentration on EA.hy 
926 cell line. At high concentration (0.1 mg/ml) ascorbic acid was toxic to the cells 
and could not prevent cytotoxic effects of tBHP. Cell viability in the presence of 
ascorbic acid (0.1 mg/ml) and tBHP (2.5 mM) was significantly (p < 0.05) lower 
than the cell viability in the presence of tBHP alone. At lower concentrations of 
ascorbic acid, cell viability was significantly higher compared to the higher 
concentration (p < 0.05). Viability of the cells in the presence of ascorbic acid
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(0.0001 mg/ml) and tBHP was not significantly different from viability of the cells 
treated with tBHP alone (p > 0.05).
I  A scorb ic acid ■  A scorb ic acid+tBHP a  tBHP B con tro l
>  0 .1 5
I
0 .0 0 0 1  0 .0 0 1  0 .0 1  0 .1  2 .5  mM
co n cen tra tio n  (m g/m l)
Figure 7.8. Effect of tBHP (2.5 mM) on viability of EA.hy 926 
cell line in the pretreated with ascorbic acid at different concentrations 
(0.0001- 0.1 mg/ml). The values are averages of three replicates.
7.4.8. Effect of 2 kD fraction on nitric oxide production
Figure 7.9 indicates the effect of 2 kD fraction on the production of nitric oxide in 
EA.hy 926 cell line detected with the Griess reagent. At four concentrations (0.005,
0.0025, 0.001 and 0.0005 mg/ml), the absorbance of the supernatant after treatment 
was significantly (p < 0.05) lower indicating a decrease in nitric oxide formation. 
The 2 kD fraction contains peptides and free amino acids that may influence NO 
formation. For example, the presence of L-lysine has been shown to decrease NO 
production by inhibiting cationic amino acid transporter (CAT) which is responsible 
for transporting L-arginine (the substrate for NO synthase to produce nitric oxide). In 
other words, L-lysine might compete with L-Arg for the transporter. The 2 kD 
fraction purified from soy protein hydrolysate is rich in Lys (9.36 % ± 0.61) (table 
7.1), which may have decreased nitric oxide production.
180
0.016
0 .0 1 4  -
E 0.012 
c
°  0.010 
LH
% 0 .0 0 8  c
-8 0 .0 0 6  
0 .0 0 4  
0.002 
0.000
0 .0 0 0 5  0 .0 0 1  0 .0 0 2 5  0 .0 0 5  0 .0 1  0 .0 2
co n cen tra tio n  (m g/m l)
0 .0 4  con tro l
Figure 7.9. Effect of 2 kD fraction (0.0005-0.04 mg/ml) on nitric oxide production 
and its comparison with non-treated cells (control). Cells were treated with 
the 2 kD fraction for 24 h and nitric oxide production was assessed 
by Griess reaction. The values are averages of three replicates
7.4.9. Determining isoflavone content of the 2 kD fraction
Soy protein isolates which have not been prepared by alcoholic extraction contain 
high amounts of isoflavones. Defatting, dehulling, flaking and alcohol extraction 
removes much of the isoflavone content of soy beans. However, soy protein isolate 
may contain 0.6 to 1.0 mg isoflavones / g of protein (Sacks et al., 2006). Four 
isoflavones , daidzin, daidzein, genistein and genistin were detected in the 2 kD 
fraction by HPLC and their quantity were found to be 9.95, 22.07, 29.35 and 130.22 
pg/ 71.4 mg of the 2 kD fraction respectively (figure 2.13 and table 2.9). Isoflavones 
have been found to have different effects on endothelial cells. For instance, soya 
isoflavone, genistein and daidzein have been shown to reduce nitric oxide generation 
in RAW 264.7 murine macrophage (Ewins et al., 2006). On the other hand, soy 
isoflavones were protective against hydrogen peroxide-induced damage in human 
umbilical vein endothelial cells (ECV304), whereas, in this study the 2 kD fraction 
was not protective in EA.hy 926 cell line at tested concentrations. Since the 
isoflavone content of the 2 kD fraction was too low it is unlikely that isoflavones in 
the 2 kD fraction have any effect on their own. There is a possibility that the
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observed effects in this study are the act synergistic effect of peptides and 
isoflavones.Furthermore, the isoflavone content was determined by NMR 
spectroscopy. Since the isoflavone content was too low, it could not be detected by 
NMR (see appendix). The amino acids which were detected by NMR were as 
follows: Tyr, Gin, Lys, Ala, Phe and Ser, whereas many more detected by HPLC 
(table 2.6).
7.5. C onclusion
In this study the effect of the 2 kD fraction, tBHP on EA.hy 926 cell line was 
determined. The 2 kD fraction was found to be toxic at all tested concentration 
except 0.0001 mg/ml as determined by the MTT assay. As expected, tBHP showed 
cytotoxic effects on cells as shown by the MTT assay. ROS production was 
decreased in cells treated with tBHP. The 2 kD fraction did not show any protective 
effect against cytotoxic effects of tBHP in EA. hy 926 cell line. Flow cytometer 
analysis showed increased ROS production in cells treated with tBHP and 2 kD 
fraction. There were morphological changes in the cells treated with 2 kD fraction. 2 
kD +tBHP and tBHP compared to the control. Nitric oxide production was decreased 
in EA.hy 926 cell line treated with 2 kD fraction at four concentrations. This study 
does not prove any protective effect of the 2 KD fraction in EA.hy 926 cell line. The 
isoflavone content of the 2 kD fraction was determined using HPLC and four 
isoflavones (daidzin, daidzein, genistin and genistein ) were detected in the 2 kD 
fraction in very low quantities. It is concluded that the observed effects of the 2 kD 
fraction might be related to of the peptides and slight effects of isoflavones since 
they cannot be removed completely from the protein samples.
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C H A PT E R  8
8.0 D ISC U SSIO N  A N D  C O N C LU SIO N S
The aim of this study was to investigate the potential positive effects of soy protein 
hydrolysate fractions by evaluating particularly their antioxidant, ACE-inhibitory 
activity and anti-cancer properties. Soy protein isolate was hydrolysed in a simulated 
gastrointestinal procedure by using two digestive enzymes, pepsin and pancreatin. 
The resultant soy protein hydrolysate was fractionated to less than 10, 5, and 2 kD 
fractions using membrane ultrafiltration, gel filtration chromatography and HPLC. 
The antioxidant and ACE inhibitory activity of the soy protein hydrolysate and the 
fractions was determined and compared which are discussed below.
8.1. A ntioxidant activity in  linoleic acid m odel system
The antioxidant activity of the fractions was investigated by determining peroxide 
and TEARS value in the linoleic acid model systems. Using soy protein hydrolysate 
and its fractions in the linoleic acid model systems as potential antioxidants it was 
found that they can reduce the formation of peroxides and TEARS compared to 
control, but fractionation of soy protein hydrolystae to lower molecular weight 
fractions (10, 5, 2 kD ) did not improve their antioxidant activity. All amino acids 
were present in the fractions and no difference was observed between the fractions in 
amino acid composition and content (p > 0.05). Besides, HPLC analysis proved that 
there were minute quantities of isoflavones (picograms/mg) in all fractions which 
may affect the antioxidant activity of the fractions. Therefore, the antioxidant activity 
of the fractions could be the sum of antioxidant activity of the peptides and 
isoflavones.
Further separation techniques were used to purify active peptides from the 2 kD 
fraction. First, it was purified using gel filtration chromatography. Thirty four 
fractions were separated and their antioxidant property was determined in linoleic 
acid model system by calculation of the peroxide and TEARS values. Among 34
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fractions, fraction number 36 (GFF 36) (2.4 mg/ml) had higher peptide content and 
similar peroxide and TEARS values to the system containing BHT (100 ppm) 
(synthetic antioxidant). The peroxide and TEARS value using GFF 36 were 0.40 
Meq. / kg of oil and 0.02 pg/ml, respectively, whereas the same values for the 2 kD 
fraction were 0.45 Meq. / Kg of oil and 0.11 pg/ml. Therefore, the TEARS value for 
the GFF 36 was lower than that of the 2 kD fraction. Higher Phe and genistin content 
of the GFF 36 might be the reason for the difference.
GFF 36 was further purified by HPLC. Among the purified fractions with HPLC, 
two fractions (HPF 19 and HPF 23) had better antioxidant activity compared to other 
HPLC fractions. HPF 19 and HPF 23 had lower peroxide values and HPF 23 had 
lower TEARS value. Peroxide and TEARS values for HPF 19 and HPF 23 were 2.63 
Meq. / kg of oil, 0.42 pg/ml, and 1.57 Meq. / kg of oil and 0.13 pg/ml respectively. 
Thus, the antioxidant activity of the GFF fraction did not improve with further HPLC 
fractionation. Amino acid analysis showed that Arg and Phe content of the HPF 19 
fraction was high whereas the Tip and Phe content of HPF 23 was higher compared 
to other HPLC fractions. Contrary to expectation, the antioxidant activity of the GFF 
36 was not improved by further purification. The reason might lie in the amino acid 
sequence and composition of these fractions. Another explanation is that, 
combination of peptides might have better antioxidant activity rather than purified 
ones. The quantity of HPLC fractions was not enough to determine the isoflavone 
content. Therefore, it cannot be concluded that amino acids and peptides are the only 
reason for the antioxidant activity.
The 7S and IIS protein fractions were purified by a sequential change in pH and 
centrifugation. The fractions were hydrolysed and the 7S fraction hydrolysate was 
fractionated to a 2 kD fraction which showed antioxidant activity. Hydrolysis of the 
7S fraction improved its antioxidant activity significantly. Since these fractions were 
isolated from the soybean, the isoflavone content was assumed to be much higher 
compared to soy protein isolate which had been the starting material in former 
experiments. The gel ectrophoresis pattern of the 7S and IIS fractions showed that 
the 78 and 118 fractions were not separated completely from each other and, in each 
fraction, some fragments of other fraction existed.
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8.2. Mechanism of antioxidant activity
The mechanism of antioxidant activity of the soy protein hydrolysate (SPH) and the 
2 kD fraction was tested in different systems. Both SPH and the 2 kD fraction could 
scavenge superoxide anion, hydroxyl radicals, DPPH radicals and were capable of 
chelating ferrous iron. The soy protein hdyrolysate had hydrogen peroxide 
scavenging activity.
SPH and the 2 kD fraction were good superoxide scavengers and their activity was 
dose-dependent. Moreover, it was indicated that the scavenging activity improved 
significantly with fractionation of SPH to a fraction with lower molecular weight 
when their IC50 values were compared. The 2 kD fraction and SPH are mixture of 
bioactive peptides which can scavenge free radicals. Furthermore, the analysis of the 
SPH and the 2 kD fraction showed that they contain isoflavones daidzin, daidzein, 
genistein and genistin in minute quantities which can have a superoxide dismutase -  
like effect. Therefore, the superoxide scavenging activity of the 2 kD fraction and 
SPH could be due to the presence of peptides and isoflavones.
Hydroxyl radicals can cause severe damage in biomolecules since they have the 
ability to react with any molecule that comes into contact with. Reaction of hydrogen 
peroxide and metal ions produces hydroxyl radical. SPH and the 2 kD fraction had 
scavenging effect on hydroxyl radical. The IC50 value for the SPH and the 2 kD 
fraction were 1.73 and 1.85 mg/ml respectively. The hydroxyl radical scavenging 
activity was dose-dependent for both tested samples and was related to amino acid 
content and sequence of the bioactive peptides.
Hydrogen peroxide is produced in the body from the action of enzymes including 
superoxide dismutase. Hydrogen peroxide is very unstable and can generate hydroxyl 
radicals in the Fenton reaction. Therefore, it is vital to remove excess hydrogen 
peroxide from biological systems. SPH was shown to have hydrogen peroxide 
scavenging activity and the IC50 value was 0.65 mg/ml. The amino acid content and 
structure and probably presence of minute quantities of isoflavones are responsible 
for the observations.
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1, l-diphenyl-2-picryl hydrazyl DPPH is a free radical, widely used for investigating 
antioxidant activities. The scavenging of DPPH by antioxidants occurs via proton 
donation. Both SPH and the 2 kD fraction showed DPPH radical scavenging activity 
and their IC50 values were 15.25 and 4.64 mg/ml, respectively. The 2 kD fraction 
was significantly better DPPH radical scavenger compared to SPH when the IC50 
values compared. SPH and the 2 kD fraction used in this study were protein 
hydrolysates which contain peptides, amino acids and isoflavones responsible for 
radical scavenging activity. Isoflavones daidzein and genistein have DPPH radical 
scavenging activity. Therefore, the DPPH radical scavenging activity of the fractions 
might be the sum of the activity of peptides and isoflavones.
ROS such as hydroxyl radicals can be generated during Fenton reactions from metal 
ions. Therefore, it is very important to remove or stabilize metal ions in biological 
systems. In this study, SPH and the 2 kD fraction showed iron-chelating activity. 
Amino acids such as Glu and Asp can chelate metal ions such as iron. These two 
amino acids were found in high quantities in SPH and the 2 kD fraction. 
Hydrophobic amino acids are stronger metal chelators. Hydrophobic amino acids 
were present in both SPH and the 2 kD fractions. Besides, antioxidant activity of 
flavonoids has been linked to their chelating activity. Since isoflavones were 
detected by HPLC in SPH and the 2 kD fraction, some of the activity might be due to 
the presence of these flavonoids.
8.3. C opper chelating activity o f the soy fractions
Copper chelating properties of SPH and its fractions with different molecular weights 
(10, 5, 2 kD) were evaluated in different systems. In the first method ascorbic acid 
was an indicator of oxidation by copper. The results showed that SPH and the 
fractions bind to copper due to presence of amino acids. Copper forms stable 
complexes with amino acids and its oxidizing ability are modified following this 
complexation. Oxidation of ascorbic acid increases by complexation with histidine 
oligopeptides. The higher the molecular weight of the peptide, the stronger is the 
copper-ligand complex, and therefore, the oxidizing activity is greater. In this study 
SPH, which was a mixture of peptides of high molecular weights, showed strongest
186
oxidizing activity against ascorbic acid after forming a complex with copper. As the 
molecular weight decreased the oxidizing ability of the fractions decreased. These 
experiments proved that SPH has strong chelating property. The presence of acidic 
and basic amino acids in the fractions results in strong complexes with copper ions. 
SPH and the 10 kD fraction were high in Asp and Glu. Glutamic acid is a strong 
metal chelator.
In another experiment, a linoleic acid model system was prepared and SPH and 
copper were added to the tube. Tubes were sealed and placed in the dark at 40 ° C. 
The TEARS value was determined after 7 days of storage. The TEARS value for the 
tube containing SPH was 0.32 pg/ml whereas the tube with copper and no 
antioxidant had the TEARS value of 0.82 pg/ml.
In a separate experiment, the copper chelating activity of SPH and its fractions was 
tested using the pyridine and pyrocatechol method. In this method, pyridine and 
pyrocatechol form a complex with a deep blue colour. Dissociation of this complex 
by a chelator, results in fading of the colour of the reaction mixture. The copper 
chelating activity of SPH, 10 kD, 5 kD, and 2 kD fractions were 77.34, 74.56, 75.43, 
and 84.98%, respectively.
SPH was fractionated using affinity chromatography to three fractions in order to 
purify any His-containing peptides. Since the buffer used for affinity 
chromatography had a high salt concentration, the fractions were desalted using PD- 
10 desalting columns. The copper chelating activity of the fractions was determined 
before and after desalting by the pyridine-pyrocatechol method. All fractions showed 
low chelating activity (6-8%) and their activity decreased after desalting probably 
due to loss of peptides during the desalting process.
It was known that development of atherosclerosis is dependent on the level of plasma 
low density lipoprotein. Most studies have indicated that modified, mainly oxidized, 
LDL is the agent necessary for the development of atherosclerosis. The copper 
chelating activity of P4 fraction (one of the fractions purified using affinity 
chromatography) and GFF 36 (the purified fraction after gel filtration of the 2 kD
187
fraction) were assessed against copper-dependent LDL oxidation by determining the 
production of conjugated dienes. The ability of the fractions to lengthen the lag phase 
of the oxidation and the absorbance difference (the ability of a compound to inhibit 
formation of conjugated dienes compared to a control sample without any 
antioxidant, at a point when the absorbance of the control reaches its highest point) 
were two parameters used to measure the potential chelating activity of the fractions. 
The antioxidant activity was determined according to the absorbance difference 
value and its comparison with control. Results showed that the P4 fraction could 
lengthen the lag phase of LDL oxidation and it was more effective at higher 
concentration (300 pg/ml). The antioxidant activity of the P4 fraction against copper- 
dependent LDL oxidation at 300 pg/ml was 46.68%. The gel filtration fraction 
(GFF36) could lengthen the lag phase of LDL oxidation at much lower 
concentrations (10, 30, 50 pg/ml). The antioxidant activity of the GFF fraction 
against copper-dependent LDL oxidation at 10, 30 and 50 pg/ml was 56.84, 72.93 
and 72.02%. Ascorbic acid (0.1 mg/ml) and histidine (25 pg/ml) were used as 
positive controls. In the presence of ascorbic acid, the lag time was 305 min 
whereas, for histidine, the propagation phase was not observed even after 1400 min. 
The antioxidant activity of the GFF 36 fraction against copper-dependent LDL 
oxidation might be due to the total effect of amino acids in the fraction. The reason 
behind the better antioxidant activity of the GFF 36 fraction versus P4 might be the 
presence of minute quantities of copper in the P4 fraction which could not be 
completely removed using desalting PD-10 Sephadex columns.
Interaction of flavonoids with metal ions is very important in preventing radical 
formation and accounts for their antioxidant activity. In vivo and in vitro studies have 
proved that soy isoflavones have an inhibitory effect on copper-induced LDL 
oxidation. Since isoflavones were detected in the test samples (although in low 
quantities), protein hydrolysates and peptides may not be the only reason for the 
properties which were discussed in this chapter. Peptides and isoflavones may have a 
synergistic effect on copper chelating, antioxidant and inhibitory properties against 
LDL oxidation.
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8.4. ACE inhibitory activity
The ACE inhibitory activity of the soy protein hydrolysate and its related peptidic 
fractions was determined through detection of the Hippuric acid (HA) peak 
produced from the action of angiotensin converting enzyme (ACE) on Hippuryl-L- 
Histydyl-L-Leucine in the presence of soy protein hydrolysate fractions (SPH, 10, 5, 
2 kD, gel filtration fractions and HPLC fractions). The HA peak was detected at 228 
nm on a reverse phase HPLC system equipped with a UV detector. The ACE 
inhibitory activity of SPH, 10, 5, and the 2 kD fractions were 15, 25, 36 and 56 % 
respectively. Captopril, which is a known synthetic ACE inhibitor, showed 92 % 
activity. According to other studies, the ACE prefers hydrophobic amino acids. The 2 
kD fraction was rich in leucine and phenylalanine, and had good amounts of alanine, 
valine and isoleucine. The tyrosine and arginine content of the 2 kD fraction was 
higher compared to SPH, 10 and the 5 kD fractions. The 2 kD fraction had a low 
amount of proline as well. It seems that the presence of a combination of these amino 
acids in the 2 kD fraction contributed to its significant higher ACE inhibitory 
activity. Among the fractions purified by gel filtration, GFF 57 showed higher ACE 
inhibitory activity (84.68%). GFF fraction was also rich in hydrophobic amino acids 
and its Trp content was significantly higher compared to the 2 kD fraction. The ACE 
inhibitory activity of the GFF 57 fraction was significantly better compared to the 2 
kD fraction. Among the HPLC fractions, HPF 15, HPF 16 and HPF 17 were 
collected in sufficient quantities required to do the ACE inhibitory activity test. The 
ACE inhibitory activity of the HHPF 15, 16 and 17 were 32.18, 44.07 and 20.86 %, 
respectively. The higher ACE inhibitory activity of HPLC 16 might be specifically 
due to high phenylalanine content, which is present in low quantities in HPLC 15 and 
much lower in HPLC 17. The C-terminus phenylalanine position is the favourable 
amino acid for ACE inhibition. The ACE inhibition could not be improved by 
fractionation using HPLC.
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8.5. Effect of the 2 kD fraction on cells
8.5.1. Caco-2 cell line and HCEC line
The effect of the 2 kD fraction was evaluated in different cell lines. The 2 kD 
fraction had antiproliferative properties in the caco-2 cell line which might be due to 
the presence of isoflavones, specific bioactive peptides such as lunasin or peptides 
released form Bowman-Birk Inhibitor (BBI) which are reported to have 
antiproliferative and chemo-preventive properties. Flow cytometry analysis of the 
cells treated with the 2 kD fraction and hydrogen peroxide, and their comparison 
with non-treated cells, showed that at low concentration (0.4 and 1 mg), ROS 
production did not change in cells treated with the 2 kD fraction compared to un­
treated cells, whereas, at higher concentration (5 mg/ml), production of reactive 
oxygen species (ROS) was decreased compared to the cells treated with hydrogen 
peroxide and un-treated cells indicating that the cells were dead. Besides, flow 
cytometry analysis of cell cycle in the cells treated with the 2 kD fraction, hydrogen 
peroxide and non-treated cells showed that cell cycle was blocked in Gq/G i phase in 
the cells treated with the 2 kD fraction at high concentrations.
To evaluate the antioxidant activity of the 2 kD fraction in caco-2 cell line, cells were 
pre-treated with oxidized methyl linoleate and tert-butyl hydroperoxide (tBHP) in 
separate experiments and then cells were treated with the 2 kD fraction to assess its 
protective effect against both peroxide sources. The results showed that the 2 kD 
fraction was not protective against damage from peroxide in caco-2 cells. The 2 kD 
fraction was not toxic and antiproliferative in HCEC line, as a normal cell line. The 
effect of tBHP was tested on HCEC line and its toxicity confirmed. The 2 kD 
fraction (10, 5 and 8 pg/ml) indicated antioxidant activity in tBHP-treated cells.
8.5.2. EA.hy 926 cell line
The 2 kD fraction was found to be antiproliferative, specifically at high 
concentrations (1-5 mg/ml). Besides, tBHp was toxic to cells and, as the 
concentration increased the cell viability decreased. When the tBHP-treated cells 
were treated with the 2 kD fraction to assess its antioxidant activity, no positive
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effect were observed with MTT assay. Flow cytometry analysis of the cells for ROS 
production showed that there was no significant difference between ROS production 
in 2 kD fraction and 2 kD fraction + tBHP treatments, which might be due to ability 
of 2 kD fraction to overcome the toxicity of tBHP. Moreover, it was shown that the 2 
kD fraction decreased nitric oxide production in cells which could be due to the 
presence of L-Lys in the 2 kD fraction. L-lysine has been shown to decrease NO 
production by inhibiting cationic amino acid transporter (CAT) which is responsible 
for transporting L-arginine (the substrate for NO synthase to produce nitric oxide). In 
other words, L-lysine might compete with L-Arg for the transporter. The 2 kD 
fraction purified from soy protein hydrolysate is rich in Lys (9.36 % ± 0.61), which 
may have decreased nitric oxide production. The isoflavones have been proved to 
decrease production of nitric oxide in cells, but, in this study, the amount of 
isoflavones detected was too low to conclude that the effects were due only to their 
presence. The effects observed in this study might be due to the synergistic effects of 
the 2 kD fraction and isoflavones.
8.6. Main conclusions
Enzymatic hydrolysis and antioxidant activity in linoleic acid model systems
• Enzymatic digestion of commercial soy protein isolate generated a 
hydrolysate which showed antioxidant activity by preventing the production 
of peroxides and TBARS in a linoleic acid model system.
• Soy protein hydrolysate was further fractionated to 10, 5, and 2 kD fractions 
that also demonstrated high antioxidant activity in a linoleic acid model 
system system. The 2 kD fraction was further purified by gel filtration 
chromatography and a fraction (GFF 36) with the highest antioxidant activity, 
similar to the positive control BHT, was purified.
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• Further purification of GFF 36 using RP-HPLC decreased the antioxidant 
activity. Moreover 7S and US fractions and the 7S hydrolysate purified from 
soy beans in the laboratory showed antioxidant activity which is due to the 
presence of peptides and probably isoflavones which were present at 
picogram levels.
Mechanism of antioxidant activity
• The mechanism of antioxidant activity was determined and showed that both 
SPH and the 2 kD fraction showed superoxide, hydroxyl radical and DPPH 
scavenging activity; hydrogen donating amino acids and peptides are 
responsible for free radical scavenging activity. SPH showed hydrogen 
peroxide scavenging activity. Both fractions showed iron-chelating activity.
• Copper-chelating properties of SPH, and the 10, 5 and 2 kD fractions were 
determined in different systems and demonstrated copper chelating 
properties. The gel filtration fraction (GFF 36) prevented copper-dependent 
LDL oxidation. The P4 fraction purified from SPH with affinity 
chromatography showed antioxidant activity (54.57%) against LDL oxidation 
but at a higher concentration ( 300 pg/ml) compared to GFF 36 (56.84%) (10 
pg/ml).
ACE inhibitory activity
• The ACE inhibitory activity of SPH, and the 10, 5, and 2 kD fractions were 
17.70, 29.5, 43.66 and 58.87 % respectively. Among three fractions 
fractionated by HPLC, HP16 had highest activities (44.07%). The activity of 
HP 15 and HP 17 were 32.18 and 20.86%. GFF 57 exhibited the highest 
ACE-inhibitory activity (84.68%). Captopril which is a known synthetic ACE 
inhibitor drug showed 93.72 % activity.
Cell studies on antioxidant and anticancer activity
• The 2 kD fraction showed anticancer properties in caco-2 cell line which is 
due to the presence of peptides with different amino acids content and
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sequence, and probably isoflavone content (although isoflavones were 
detected at picogram levels). Moreover, the peptide lunasin might be present 
in the 2 kD fraction since it resists enzymatic digestion.
The 2 KD fraction showed antioxidant activity against the cytotoxic effects of 
the oxidant tBHP in normal HCEC line at 10, 5 and 8 pg/ml and the viability 
of the cells at these two concentrations was 112, 96 and 115 %, respectively.
The 2 kD fraction did not show any protection against cytotoxic effects of 
tBHP in cancer EA.hy 926 cell line. Flow cytometry analysis showed 
increased ROS production in cells treated with tBHP and the 2 kD fraction.
Nitric oxide production in cells treated with the 2 kD fraction was decreased. 
Observed effects of the 2 kD fraction might be related to the synergistic effect 
of the peptides and isoflavones since isoflavones, were detected in picogram 
quantities in the 2 kD fraction.
Conclusion
Peptides produced from soy protein isolate simulting gastrointestinal enzymatic 
digestion and possibly the minute quantities of polyphenols present in the fractions 
showed antioxidant, antihypertensive and anticancer properties in vitro. These soya 
fractions could be developed further as neutraceuticals and therapeutic agents.
Further work
1. To study anticancer properties of the GFF 36 in caco-2 cell line and other 
cancer cells (liver and breast) and its mechanism of action.
2. To investigate the ACE-inhibitory properties of the GFF 57 in spontaneously 
hypertensive rats and the mechanism of action.
3. To study antioxidant activity of the GFF 36 against LDL oxidation in 
animals.
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APPENDICES
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Appendix 1. Analysis of soy protein fractions for presence of isoflavones. From the 
bottom upwards the spectra represent the following: SPH (A), 10 kD (B), 5 kD(C 
),2kD (D), GFF36(E), daidzein(F), genistein(G), daidzin(H), genistin(I
), formononetin (J).
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Appendix 2. Analysis of soy protein fractions for presence of amino acids. From the 
bottom upwards the spectra represent the following: SPH (A ), 10 kD (B), 5 kD (C), 
2 kD (D), GFF 36 ( E) tyrosine (F), valine (G), lysine (H), leucine (I), glutamine (J), 
cysteine (K), hydroxy proline (L).
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Appendix 3. Analysis of soy protein fractions for presence of amino acids. From the 
bottom upwards the spectra represent the following: SPH (A), 10 Kd(B), 5 Kd(C), 2 
kD(D), GFF 36(E), tryptophan (F), asparagine (G), arginine(H), proline(I), serine(J), 
threonine(K).
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Appendix 4. Analysis of soy protein fractions for presence of amino acids. From the 
bottom upwards the spectra represent the following: SPH(A), 10 kD(B), 5 kD(C), 2 
kD(D), GFF 36(E), isoleucine(F), methioninem(G), H-proline(H), aspartic acid(I).
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Appendix 5. Analysis of soy protein fractions for presence of amino acids. From the 
bottom upwards the spectra represent the following: GFF 57 (A), amino acid 
standards tyrosine(B), valine(C), lysine(D), leucine(E), glutamine(F), cysteine(G), 
hydroxy proline(H), alanine(I), phenylalanine(J), glutamic acid(K), asparagine(L), 
cysteine(M), glycine(N), tryptophan(O), asparagine(P), arginine(Q), proline(R), 
serine (S), threonine(T), isoleucine(U), methionen(V), hydroxy proline(W), aspartic 
acid.
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